Compound ID,Uniprot ID,Compound Name,Standard inchi key,Max Phase,Target Pref Name,Gene Names,Target Class,Wild type or mutant,Mutation information,PubMed ID,End Point Standard Type,End Point Standard Relation,End Point Standard Value,End Point Standard Units,Endpoint Mode of Action,Assay Format,Assay Type,Assay Sub Type,Inhibitor Type,Detection Technology,Compound concentration value,Compound concentration value units,Substrate type,Substrate Type Standard Relation,Substrate Type Standard Value,Substrate Type Standard Units,Assay cell line,Assay Description,Activity Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation Comments,Assay ID,DTC Tid,DTC Activity ID,DTC Molregno,Record ID,DTC Document ID
CHEMBL100100,P22894,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1453248,DTCC00264536,982314,3373
CHEMBL100100,P22894,,ZRDGYJAMDSHROJ-RPBOFIJWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258618,DTCC00264536,972938,24803
CHEMBL100273,P22894,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,4000,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1478678,DTCC00264430,885728,3373
CHEMBL100273,P22894,,CVJMAXDBGIRLPL-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3981.07,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258622,DTCC00264430,876665,24803
CHEMBL100678,P22894,"INDAN-2,2-DICARBOXYLIC ACID BENZYLAMIDE HYDROXYAMIDE",XIJAGSWGJPJOMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,1500,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1693517,DTCC01742030,356906,14753
CHEMBL102373,P22894,,QCOAXSJLEXJOSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,1100,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1708849,DTCC00271794,1164117,14753
CHEMBL102873,P22894,,AZWBRVJQJIHTAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,9600,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1697210,DTCC00271948,453198,14753
CHEMBL103129,P22894,,NIDVHWYOCOCSER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,45000,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1703547,DTCC00271772,193822,14753
CHEMBL103200,P22894,,NZVNWWNLDSMXQI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,41000,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1712918,DTCC00271856,258427,14753
CHEMBL103480,P22894,,TYYXEMCROUHDEJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,380,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1692291,DTCC00271774,1839147,14753
CHEMBL103722,P22894,,LRKAQINIHXCVHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,41000,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1698342,DTCC00271821,1424421,14753
CHEMBL10454,P22894,,UXURFMZZZWZYFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1321639,DTCC00138391,578578,16328
CHEMBL104870,P22894,,BZDNZMAIXJGVGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,8100,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1688518,DTCC00272252,1935424,14753
CHEMBL105352,P22894,,YTRVZNHAMCBMCT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,300,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1712919,DTCC00271927,97090,14753
CHEMBL1082317,P22894,,QOWJHUFMPPFELP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529685,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634122,DTCT0024061,3346214,DTCC00647799,780673,35540
CHEMBL1082318,P22894,,HWZVYNMATDDRGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529685,IC50,=,9400,NM,,,,,,,,,,,,,,Inhibition of MMP8,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634122,DTCT0024061,3346215,DTCC00647800,2038151,35540
CHEMBL1082381,P22894,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,1.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14742622,DTCC00031197,2108114,69259
CHEMBL1082381,P22894,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529684,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634113,DTCT0024061,3346123,DTCC00031197,792376,35532
CHEMBL1082381,P22894,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005864,DTCC00031197,781480,45214
CHEMBL1082381,P22894,SC-276,WXNWNNKHEJMQOM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936639,DTCC00031197,799452,44425
CHEMBL1084238,P22894,,UFKFLDDRYBWLPH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529684,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634113,DTCT0024061,3346120,DTCC00647546,80529,35532
CHEMBL1084509,P22894,,VCKIKUWRRCAZBI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529684,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634113,DTCT0024061,3346121,DTCC00647547,1601315,35532
CHEMBL1084510,P22894,,HMVRHAWMVBUIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529684,IC50,=,59.2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective alpha-sulfone hydroxamates.",Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, Boehm TL, Carroll JN, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Rico JG, Stehle NW, Swearingen C, Becker DP",,634113,DTCT0024061,3346122,DTCC00647548,1375495,35532
CHEMBL108494,P22894,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,>,15000,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1704492,DTCC00282283,1196752,16424
CHEMBL108494,P22894,,MBSMJAHZPVXQCK-HIGJEIRPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,>,15000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457386,DTCC00282283,1210750,32556
CHEMBL1085257,P22894,,WVNVANHURONWTG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20529685,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,MMP-13 selective isonipecotamide alpha-sulfone hydroxamates.,Bioorg. Med. Chem. Lett.,2010,20,12,"Kolodziej SA, Hockerman SL, DeCrescenzo GA, McDonald JJ, Mischke DA, Munie GE, Fletcher TR, Stehle N, Swearingen C, Becker DP",,634122,DTCT0024061,3346224,DTCC00647802,262531,35540
CHEMBL109214,P22894,,PDKBAEDNMKVROV-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1718165,DTCC00282259,422410,16424
CHEMBL109353,P22894,,JXHAGXRDZALSLG-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,150,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1716615,DTCC00282683,357026,16424
CHEMBL109579,P22894,,LEDMBBYIVRLZAS-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,190,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1713951,DTCC00282314,258563,16424
CHEMBL109603,P22894,,JOKZNFFZUNYVMR-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,780,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1693271,DTCC00281761,2034295,16424
CHEMBL109655,P22894,,PDKBAEDNMKVROV-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,300,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1689448,DTCC00281762,2066041,16424
CHEMBL109770,P22894,,MYFWCGILTGDUAM-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,260,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1685580,DTCC00282704,1553370,16424
CHEMBL109806,P22894,,JJTWETADXAELLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,480,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1709909,DTCC00281760,1871211,16424
CHEMBL109861,P22894,,BTMGFNYLYGWAKT-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,60,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1703223,DTCC00282336,1003340,16424
CHEMBL110750,P22894,,WOIMZSMDPIJLFO-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,110,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1683057,DTCC00281785,518969,16424
CHEMBL110970,P22894,,WOIMZSMDPIJLFO-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,210,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1713943,DTCC00281754,1035753,16424
CHEMBL111179,P22894,,GINBTQGVSPUJLE-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,200,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1715090,DTCC00282652,389663,16424
CHEMBL111257,P22894,,JXHAGXRDZALSLG-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,730,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1696858,DTCC00282583,809139,16424
CHEMBL111450,P22894,,IIABJCHWKFZJBK-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,230,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1701965,DTCC00282684,291838,16424
CHEMBL111678,P22894,,WJWOJAKOSRCFKB-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1688176,DTCC00282653,809140,16424
CHEMBL111856,P22894,,ZBRHTUMWSDPCMI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15177439,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,105211,DTCT0024061,1496216,DTCC00287961,76527,6475
CHEMBL11306,P22894,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,507673,DTCC00139917,356636,13104
CHEMBL11306,P22894,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,=,0.046,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438452,DTCC00139917,359575,30977
CHEMBL11306,P22894,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,832560,DTCC00139917,368874,1497
CHEMBL11306,P22894,,MOPRTFSMCQNUCT-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,2,NM,,,,,,,,,,,,,,Inhibitory concentration of compound against human fibroblast stromelysin (HFS) was determined,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102110,DTCT0024061,585746,DTCC00139917,368856,1496
CHEMBL113827,P22894,,WKIMWNKNDQXNCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,3100,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1555154,DTCC00290739,30930,15030
CHEMBL113827,P22894,,WKIMWNKNDQXNCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,3090.3,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258682,DTCC00290739,8958,24803
CHEMBL114357,P22894,,ZFCJDZRVAOLEGY-ZTNFWEORSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,1192,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1443596,DTCC00287866,433860,16438
CHEMBL114804,P22894,,VUKNURXXGDIFMO-ZTNFWEORSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,9.2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1413776,DTCC00287203,917654,16438
CHEMBL114878,P22894,,LCWWOMJWYGNKJF-IARZGTGTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585440,KI,=,272,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105199,DTCT0024061,1322676,DTCC00286952,724080,16439
CHEMBL115082,P22894,,PUKQZUALFZRFQE-KKVAFCGZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,40000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1427164,DTCC00287445,1818512,16438
CHEMBL115189,P22894,,OCSMOTCMPXTDND-JKIOLJMWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10669559,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8 (MMP-8).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,105808,DTCT0024061,1072595,DTCC00289405,1035817,16063
CHEMBL115263,P22894,,SOPDPCOBVSOXIM-ZDXQCDESSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585440,KI,=,428,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105199,DTCT0024061,1309693,DTCC00287904,433861,16439
CHEMBL115330,P22894,,CNTKCZYUAOGQFT-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,20000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1528778,DTCC00290594,950266,15030
CHEMBL115653,P22894,CIPEMASTAT,GFUITADOEPNRML-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10669559,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8 (MMP-8).,,Protease inhibitors: current status and future prospects.,J. Med. Chem.,2000,43,3,"Leung D, Abbenante G, Fairlie DP",,105815,DTCT0024061,1065650,DTCC00288838,1839322,16063
CHEMBL115712,P22894,,ZYIMYAJZHPOFQU-IVMMDQJWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,303,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1442403,DTCC00287104,917655,16438
CHEMBL115774,P22894,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,14711305,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,105074,DTCT0024061,1264839,DTCC00287265,336153,17924
CHEMBL115774,P22894,,YQEMFOGNUTYMTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16392792,IC50,=,2.5,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329826,DTCT0024061,1880223,DTCC00287265,325923,20214
CHEMBL1160559,P22894,QUINALDIC ACID,LOAUVZALPPNFOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102609,DTCC00648701,183412,43205
CHEMBL1160685,P22894,CYCLOHEXANAMINIUM HYDROGEN (ISOBUTYLAMINO)CARBONYLPHOSPHONATE,JAOQWUBVSCNFML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,1000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1301426,DTCC00648810,401328,17838
CHEMBL1160686,P22894,,SPZJLPXBRLFGFY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,50000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1302615,DTCC00648811,1273344,17838
CHEMBL1161012,P22894,,DLGBEGBHXSAQOC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103059,DTCC00649095,1057326,43205
CHEMBL116150,P22894,,QAPOPAUODGASKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,240,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1548724,DTCC00290822,2045645,15030
CHEMBL116150,P22894,,QAPOPAUODGASKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,239.88,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258675,DTCC00290822,2036414,24803
CHEMBL116318,P22894,,UICDMTYNXJBPNZ-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,839744,DTCC00293444,1723601,1497
CHEMBL116523,P22894,,MXTBHPDVCDUGQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,189000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1533397,DTCC00290767,1047345,15030
CHEMBL116523,P22894,,MXTBHPDVCDUGQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,190546.07,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258684,DTCC00290767,1037851,24803
CHEMBL116529,P22894,,JCBQQIGSXUEVIL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,36000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1551511,DTCC00290586,2077716,15030
CHEMBL116557,P22894,,XKSDROXJWZNHOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,490,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1524011,DTCC00290764,2045646,15030
CHEMBL116557,P22894,,XKSDROXJWZNHOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,489.78,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258677,DTCC00290764,2036413,24803
CHEMBL116588,P22894,,VLPFEOZNNBAFGH-PUODRLBUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,194000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1541774,DTCC00107204,401690,15030
CHEMBL116641,P22894,,XKYMHQLYNCGEBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,540,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1547583,DTCC00290709,2077717,15030
CHEMBL116641,P22894,,XKYMHQLYNCGEBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,537.03,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258680,DTCC00290709,2068206,24803
CHEMBL116752,P22894,,VFRJAWOYJAMXJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,2300,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1544208,DTCC00290710,1208079,15030
CHEMBL116752,P22894,,VFRJAWOYJAMXJN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,2290.87,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258681,DTCC00290710,1198923,24803
CHEMBL1169,P22894,AMINOSALICYLIC ACID,WUBBRNOQWQTFEX-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,8,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103269,DTCC00290367,669653,43205
CHEMBL117296,P22894,,MCDVAZDSWVFMGC-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,170,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,828557,DTCC00293413,1338924,1497
CHEMBL117316,P22894,,GAGZCJQIQJEPOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,98000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1523076,DTCC00107202,1306217,15030
CHEMBL117316,P22894,,GAGZCJQIQJEPOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,97723.72,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258686,DTCC00107202,1296590,24803
CHEMBL117503,P22894,,LYADDPSIOZXGRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,25000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1531168,DTCC00291067,1850696,15030
CHEMBL117664,P22894,,MKISCPLAOHQXKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,35000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1548723,DTCC00107203,2045644,15030
CHEMBL117720,P22894,,XJLATMLVMSFZBN-BZEOVNSFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,190,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,817079,DTCC00293037,76595,1497
CHEMBL117932,P22894,,NTDIUCAPLIESFB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,50000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1539324,DTCC00290766,173426,15030
CHEMBL117932,P22894,,NTDIUCAPLIESFB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,50118.72,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258683,DTCC00290766,164165,24803
CHEMBL117997,P22894,,HBFZTZFQAVERTR-OYKVQYDMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,1600,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1539323,DTCC00290563,659650,15030
CHEMBL119061,P22894,,DRHDCVWPJRCUCJ-WCSIJFPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,1400,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1541775,DTCC00291091,627400,15030
CHEMBL119083,P22894,,IQXWFHDFTAZGNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103055,DTCC00298384,701897,43205
CHEMBL119647,P22894,,UFVLIVCXTIGACT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,91,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103774,DTCC00292472,540481,43205
CHEMBL120049,P22894,,HHJKMUMZRIIHIU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,101,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1632996,DTCC00107516,917812,15919
CHEMBL120934,P22894,,YNOGLIGOUAHYJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,71000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1636618,DTCC00298635,1468303,15919
CHEMBL121188,P22894,TROPOLONE,MDYOLVRUBBJPFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103849,DTCC00298736,183415,43205
CHEMBL121501,P22894,,CDRGZNIXJYUKQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,24000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1610015,DTCC00299141,238022,15919
CHEMBL121557,P22894,E637,YIKYNHJUKRTCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103294,DTCC00298041,1445791,43205
CHEMBL121559,P22894,,XMJJPCJUQLGGND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,64000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1620368,DTCC00298606,950358,15919
CHEMBL121592,P22894,,YNYVAXYTOIAEND-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,16000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1639319,DTCC00298632,691932,15919
CHEMBL121729,P22894,,UYGXLIUFUDWVHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,15000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1602503,DTCC00298661,1047445,15919
CHEMBL121916,P22894,,SUEBJDNLBVTIQP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,126,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1629118,DTCC00299015,1564995,15919
CHEMBL122109,P22894,,XSOOLQYDISZIKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,23000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1608688,DTCC00298851,1500649,15919
CHEMBL122651,P22894,,LEWMAZXEBPMBSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1630522,DTCC00298572,1435960,15919
CHEMBL122711,P22894,,ROMGJVVZNVJOPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1613750,DTCC00298574,1500650,15919
CHEMBL122719,P22894,,ZHENEPVPETWBJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,5.5,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1629126,DTCC00299183,270685,15919
CHEMBL122831,P22894,,DUCBSHDQTBWWLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,6.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1634315,DTCC00299399,173533,15919
CHEMBL122836,P22894,,UGZOJBSDACNWAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,2.3,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1599884,DTCC00299434,2077808,15919
CHEMBL122868,P22894,,MBKXTRZDNQFIJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,16000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627954,DTCC00299111,303682,15919
CHEMBL122925,P22894,,FPJLTHNGOJRXMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1612448,DTCC00299110,530554,15919
CHEMBL122950,P22894,,LSHFFFVFHVCTTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,10000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1617699,DTCC00298794,465561,15919
CHEMBL1229868,P22894,SC-77774,FOSWRYKPHVPIDJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,9.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005887,DTCC00032045,781475,45214
CHEMBL123041,P22894,,IWTGCCHOUSDKHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,4.9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1634307,DTCC00299582,38898,15919
CHEMBL123064,P22894,,RRPKGUUYTHFUPN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,36000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627946,DTCC00298793,595002,15919
CHEMBL123105,P22894,,HBZIAYRTJNOIOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,21000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1611262,DTCC00299584,31106,15919
CHEMBL1231240,P22894,,IPBPOBHSNJFRFT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25265401,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1432370,DTCT0024061,13993805,DTCC00694031,1204120,60040
CHEMBL123167,P22894,,WWQRPJINVFSPDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,125,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627914,DTCC00299223,853820,15919
CHEMBL1232074,P22894,,RBZQWZODGBMNHX-USACIQFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,9.1,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018599,DTCC00126156,1654736,42241
CHEMBL123233,P22894,,UIBGOVKOYKPDFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,12000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1631613,DTCC00298759,2013481,15919
CHEMBL1232487,P22894,,KOVQMCGGWATESY-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,181,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247569,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168646,DTCC00694177,1422152,64498
CHEMBL1232489,P22894,,LIIRZRQVACDFBI-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,112,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247580,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,160423,DTCC00694178,484290,64498
CHEMBL1232492,P22894,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,410,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247660,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,158554,DTCC00694179,1680179,64498
CHEMBL1232492,P22894,,MMIHYNVQXYWTFM-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247661,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,158271,DTCC00694179,1680179,64498
CHEMBL1233772,P22894,,QQDWEVONJRXVDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,4.6,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018606,DTCC00694315,1939891,42241
CHEMBL123382,P22894,,CPWMZTRXCCYTDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,123,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1630514,DTCC00298903,498461,15919
CHEMBL123404,P22894,,PORUPJYSNWMWCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,69000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1631621,DTCC00299414,788555,15919
CHEMBL1234326,P22894,3-HYDROXYPICOLINIC ACID,BRARRAHGNDUELT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,56,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102618,DTCC00032094,1607385,43205
CHEMBL1234370,P22894,,CYYCSKFJEOSZTF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,881,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1371839,DTCC00694384,1883251,15412
CHEMBL123443,P22894,,STWCTQDLUUVJMC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,108,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1599876,DTCC00299356,562771,15919
CHEMBL123463,P22894,,SNYKGOMEURTYMK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1610007,DTCC00299603,36667,15919
CHEMBL1234724,P22894,,IVGHGMHNUBCTDC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018600,DTCC00694419,1072323,42241
CHEMBL1235568,P22894,,XYEPUTZVZYUENX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,75,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103081,DTCC00694512,1283744,43205
CHEMBL123775,P22894,,DJASZHFLBWUJAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1625331,DTCC00299432,950355,15919
CHEMBL1241348,P22894,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20823284,INHIBITION,=,6,%,,,,,,,,,,,,,,Inhibition of human MMP-8 at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010,54,11,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724364,DTCT0024061,5125910,DTCC00126282,118904,43507
CHEMBL124237,P22894,,ACUCWGGAKLORQX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1605171,DTCC00298788,1597483,15919
CHEMBL1255934,P22894,,SWELIMKTDYHAOY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103916,DTCC00699570,1672007,43205
CHEMBL1330588,P22894,METHYLTHIOURACIL,HWGBHCRJGXAGEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103296,DTCC00739824,896233,43205
CHEMBL1350,P22894,TILUDRONIC ACID,DKJJVAGXPKPDRL-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,32000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629949,DTCC00380285,609949,56259
CHEMBL1368601,P22894,,UHBIKXOBLZWFKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,88,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103135,DTCC00775206,734154,43205
CHEMBL1371684,P22894,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,ACTIVITY,=,106.2,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799332,DTCT0024061,7597012,DTCC00778134,283182,47025
CHEMBL1371684,P22894,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,IC50,>,40000,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799328,DTCT0024061,7596122,DTCC00778134,283182,47025
CHEMBL1371684,P22894,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,INHIBITION,=,0,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799264,DTCT0024061,7596109,DTCC00778134,283182,47025
CHEMBL1371684,P22894,,SEZPRMPVJMVCBV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384327,DTCC00778134,280320,33038
CHEMBL13766,P22894,GUAIACOL,LHGVFZTZFXWLCP-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103828,DTCC00143437,798492,43205
CHEMBL137835,P22894,,RNWNGVUCFRPGIO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1048554,DTCC00324330,1586062,15462
CHEMBL137900,P22894,,LERSXUYNVGTZOT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1036999,DTCC00324998,1743004,15462
CHEMBL137929,P22894,,VOORVZQGMACJHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017370,DTCC00324853,939175,15462
CHEMBL137966,P22894,,BMKJAROLBFYRMM-RSXQAXDFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1046073,DTCC00324328,1521758,15462
CHEMBL138181,P22894,,YXXPZIJDDIJKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,90,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020051,DTCC00324497,453845,15462
CHEMBL138264,P22894,,SRXJKOWUSBFUNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,600,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1034593,DTCC00324800,5683,15462
CHEMBL138273,P22894,,CLKXWRSURRSEKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1029860,DTCC00324622,1003829,15462
CHEMBL138338,P22894,,MYZZCJKXPLJTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1047277,DTCC00324060,1306658,15462
CHEMBL138400,P22894,,FNUQESAUEFWUCJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1016239,DTCC00324799,939174,15462
CHEMBL138535,P22894,,AGYRDWGTLLSXLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1042538,DTCC00324315,1325127,15462
CHEMBL138613,P22894,,PNICWAPKRSLYIU-ZDGMYTEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1028720,DTCC00324253,1807302,15462
CHEMBL138643,P22894,,BXZZUNDHINECCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1024933,DTCC00324039,1164745,15462
CHEMBL138656,P22894,,DHXMAFQQCCOWGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017367,DTCC00324418,1871729,15462
CHEMBL138696,P22894,,HYNBRLICGGQMNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,50,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1034590,DTCC00324548,745254,15462
CHEMBL138814,P22894,,LTRQYQYXWUQKJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1044758,DTCC00324040,292337,15462
CHEMBL138858,P22894,,ZQJORJBIVFLYIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017358,DTCC00324358,1424988,15462
CHEMBL138953,P22894,,PBJWRLBRUGJQMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1036993,DTCC00323939,1489532,15462
CHEMBL139542,P22894,,ROVRDWIOAVCKAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1053589,DTCC00324305,5684,15462
CHEMBL140152,P22894,,TVNINFNNQVBJHI-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1390648,DTCC00326357,1080274,15412
CHEMBL140305,P22894,,QESMDPOTHYLJHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1024930,DTCC00323986,1774849,15462
CHEMBL140335,P22894,,GIKKFOVDJPQBSW-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020054,DTCC00324431,357519,15462
CHEMBL140368,P22894,,WVDBZKCLVKPIHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1042541,DTCC00324430,1489530,15462
CHEMBL140426,P22894,,YOFBHXUFTFPQDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1042535,DTCC00324309,1774847,15462
CHEMBL140439,P22894,,NKTGQIQCKMXEOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,7,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020042,DTCC00324854,712958,15462
CHEMBL140454,P22894,,DOLJQSYCTYZCTL-ZHACJKMWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,60,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1049771,DTCC00324513,1969327,15462
CHEMBL140543,P22894,,FDELEKDMYZLVHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1033392,DTCC00324342,1294866,15462
CHEMBL140602,P22894,,OGWVESDVKZYNCK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1031124,DTCC00324652,2034772,15462
CHEMBL140863,P22894,,MKTUSESWUSYVIL-RSXQAXDFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020036,DTCC00324308,487229,15462
CHEMBL140888,P22894,,CVMQTPIUJOGYIP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1024936,DTCC00324522,712959,15462
CHEMBL140970,P22894,,CYYCSKFJEOSZTF-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1385756,DTCC00325595,692228,15412
CHEMBL141004,P22894,,UKBWLBZDMUKXSY-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1024938,DTCC00324341,1618735,15462
CHEMBL141038,P22894,,DTFUJQWTCDBNIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1034596,DTCC00325158,907520,15462
CHEMBL141080,P22894,,ULILDPSFFUSXJH-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1401847,DTCC00108095,821220,15412
CHEMBL141098,P22894,,MSWCSYXARJOPRA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1022548,DTCC00324370,2001891,15462
CHEMBL141283,P22894,,LKNQKZXVRWZYQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020048,DTCC00324512,487228,15462
CHEMBL141339,P22894,,SDOLDYMSRUFDDY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1041222,DTCC00324545,357521,15462
CHEMBL141340,P22894,,WYWULSIANADMTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1049761,DTCC00324313,390163,15462
CHEMBL141359,P22894,,CCOMNSWISYQLEX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1038489,DTCC00325190,1586063,15462
CHEMBL141470,P22894,,LKFQHLGPHTXZAW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,90,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1029863,DTCC00324511,971249,15462
CHEMBL141471,P22894,,RDHFQPOQGDBVBN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1029857,DTCC00324424,1774850,15462
CHEMBL141475,P22894,,WVJHDQDLYDFIKS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1048551,DTCC00324153,1489534,15462
CHEMBL141504,P22894,,KGEKBYNTOIYJHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1043543,DTCC00324423,712961,15462
CHEMBL141534,P22894,,YJKSIUVAMOZWEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1032283,DTCC00324400,809611,15462
CHEMBL141560,P22894,,IGRVUOPMHNISAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017373,DTCC00325113,357520,15462
CHEMBL141589,P22894,,ZKKQCCSHBYRQHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1036996,DTCC00324320,519434,15462
CHEMBL141672,P22894,,ULQUQVTVRZFECE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1043548,DTCC00324377,1807301,15462
CHEMBL141673,P22894,,GSLSWNSJTMLFSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1033389,DTCC00324378,390165,15462
CHEMBL141674,P22894,,PZNZBFBEAZCEQK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1021176,DTCC00324650,390164,15462
CHEMBL141675,P22894,,ALUHGPANWKZMAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1031121,DTCC00324399,5685,15462
CHEMBL141835,P22894,,DNFKKMGBEKWECE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1021179,DTCC00324761,1360202,15462
CHEMBL142071,P22894,,YNCNUFDRUOIACX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1035834,DTCC00324316,1489531,15462
CHEMBL142095,P22894,,UJACCCBUXXMATQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020039,DTCC00324855,1229458,15462
CHEMBL142134,P22894,,BYJSIHNQXBCYBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017376,DTCC00324514,2034771,15462
CHEMBL1427477,P22894,QUINOLINE-8-CARBOXYLIC ACID,QRDZFPUVLYEQTA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,38,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103189,DTCC00032919,86518,43205
CHEMBL1432,P22894,"2,3-DIHYDROXYBENZOIC ACID",GLDQAMYCGOIJDV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,10,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103092,DTCC00442073,540482,43205
CHEMBL1433,P22894,DOXYCYCLINE,JBIWCJUYHHGXTC-AKNGSSGZSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17267227,IC50,=,31000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441980,DTCT0024061,2144982,DTCC00443319,370710,23207
CHEMBL1440,P22894,TETRACYCLINE,OFVLGDICTFRJMM-WESIUVDSSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17267227,IC50,=,180000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441980,DTCT0024061,2144979,DTCC00445351,34477,23207
CHEMBL1448518,P22894,,LYTWDWCQUGSJLP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,INHIBITION,=,20,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799264,DTCT0024061,7596111,DTCC00849624,1351285,47025
CHEMBL1461,P22894,GENTISIC ACID,WXTMDXOMEHJXQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103213,DTCC00460344,1731965,43205
CHEMBL148169,P22894,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12408705,KI,=,257,NM,,,,,,,,,,,,,,Affinity for Matrix metalloprotease-8 (MMP-8),,"Discovery of gamma-lactam hydroxamic acids as selective inhibitors of tumor necrosis factor alpha converting enzyme: design, synthesis, and structure-activity relationships.",J. Med. Chem.,2002,45,23,"Duan JJ, Chen L, Wasserman ZR, Lu Z, Liu RQ, Covington MB, Qian M, Hardman KD, Magolda RL, Newton RC, Christ DD, Wexler RR, Decicco CP",,105075,DTCT0024061,697260,DTCC01743557,205947,17028
CHEMBL148169,P22894,IK-682,YDMIPBHQKFOFQW-NSYGIPOTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,257,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457295,DTCC01743557,208203,32556
CHEMBL1515648,P22894,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,ACTIVITY,=,93.8,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799332,DTCT0024061,7597013,DTCC00912100,185710,47025
CHEMBL1515648,P22894,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,IC50,>,40000,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799328,DTCT0024061,7596123,DTCC00912100,185710,47025
CHEMBL1515648,P22894,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,INHIBITION,=,8,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799264,DTCT0024061,7596110,DTCC00912100,185710,47025
CHEMBL1515648,P22894,,XDOXZFXJIASILF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384324,DTCC00912100,184075,33038
CHEMBL151741,P22894,,FGDQQAHGMHOQDV-NGXZDTIWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,24,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1382334,DTCC00344136,787756,14854
CHEMBL152104,P22894,,FGDQQAHGMHOQDV-WVQWTBLQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,130,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1369658,DTCC00343439,172749,14854
CHEMBL1566001,P22894,,SDQFKDFGDPUANU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384329,DTCC00959006,1991474,33038
CHEMBL1627009,P22894,LITHIUM ETHYL (CYCLOHEXYLAMINO)CARBONYLPHOSPHONATE,UNVAKRAJEPVVLT-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1288021,DTCC01014520,627063,17838
CHEMBL1632637,P22894,,FAJZOFHZLDUFEM-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,24,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018601,DTCC01018413,1331294,42241
CHEMBL1632638,P22894,,VDUBALDTEGAJSW-JOYOIKCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018602,DTCC01018414,716738,42241
CHEMBL1632639,P22894,,PCRITYAGTCCZEK-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018603,DTCC01018415,426689,42241
CHEMBL1632640,P22894,,YNIHTMMJQXUNPE-GMSGAONNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018604,DTCC01018416,1072324,42241
CHEMBL1632641,P22894,,KHCZZISCPQRODX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,173,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018605,DTCC01018417,69261,42241
CHEMBL1632642,P22894,,OEHVKBKRRIUTOR-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,48,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018607,DTCC01018418,1137369,42241
CHEMBL1649594,P22894,,PVQRWPNLEMQCSX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,102,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103771,DTCC01022968,960351,43205
CHEMBL1650458,P22894,6-METHYLPICOLINIC ACID,LTUUGSGSUZRPRV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102649,DTCC00033455,604860,43205
CHEMBL1650601,P22894,8-HYDROXYQUINOLINE 1-OXIDE,FJKUOCCQEBLPNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,64,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103283,DTCC00033473,1024885,43205
CHEMBL1650602,P22894,6-HYDROXYPICOLINIC ACID,VRCWSYYXUCKEED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,20,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102645,DTCC00033474,1731964,43205
CHEMBL1650603,P22894,6-BROMOPICOLINIC ACID,XURXQNUIGWHWHU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103271,DTCC00033475,442587,43205
CHEMBL1650604,P22894,,PHQBKLKZIXCRIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103371,DTCC01022962,280902,43205
CHEMBL1650605,P22894,CLOPYRALID,HUBANNPOLNYSAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103363,DTCC01022963,1990718,43205
CHEMBL1650606,P22894,ISOQUINOLINE-1-CARBOXYLIC ACID,XAAKCCMYRKZRAK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102611,DTCC00033476,798490,43205
CHEMBL1650607,P22894,PYRIMIDIN-2-OL,VTGOHKSTWXHQJK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104005,DTCC00033477,830994,43205
CHEMBL1650608,P22894,2-THIOURACIL,OVONXEQGWXGFJD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,83,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103173,DTCC00033478,1860584,43205
CHEMBL1650609,P22894,,RAFAYWADRVMWFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,49,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103185,DTCC01022964,1024886,43205
CHEMBL1650610,P22894,,PZVLJGKJIMBYNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,2,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103124,DTCC01022965,346294,43205
CHEMBL1650611,P22894,,STUQITWXBMZUGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,25,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103814,DTCC01022966,280898,43205
CHEMBL1650612,P22894,,BPSGVKFIQZZFNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103366,DTCC00127529,572604,43205
CHEMBL1650613,P22894,,UQFHLJKWYIJISA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103006,DTCC00127530,1478226,43205
CHEMBL1650614,P22894,,SHVCSCWHWMSGTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,11,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103370,DTCC01022967,1639739,43205
CHEMBL1650615,P22894,,GKLSXUGPECNEMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,101,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103848,DTCC01022969,1672008,43205
CHEMBL1650616,P22894,,KKEBDEYRNMMBPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103794,DTCC01022970,1413986,43205
CHEMBL1650617,P22894,,NFPVFWUVBGEVHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,55,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103789,DTCC01022971,378880,43205
CHEMBL1650618,P22894,,LIPRKYKMVQPYPG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,68,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103785,DTCC01022972,1574896,43205
CHEMBL1650619,P22894,,YBBJKCMMCRQZMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,90,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103702,DTCC01022973,572605,43205
CHEMBL1650620,P22894,,SVOBTPSWHFSTQO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,95,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103773,DTCC01022974,896235,43205
CHEMBL1650621,P22894,,SQEXIHSVVCJZTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,96,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103324,DTCC01022975,798491,43205
CHEMBL1650622,P22894,,QJEZBSWVHDOAFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,89,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103021,DTCC01022976,572606,43205
CHEMBL1650623,P22894,,HMXGIMVMTIFQHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,94,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103327,DTCC01022977,1763873,43205
CHEMBL1650624,P22894,,XTMONGQRZFRDAJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,93,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103697,DTCC01022978,1381650,43205
CHEMBL1650625,P22894,4-METHYLSALICYLIC ACID,NJESAXZANHETJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,16,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103147,DTCC00033479,1892888,43205
CHEMBL1650626,P22894,,TTZOLDXHOCCNMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,4,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103037,DTCC01022979,766406,43205
CHEMBL1650627,P22894,,KXZQYLBVMZGIKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104004,DTCC01022980,1185923,43205
CHEMBL1650628,P22894,"1,4,7-TRIAZONANE",ITWBWJFEJCHKSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,104,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103694,DTCC00033480,1542780,43205
CHEMBL1650629,P22894,,RRXGRDMHWYLJSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104003,DTCC01022981,1122425,43205
CHEMBL1650630,P22894,,IQGMRVWUTCYCST-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,67,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103282,DTCC01022982,1445793,43205
CHEMBL1650631,P22894,,GHGZVWOTJDLREY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103109,DTCC01022983,1024888,43205
CHEMBL1650632,P22894,,MVVGSPCXHRFDDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,40,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102668,DTCC01022984,1607386,43205
CHEMBL1650633,P22894,,GSOHKPVFCOWKPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103377,DTCC01022985,1763874,43205
CHEMBL1650634,P22894,,GUARKOVVHJSMRW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103038,DTCC01022986,1796211,43205
CHEMBL1650635,P22894,,VLRGXXKFHVJQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103274,DTCC01022987,151277,43205
CHEMBL1668126,P22894,,GZVYRVDFHLLJPP-IDRUGXTQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21130662,ACTIVITY,,,,,,,,,,,,,,,,,Activity at MMP8,Not Active,Functional in vivo imaging of cysteine cathepsin activity in murine model of inflammation.,Bioorg. Med. Chem.,2011,19,3,"Caglic D, Globisch A, Kindermann M, Lim NH, Jeske V, Juretschke HP, Bartnik E, Weithmann KU, Nagase H, Turk B, Wendt KU",,717558,DTCT0024061,5112232,DTCC01024969,1122449,43232
CHEMBL170103,P22894,,BNPMWDDIMRPKMZ-JTSKRJEESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,6,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1129977,DTCC00371438,777871,5419
CHEMBL170103,P22894,,BNPMWDDIMRPKMZ-JTSKRJEESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,1000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1129976,DTCC00371438,777871,5419
CHEMBL170346,P22894,,BNFQSPBDDPIXCF-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,89,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1126114,DTCC00371364,584245,5419
CHEMBL170625,P22894,,AEAOFBYNIYSJQK-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,5,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1111702,DTCC00371444,1036734,5419
CHEMBL1708633,P22894,,HPKSJRQGNKXSTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384326,DTCC01043279,476446,33038
CHEMBL171466,P22894,,XVXXOYBXUAACNT-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,0,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1123507,DTCC00371065,843002,5419
CHEMBL171466,P22894,,XVXXOYBXUAACNT-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,300,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1123506,DTCC00371065,843002,5419
CHEMBL1717700,P22894,,GSRFVSAKODJJAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384328,DTCC01052041,1284452,33038
CHEMBL171949,P22894,,HRMFOWHCPWWSTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,18,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1133854,DTCC00373680,1230017,5419
CHEMBL1720056,P22894,,RWAABDCMXWMEQF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384330,DTCC01054321,314376,33038
CHEMBL172180,P22894,,WKWHTFBYSLLKLG-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,4,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1103409,DTCC00371752,1490105,5419
CHEMBL172180,P22894,,WKWHTFBYSLLKLG-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,1000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1103408,DTCC00371752,1490105,5419
CHEMBL172251,P22894,,FRRIILVFUOBZCJ-MBABXSBOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,5,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1110249,DTCC00371594,1619276,5419
CHEMBL172874,P22894,,QXLUKDZXPBRJKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,12,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1124721,DTCC00370663,1715183,5419
CHEMBL172874,P22894,,QXLUKDZXPBRJKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,7000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1124720,DTCC00370663,1715183,5419
CHEMBL173284,P22894,,IHNYAHCZDRILEC-YPMHNXCESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,74,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1119537,DTCC00370419,1904589,5419
CHEMBL173382,P22894,,HCKYIMJMJTUVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,15,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1119543,DTCC00370756,1586614,5419
CHEMBL173382,P22894,,HCKYIMJMJTUVAP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,14000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1119542,DTCC00370756,1586614,5419
CHEMBL173533,P22894,,ODZPYMWQRDBEPD-LOSJGSFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,10,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1100877,DTCC00372545,971793,5419
CHEMBL173544,P22894,,VLUPODOOTLRMGI-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,56,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1095530,DTCC00371020,358059,5419
CHEMBL1736529,P22894,,UFCNXRFIGHNKSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",inactive,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384323,DTCC01070299,1704439,33038
CHEMBL173818,P22894,,KKZUWROSSZALIB-ZETCQYMHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,72,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1122328,DTCC00370650,259623,5419
CHEMBL174084,P22894,,RJZVOLUHBQERAD-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,47,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1104966,DTCC00371209,1743527,5419
CHEMBL174373,P22894,,AIDZFVBIMNVQQY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,44,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1096965,DTCC00371066,584244,5419
CHEMBL174373,P22894,,AIDZFVBIMNVQQY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,28000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1096964,DTCC00371066,584244,5419
CHEMBL174422,P22894,,LQPUQCAPJTUCIA-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,1,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1114187,DTCC00371013,745783,5419
CHEMBL174865,P22894,,MKXCYCNTSAOKDX-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,0,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1123512,DTCC00372935,520000,5419
CHEMBL174865,P22894,,MKXCYCNTSAOKDX-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,250,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1123511,DTCC00372935,520000,5419
CHEMBL174993,P22894,,WFYLXIFCLIAISI-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,43,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1121070,DTCC00373042,745782,5419
CHEMBL174993,P22894,,WFYLXIFCLIAISI-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,22000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1121069,DTCC00373042,745782,5419
CHEMBL175009,P22894,,JQVKKTYOFNLOIP-MBSDFSHPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,5,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1135125,DTCC00372934,713481,5419
CHEMBL176467,P22894,,RTBMLCLTYAPKIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327602,IC50,=,81,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase-I, Matrix metalloprotease-8",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,105069,DTCT0024061,970232,DTCC00374112,1662912,4784
CHEMBL176602,P22894,,KGUVBHLPMGERAT-NIYFSFCBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9888835,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,105809,DTCT0024061,1151839,DTCC00373473,2078653,15162
CHEMBL176832,P22894,,CQGUKDZSAPDCJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327602,IC50,=,130,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase-I, Matrix metalloprotease-8",,"Novel 5,5-disubstitutedpyrimidine-2,4,6-triones as selective MMP inhibitors.",Bioorg. Med. Chem. Lett.,2001,11,8,"Foley LH, Palermo R, Dunten P, Wang P",,105069,DTCT0024061,959844,DTCC00374111,1209081,4784
CHEMBL176993,P22894,,VMVSKQSBVKMLRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,14,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1103418,DTCC00109233,1490104,5419
CHEMBL1770157,P22894,,STMMWXRQAOVQNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,31,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936652,DTCC01080448,961249,44425
CHEMBL177048,P22894,,IFKOWFBQQCCFPQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,15,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1122333,DTCC00373478,1262886,5419
CHEMBL177048,P22894,,IFKOWFBQQCCFPQ-AWEZNQCLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,6000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1122332,DTCC00373478,1262886,5419
CHEMBL1770697,P22894,,CLXRDURJLYSMHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,49,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936654,DTCC01080449,799451,44425
CHEMBL1770698,P22894,,RCSWIFOOANTXTQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936640,DTCC01080450,49638,44425
CHEMBL1770699,P22894,,WBIKMXRYXWFRCE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936641,DTCC01080451,831943,44425
CHEMBL1770700,P22894,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,900,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936643,DTCC01080452,1058218,44425
CHEMBL1770700,P22894,,MASDJPGVHCTFLM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,900,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930566,DTCC01080452,1040141,44430
CHEMBL1770701,P22894,,OICBVOJTVMMIHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936644,DTCC01080453,314520,44425
CHEMBL1770702,P22894,,JNMYIRAUFFFDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936645,DTCC01080454,1025844,44425
CHEMBL1770703,P22894,,KLRCKSDGEDNMNL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,700,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936646,DTCC01080455,1186873,44425
CHEMBL1770704,P22894,,UKBSDNIYHDAZDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,3100,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936647,DTCC01080456,767291,44425
CHEMBL1770705,P22894,,NVZOQOOLHGCJGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936648,DTCC01080457,638469,44425
CHEMBL1770706,P22894,,SJTWWQWUAQAYAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936649,DTCC01080458,87486,44425
CHEMBL1770707,P22894,,CADOQGNFDXDEHI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,170,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936650,DTCC01080459,1829540,44425
CHEMBL1770708,P22894,,WWVWMBFCEZHXFR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936651,DTCC01080460,1349992,44425
CHEMBL1770709,P22894,,PCOMQZCYLOTKTN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936653,DTCC01080461,1349993,44425
CHEMBL1770710,P22894,,DZVDZJSJBKHJOK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,800,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936655,DTCC01080462,1446682,44425
CHEMBL1770711,P22894,,WNBNYVCTXXPOJB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,2.6,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936656,DTCC01080463,1414913,44425
CHEMBL1770712,P22894,,DLMROZSTEBHAOO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21493063,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1' amides.,Bioorg. Med. Chem. Lett.,2011,21,10,"Fobian YM, Freskos JN, Barta TE, Bedell LJ, Heintz R, Kassab DJ, Kiefer JR, Mischke BV, Molyneaux JM, Mullins P, Munie GE, Becker DP",,744870,DTCT0024061,5936657,DTCC01080464,1349994,44425
CHEMBL1771212,P22894,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005870,DTCC00033985,1557982,45214
CHEMBL1771212,P22894,SD-2590,NXUHVWMBPOFLMA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930564,DTCC00033985,1557806,44430
CHEMBL1771213,P22894,,QCRPOQONCVCBFI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930565,DTCC01080938,1040140,44430
CHEMBL1771214,P22894,,UIGGXLFLAQCMAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,IC50,=,190,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930567,DTCC01080939,134084,44430
CHEMBL1771215,P22894,,BNPWNBBKUMLEJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,170,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930568,DTCC01080940,361645,44430
CHEMBL1771216,P22894,,MTRATHZFTCSGDT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,80,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930569,DTCC01080941,1233526,44430
CHEMBL1771217,P22894,,MMCUCOOPEAHRPL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930570,DTCC01080942,1040142,44430
CHEMBL1771218,P22894,,LIQFLIXIOKMDTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,250,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930571,DTCC01080943,1908020,44430
CHEMBL1771219,P22894,,VCIBNYPUVKINDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,180,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930572,DTCC01080944,975250,44430
CHEMBL1771220,P22894,,NVQGQIYFJRAZLX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,260,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930573,DTCC01080945,1590129,44430
CHEMBL1771221,P22894,,JRPLACGAMSWTCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,74,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930574,DTCC01080946,230822,44430
CHEMBL1771222,P22894,,FVPQYGSYGOKFLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,140,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930575,DTCC01080947,1105335,44430
CHEMBL1771223,P22894,,UAFRGDNTZQMZFA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21507637,KI,=,72,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,MMP-13 selective a-sulfone hydroxamates: A survey of P1' heterocyclic amide isosteres.,Bioorg. Med. Chem. Lett.,2011,21,10,"Barta TE, Becker DP, Bedell LJ, Easton AM, Hockerman SL, Kiefer J, Munie GE, Mathis KJ, Li MH, Rico JG, Villamil CI, Williams JM",,744953,DTCT0024061,5930576,DTCC01080948,587727,44430
CHEMBL179288,P22894,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15713379,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,N-i-Propoxy-N-biphenylsulfonylaminobutylhydroxamic acids as potent and selective inhibitors of MMP-2 and MT1-MMP.,Bioorg. Med. Chem. Lett.,2005,15,5,"Rossello A, Nuti E, Carelli P, Orlandini E, Macchia M, Nencetti S, Zandomeneghi M, Balzano F, Uccello Barretta G, Albini A, Benelli R, Cercignani G, Murphy G, Balsamo A",,305736,DTCT0024061,1747885,DTCC00381940,1069270,18841
CHEMBL179288,P22894,,DGZZVIWCMGVHGV-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044911,DTCC00381940,1071500,35647
CHEMBL1795351,P22894,,YZKJTNXYLZWHHJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000210,DTCC01091696,1893893,44948
CHEMBL1795857,P22894,,VZNWQFCLBMVARX-SSEXGKCCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,490,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000217,DTCC01091697,1673074,44948
CHEMBL1795858,P22894,,ABUCHUKPMIVSQV-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,440,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000224,DTCC01091698,638553,44948
CHEMBL1795859,P22894,,RSAGFYGPXOAVNX-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000231,DTCC01091699,119860,44948
CHEMBL1795860,P22894,,YPLZYOZJLNQLST-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000238,DTCC01091700,1640794,44948
CHEMBL1795861,P22894,,KGOHHLONXFWMRE-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,500,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000245,DTCC01091701,1861595,44948
CHEMBL1795862,P22894,,OTEWYJZEFZRZKI-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000253,DTCC01091702,767378,44948
CHEMBL179936,P22894,,YMPRSEQZGBKKAZ-HMTLIYDFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15780605,IC50,=,10,NM,,,,,,,,,,,,,,Binding affinity for human Matrix metalloprotease-8,,QSAR-by-NMR: quantitative insights into structural determinants for binding affinity by analysis of 1H/15N chemical shift differences in MMP-3 ligands.,Bioorg. Med. Chem. Lett.,2005,15,7,"Matter H, Schudok M, Elshorst B, Jacobs DM, Saxena K, Kogler H",,306089,DTCT0024061,1748660,DTCC00383350,174490,18912
CHEMBL1801044,P22894,,XQXSQQVRMVVPJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005893,DTCC01094745,1557976,45214
CHEMBL1801045,P22894,,KOPIIXVBCHXDHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005892,DTCC01094746,1747121,45214
CHEMBL1801046,P22894,,HBYRXCFAHCMHAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005891,DTCC01094747,1364426,45214
CHEMBL1801047,P22894,,RDFQXFRQTOWZEQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005890,DTCC01094748,1525962,45214
CHEMBL1801050,P22894,,SPEYRVQKGFNUCY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005889,DTCC01094751,2070708,45214
CHEMBL1801051,P22894,,VFDSDRZNXLFCFF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,30,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005888,DTCC01094752,1811467,45214
CHEMBL1801052,P22894,,QLTNWLFWQKKDEO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005886,DTCC01094753,1105534,45214
CHEMBL1801054,P22894,,PGEMRSCSFPLCBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005885,DTCC01094755,1940371,45214
CHEMBL1801056,P22894,,GXZSIAVJNPWNMR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005884,DTCC01094757,1811468,45214
CHEMBL1801057,P22894,,QJNGNVJSSUXWBO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005883,DTCC01094758,1687244,45214
CHEMBL1801393,P22894,,JATUSZYMCBLDQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005867,DTCC01095085,1622970,45214
CHEMBL1801396,P22894,,QDGVTWBFTFHWOG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005866,DTCC01095088,1072789,45214
CHEMBL1801399,P22894,,HYIVZTPHVNIXFU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005865,DTCC01095091,1266628,45214
CHEMBL1801413,P22894,,SIEIWCDBNIGNIG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.6,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005882,DTCC01095103,846766,45214
CHEMBL1801415,P22894,,SXSIQUOYBXOPSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005881,DTCC01095105,1396864,45214
CHEMBL1801419,P22894,,SYYRIPAKWJBIOW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005880,DTCC01095109,1072790,45214
CHEMBL1801420,P22894,,LMIHEFSBOIGKDH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005879,DTCC01095110,879231,45214
CHEMBL1801421,P22894,,BDONYXHHXNTUSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005878,DTCC01095111,1557981,45214
CHEMBL1801423,P22894,,XFBRPTYLOIFAQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005877,DTCC01095113,1429093,45214
CHEMBL1801424,P22894,,AOPZFYOXZYZEAC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005876,DTCC01095114,101933,45214
CHEMBL1801425,P22894,,DZCGIZPIPKWUIX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005875,DTCC01095115,1779153,45214
CHEMBL1801426,P22894,,LTCNKRUYOJZZJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005874,DTCC01095117,1843781,45214
CHEMBL1801427,P22894,,JKRVXAWKSWVVCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005873,DTCC01095118,1169008,45214
CHEMBL1801428,P22894,,ORSWNUGKUNQTLF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005872,DTCC01095119,1687248,45214
CHEMBL1801429,P22894,,LCYYUMHWMVOGPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.7,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005871,DTCC01095120,717206,45214
CHEMBL1801430,P22894,SC-77964,NBRBWZJMBITNBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005869,DTCC00034383,620315,45214
CHEMBL1801431,P22894,,IXVDOEAUVAJHER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20726512,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of human MMP8 assessed as cleavage of fluorogenic peptide MCAPro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorometric assay,,"Orally active MMP-1 sparing a-tetrahydropyranyl and a-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.",J. Med. Chem.,2010,53,18,"Becker DP, Barta TE, Bedell LJ, Boehm TL, Bond BR, Carroll J, Carron CP, Decrescenzo GA, Easton AM, Freskos JN, Funckes-Shippy CL, Heron M, Hockerman S, Howard CP, Kiefer JR, Li MH, Mathis KJ, McDonald JJ, Mehta PP, Munie GE, Sunyer T, Swearingen CA, Villamil CI, Welsch D, Williams JM, Yu Y, Yao J",,754462,DTCT0024061,6005868,DTCC01095121,263383,45214
CHEMBL181244,P22894,,PHGLPDURIUEELR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859461,DTCC00381891,1588877,34421
CHEMBL181682,P22894,,VWGKXDUPRHRCAO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16002291,IC50,=,25000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Structure-based design and synthesis of novel non-zinc chelating MMP-12 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,16,"Dublanchet AC, Ducrot P, Andrianjara C, O'Gara M, Morales R, Compère D, Denis A, Blais S, Cluzeau P, Courté K, Hamon J, Moreau F, Prunet ML, Tertre A",,305121,DTCT0024061,1742481,DTCC00381375,142259,9478
CHEMBL183410,P22894,,ZTJUBPXNBSLSGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15780611,IC50,=,31,NM,,,,,,,,,,,,,,Inhibitory concentration against matrix metalloprotease 8,,Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14.,Bioorg. Med. Chem. Lett.,2005,15,7,"Blagg JA, Noe MC, Wolf-Gouveia LA, Reiter LA, Laird ER, Chang SP, Danley DE, Downs JT, Elliott NC, Eskra JD, Griffiths RJ, Hardink JR, Haugeto AI, Jones CS, Liras JL, Lopresti-Morrow LL, Mitchell PG, Pandit J, Robinson RP, Subramanyam C, Vaughn-Bowser ML, Yocum SA",,305082,DTCT0024061,1754256,DTCC00384419,1113613,18917
CHEMBL186422,P22894,QUINOLIN-2-OL,LISFMEBWQUVKPJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,33,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102607,DTCC00000874,1763872,43205
CHEMBL187092,P22894,,LTVIJEFEZVFIST-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15953722,IC50,=,1,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Discovery of 3-OH-3-methylpipecolic hydroxamates: potent orally active inhibitors of aggrecanase and MMP-13.,Bioorg. Med. Chem. Lett.,2005,15,14,"Noe MC, Natarajan V, Snow SL, Wolf-Gouveia LA, Mitchell PG, Lopresti-Morrow L, Reeves LM, Yocum SA, Otterness I, Bliven MA, Carty TJ, Barberia JT, Sweeney FJ, Liras JL, Vaughn M",,304624,DTCT0024061,1774125,DTCC00390625,681417,18571
CHEMBL191613,P22894,"2,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",KASHBTOPZJTDFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629026,DTCC00399306,383982,56259
CHEMBL191625,P22894,"PENTANE-2,4-DIONE",YRKCREAYFQTBPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-6,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103321,DTCC00001048,1957906,43205
CHEMBL1935291,P22894,,MUMVNZHARHFSLP-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22153340,IC50,=,154,NM,,,,,,,,,,,,,,Inhibition of human MMP-8,,Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).,Bioorg. Med. Chem. Lett.,2012,22,1,"Wu Y, Li J, Wu J, Morgan P, Xu X, Rancati F, Vallese S, Raveglia L, Hotchandani R, Fuller N, Bard J, Cunningham K, Fish S, Krykbaev R, Tam S, Goldman SJ, Williams C, Mansour TS, Saiah E, Sypek J, Li W",,796149,DTCT0024061,7576411,DTCC01169633,51895,46933
CHEMBL1939844,P22894,,FTRCUXMVUJZMHT-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22017477,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799079,DTCT0024061,7595878,DTCC01171473,2071098,47023
CHEMBL1939845,P22894,,JVBFGGAYMSJQBZ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22017477,IC50,=,67,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799079,DTCT0024061,7595880,DTCC01171474,1811871,47023
CHEMBL1939846,P22894,,RQCBSNJRFVZHOS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22017477,IC50,=,21,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate preincubated for 4 hrs measured every 15 secs for 20 mins by fluorescence analysis,,"Novel 1-hydroxypiperazine-2,6-diones as new leads in the inhibition of metalloproteinases.",J. Med. Chem.,2011,54,24,"Marques SM, Tuccinardi T, Nuti E, Santamaria S, André V, Rossello A, Martinelli A, Santos MA",,799079,DTCT0024061,7595879,DTCC01171475,1461560,47023
CHEMBL1939876,P22894,,MMJPVSDTLGFIQW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22017539,IC50,>,22000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 after 30 mins by fluorimetry,,Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.,J. Med. Chem.,2011,54,23,"Taylor SJ, Abeywardane A, Liang S, Muegge I, Padyana AK, Xiong Z, Hill-Drzewi M, Farmer B, Li X, Collins B, Li JX, Heim-Riether A, Proudfoot J, Zhang Q, Goldberg D, Zuvela-Jelaska L, Zaher H, Li J, Farrow NA",,799153,DTCT0024061,7596039,DTCC01171504,1734238,47024
CHEMBL194377,P22894,,LRMGKWDRORXPRE-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,101,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860395,DTCC00407675,110120,19837
CHEMBL194430,P22894,,FXZROVPZUUATHR-SANMLTNESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,110,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860443,DTCC00407681,596206,19837
CHEMBL1946141,P22894,,BRXGWWVUCIZYMM-VNRZBHCFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,138,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619073,DTCC01174040,736427,47195
CHEMBL1946142,P22894,,HSQOMGXZKXTHEM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,129,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619074,DTCC01174041,866229,47195
CHEMBL1946143,P22894,,BCOFTFDFNHXYGF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619075,DTCC01174042,1766168,47195
CHEMBL1946144,P22894,,APJIPTNFOKEMIQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,48,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619076,DTCC01174043,1124683,47195
CHEMBL1946145,P22894,,LEIFVUOVYOUZFH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,49,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619077,DTCC01174044,866230,47195
CHEMBL1946146,P22894,,HSWKOBISGMUSTR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,58,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619078,DTCC01174045,704155,47195
CHEMBL1946147,P22894,,GGMOCOYDYRCVAH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,150,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619079,DTCC01174046,185744,47195
CHEMBL1946148,P22894,,LWNWGJXWKYGLPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,107,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619080,DTCC01174047,1706054,47195
CHEMBL1946149,P22894,,SVUOUTRIPGSFHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,27,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619081,DTCC01174048,1513025,47195
CHEMBL1946275,P22894,,RWOLXJOULAGHOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,19,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619082,DTCC01174168,542782,47195
CHEMBL1946276,P22894,,JZIODDCGNMBMLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619083,DTCC01174169,1830895,47195
CHEMBL1946277,P22894,,PTJXSKQZLWNDNB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22118188,IC50,=,116,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins measured after 10 mins by fluorescence analysis",,"A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.",J. Med. Chem.,2012,55,1,"Schrigten D, Breyholz HJ, Wagner S, Hermann S, Schober O, Schäfers M, Haufe G, Kopka K",,800774,DTCT0024061,7619084,DTCC01174170,833388,47195
CHEMBL1956115,P22894,,GDYIQUFNICPYHF-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22175825,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Potent inhibitors of LpxC for the treatment of Gram-negative infections.,J. Med. Chem.,2012,55,2,"Brown MF, Reilly U, Abramite JA, Arcari JT, Oliver R, Barham RA, Che Y, Chen JM, Collantes EM, Chung SW, Desbonnet C, Doty J, Doroski M, Engtrakul JJ, Harris TM, Huband M, Knafels JD, Leach KL, Liu S, Marfat A, Marra A, McElroy E, Melnick M, Menard CA, Montgomery JI, Mullins L, Noe MC, O'Donnell J, Penzien J, Plummer MS, Price LM, Shanmugasundaram V, Thoma C, Uccello DP, Warmus JS, Wishka DG",,806642,DTCT0024061,7652739,DTCC01177834,866270,47510
CHEMBL1957601,P22894,,CYFUZHPFHKFWQX-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640541,DTCC01179286,1642107,47642
CHEMBL1957602,P22894,,UCAJNLLYTGJPBY-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640542,DTCC01179287,1798652,47642
CHEMBL1957603,P22894,,WIOGWLUNCZARAP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,Not Determined,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640543,DTCC01179288,1027325,47642
CHEMBL1957604,P22894,,FYFJMQCWKQDEQR-FZADBTJQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,=,400,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640544,DTCC01179289,1609806,47642
CHEMBL1957605,P22894,,VVEIZVKRPYJCPP-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640545,DTCC01179290,1862951,47642
CHEMBL1957606,P22894,,LXQUQEBAZBLBEJ-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22386984,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate preincubated for 1 hr prior substrate addition measured after 30 mins by spectrofluorimetry,,In silico scaffold evaluation and solid phase approach to identify new gelatinase inhibitors.,Bioorg. Med. Chem.,2012,20,7,"Topai A, Breccia P, Minissi F, Padova A, Marini S, Cerbara I",,805645,DTCT0024061,7640546,DTCC01179291,1513073,47642
CHEMBL19611,P22894,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.18,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1369662,DTCC00151638,1882182,14854
CHEMBL19611,P22894,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17623656,IC50,=,9.7,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507875,DTCT0024061,2388627,DTCC00151638,1885151,29282
CHEMBL19611,P22894,ILOMASTAT,NITYDPDXAAFEIT-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,1,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,842075,DTCC00151638,1882893,1497
CHEMBL197921,P22894,,XQTQPJFARUOTCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16242329,IC50,>,380000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327981,DTCT0024061,1875155,DTCC00410753,1937031,20151
CHEMBL198039,P22894,,IRPQGYYABIPNQJ-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,1860351,DTCC00407671,1048682,19837
CHEMBL198262,P22894,,HHHAELOQIYTSIY-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,73,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860305,DTCC00407624,1405256,19837
CHEMBL198389,P22894,,HAWUDCIVXQTNAF-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,1860362,DTCC00407672,304937,19837
CHEMBL199018,P22894,,XTRLBSLKNQZDBD-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,1860406,DTCC00407676,822181,19837
CHEMBL199241,P22894,,LSKSBHBGNRQEFN-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,404,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860340,DTCC00407670,1787390,19837
CHEMBL200274,P22894,,JGRIYRSQHHLUHI-BSOSBYQFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16392792,IC50,=,20,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329826,DTCT0024061,1880240,DTCC00411964,1004812,20214
CHEMBL200385,P22894,,DBVIHPVOZIIXAL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16242329,IC50,=,1000000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327981,DTCT0024061,1875154,DTCC00410754,1970289,20151
CHEMBL200435,P22894,,GVMUNGGWXRKCEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16242329,IC50,=,1200000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327981,DTCT0024061,1875156,DTCC00410823,1425968,20151
CHEMBL202932,P22894,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887709,DTCC00413183,1274996,20245
CHEMBL202932,P22894,,BZVYQWLRCHLAGK-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,1.4,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061780,DTCC00413183,1263648,22402
CHEMBL204543,P22894,"NAPHTHALENE-1,2-DIOL",NXPPAOGUKPJVDI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104000,DTCC00001534,1892886,43205
CHEMBL2047536,P22894,,DACARRUBIAXSBX-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22175799,IC50,=,3200,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827024,DTCT0024061,10526936,DTCC01242723,653432,48586
CHEMBL2047537,P22894,,CZRLAOXITNZAJA-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22175799,IC50,>,20000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using MCA-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2.AcOH as substrate preincubated for 10 mins measured by fluorescence analysis,,"Discovery and evaluation of a non-Zn chelating, selective matrix metalloproteinase 13 (MMP-13) inhibitor for potential intra-articular treatment of osteoarthritis.",J. Med. Chem.,2012,55,2,"Gege C, Bao B, Bluhm H, Boer J, Gallagher BM, Korniski B, Powers TS, Steeneck C, Taveras AG, Baragi VM",,827024,DTCT0024061,10526937,DTCC01242724,1655819,48586
CHEMBL2064540,P22894,,GKLOCXVNLLEZMX-DIPNUNPCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563927,DTCC01248689,284246,48958
CHEMBL2064541,P22894,,GDXZUNJRYLVZAT-WJOKGBTCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.2,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563926,DTCC01248690,1254587,48958
CHEMBL2064542,P22894,,YDSGUUACYYBPLW-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.11,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563925,DTCC01248691,1028287,48958
CHEMBL2064543,P22894,,HBDUXNUNXGZOCK-VLIRCAPWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,58,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563928,DTCC01248692,316917,48958
CHEMBL2064544,P22894,,JZHHNBACJYFNCE-LDLOPFEMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563929,DTCC01248693,543756,48958
CHEMBL2064545,P22894,,JLXRKMSJFVPFIG-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,14,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563930,DTCC01248694,1707024,48958
CHEMBL2064546,P22894,,ANZWBBMLNAIBAB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563931,DTCC01248695,186735,48958
CHEMBL2064547,P22894,,LOPZANGJCBIBLO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.02,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563932,DTCC01248696,382253,48958
CHEMBL2064548,P22894,,FGQWFLDBWZDRJJ-GDLZYMKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.03,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563933,DTCC01248697,1319659,48958
CHEMBL2064549,P22894,,NRRIJAHIBBGLNH-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.04,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563934,DTCC01248698,1767171,48958
CHEMBL2064550,P22894,,UMBBJTOZRJURJL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563935,DTCC01248699,1449098,48958
CHEMBL2064551,P22894,,JXMJSOSLBMBYGM-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563936,DTCC01248700,316918,48958
CHEMBL2064552,P22894,,TUYLXABAVZEOSZ-WGVHSKNFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,0.5,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563937,DTCC01248701,769661,48958
CHEMBL2064553,P22894,,YWHKQQSHVPCBRN-LQFQNGICSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563938,DTCC01248702,1319660,48958
CHEMBL207305,P22894,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16516466,KI,>,3100,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354471,DTCT0024061,1926606,DTCC00421580,552632,20786
CHEMBL207305,P22894,,NUVSGXIVCJBRBF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,>,3100,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457279,DTCC00421580,565360,32556
CHEMBL208009,P22894,,BODLESUVCQEUII-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16516466,KI,=,217,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,"Synthesis and structure-activity relationship of a novel, achiral series of TNF-alpha converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,2006,16,10,"Gilmore JL, King BW, Harris C, Maduskuie T, Mercer SE, Liu RQ, Covington MB, Qian M, Ribadeneria MD, Vaddi K, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,354471,DTCT0024061,1926605,DTCC00421655,1037257,20786
CHEMBL2111961,P22894,,ZOJMJLMSZDGBHC-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,538321,DTCC01264339,1838383,15186
CHEMBL2111961,P22894,,ZOJMJLMSZDGBHC-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1047280,DTCC01264339,1839737,15462
CHEMBL2115165,P22894,ABT-518,IVPPTWCRAFCOFJ-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11754593,IC50,=,5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,105209,DTCT0024061,1572603,DTCC00045007,550427,16699
CHEMBL2151348,P22894,,NWWZGWZTAZLVRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,42900,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370874,DTCC01284445,135194,50870
CHEMBL2151349,P22894,,LXUDTRDQVKIQBB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,8200,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370875,DTCC01284446,1106416,50870
CHEMBL2151350,P22894,,NYMLUNFPRGMRNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,6800,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370876,DTCC01284447,297496,50870
CHEMBL2151351,P22894,,LGIWFZRBXLCBCI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,63000,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370877,DTCC01284448,1941376,50870
CHEMBL2151352,P22894,,QYUJNLGEANWSCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,266,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370878,DTCC01284449,1494536,50870
CHEMBL2151353,P22894,,HWKBTEUWFWNXHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,4500,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370879,DTCC01284450,1494537,50870
CHEMBL2151354,P22894,,PMSYYJDPQTWTTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,2600,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370880,DTCC01284451,1526825,50870
CHEMBL2151355,P22894,,AADOVZDIDBIZSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,336,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370881,DTCC01284452,718092,50870
CHEMBL2151356,P22894,,AHVFZGRDMQDODJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,271,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370882,DTCC01284453,1558882,50870
CHEMBL2151357,P22894,,FHMXFHQIBLHDDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,210,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370884,DTCC01284454,231886,50870
CHEMBL2151358,P22894,,AGAWLHFJRLMKEA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,184,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370885,DTCC01284455,2007154,50870
CHEMBL2151359,P22894,,SDXNOQQCPWCNQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,715,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370886,DTCC01284456,814777,50870
CHEMBL2151360,P22894,,NNAGWFHDLZVPJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,313,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370887,DTCC01284457,1688074,50870
CHEMBL2151361,P22894,,DUYNKLSOEWBOEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,66,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370888,DTCC01284458,1779983,50870
CHEMBL2151362,P22894,,HIPJPXVTDXVQMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,109,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370889,DTCC01284459,1397773,50870
CHEMBL2151363,P22894,,OROXFGPUFVFZQS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,586,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370890,DTCC01284460,1041255,50870
CHEMBL2151364,P22894,,BHEWROOMWGCNFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,2020,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370891,DTCC00131095,1719403,50870
CHEMBL2151365,P22894,,VGXSIAPPDJZRCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,IC50,=,153,NM,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854274,DTCT0024061,11370892,DTCC00131096,685778,50870
CHEMBL2151366,P22894,,XMDWOYHLYOJZLU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 100 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854279,DTCT0024061,11370901,DTCC01284461,814778,50870
CHEMBL2151367,P22894,,FJUYBDSGTYSLQA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23149299,INHIBITION,=,71,%,,,,,,,,,,,,,,Inhibition of recombinant MMP8 catalytic site using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg as substrate at 100 uM incubated for 30 mins prior to substrate addition measured after 3 hrs by fluorimetric assay,,"Design, synthesis and biological evaluation of 5-hydroxy, 5-substituted-pyrimidine-2,4,6-triones as potent inhibitors of gelatinases MMP-2 and MMP-9.",Eur. J. Med. Chem.,2012,58,,"Nicolotti O, Catto M, Giangreco I, Barletta M, Leonetti F, Stefanachi A, Pisani L, Cellamare S, Tortorella P, Loiodice F, Carotti A",,854279,DTCT0024061,11370902,DTCC01284462,264295,50870
CHEMBL2153737,P22894,,LHVGXRIIQBVWQU-JHOVWCEZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21780776,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850718,DTCT0024061,11357593,DTCC01286634,284807,50957
CHEMBL2153738,P22894,,CGPJRIXIBMANTN-PHCUSUGSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21780776,KI,>,200000,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Remarkable potential of the a-aminophosphonate/phosphinate structural motif in medicinal chemistry.,J. Med. Chem.,2011,54,17,"Mucha A, Kafarski P, Berlicki L",,850718,DTCT0024061,11357661,DTCC01286635,705682,50957
CHEMBL2205657,P22894,,XGNIOZCAZTWXMZ-WCHFFXHOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,ACTIVITY,,,,,,,,,,,,,,,,,Activity at MMP8,Active,,ACS Med. Chem. Lett.,2012,3,8,,,879883,DTCT0024061,11466124,DTCC01300890,738152,51794
CHEMBL2205657,P22894,,XGNIOZCAZTWXMZ-WCHFFXHOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,DRUG METABOLISM,,,,,,,,,,,,,,,,,Prodrug conversion assessed as recombinant human MMP-8 mediated compound conversion to 2-(biphenyl-4-ylsulfonamido)acetic acid by HPLC analysis,Not Active,,ACS Med. Chem. Lett.,2012,3,8,,,879890,DTCT0024061,11466106,DTCC01300890,738152,51794
CHEMBL225164,P22894,CLOXYQUIN,CTQMJYWDVABFRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,73,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102626,DTCC00445307,1828598,43205
CHEMBL226345,P22894,ADENINE,GFFGJBXGBJISGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103266,DTCC00449510,86517,43205
CHEMBL227484,P22894,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,0.39,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061794,DTCC00447716,326283,22402
CHEMBL227484,P22894,,CJTUBZULFXKTAT-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,0.39,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061838,DTCC00447716,326284,22402
CHEMBL227501,P22894,,WNLZTTHHHYZJMB-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061791,DTCC00447830,1426294,22402
CHEMBL227553,P22894,,FHZGYMLWCVBBPM-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,260,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061790,DTCC00447831,1166105,22402
CHEMBL227598,P22894,,VKFNDAOTTJONML-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061797,DTCC00447803,972589,22402
CHEMBL227824,P22894,,RVKPGECPCLBLDB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,0.37,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061798,DTCC00447798,940549,22402
CHEMBL228141,P22894,,AGSXHHFUSDGSSO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061789,DTCC00447839,520801,22402
CHEMBL228187,P22894,,NZKKRYAESABOSS-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061793,DTCC00447819,1684493,22402
CHEMBL228188,P22894,,BGBWSADVPWNBME-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,1.3,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061792,DTCC00447820,1102691,22402
CHEMBL229239,P22894,5-FLUOROSALICYLIC ACID,JWPRICQKUNODPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103128,DTCC00002746,183414,43205
CHEMBL230806,P22894,AGELADINE A,QAKGJAQGTQLMFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21413800,IC50,=,0.39,UG.ML-1,,,,,,,,,,,,,,Inhibition of MMP8,,A one-pot synthesis and biological activity of ageladine A and analogues.,J. Med. Chem.,2011,54,7,"Shengule SR, Loa-Kum-Cheung WL, Parish CR, Blairvacq M, Meijer L, Nakao Y, Karuso P",,853825,DTCT0024061,11368656,DTCC00454296,1189861,50935
CHEMBL2311765,P22894,,WPGRSZLFNFYSPR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,98,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750456,DTCC01335238,770711,53282
CHEMBL2311766,P22894,,XLNFBXKUCFOQRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,91,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750455,DTCC01335239,1897286,53282
CHEMBL2311767,P22894,,DRCOOMXUPYOBBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,125,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750453,DTCC01335240,900591,53282
CHEMBL2311768,P22894,,BZTZPJQXNWROKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,217,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750452,DTCC01335241,674087,53282
CHEMBL2311769,P22894,,BUELAJMDFCPTAV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,282,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750451,DTCC01335242,1995132,53282
CHEMBL2311770,P22894,,FHCIUVTYGHWJQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,162,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750450,DTCC01335243,996895,53282
CHEMBL2311771,P22894,,UKASSNVNXOWYDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,46,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750449,DTCC01335244,416242,53282
CHEMBL2311774,P22894,,PHKLGXHLOXCURO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,44,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750461,DTCC01335247,1800637,53282
CHEMBL2311775,P22894,,XATUMTIXUAJCSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,85,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750460,DTCC01335248,383300,53282
CHEMBL2311776,P22894,,HTUSESRFPXTJLY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,60,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750459,DTCC01335249,1768162,53282
CHEMBL2311777,P22894,,LYRSIRCJLISGFP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,117,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750458,DTCC01335250,2027994,53282
CHEMBL2311778,P22894,,WDDBBBHPBMFFCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23246356,IC50,=,88,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 after 45 mins by fluorogenic assay,,MMP inhibition by barbiturate homodimers.,Bioorg. Med. Chem. Lett.,2013,23,2,"Wang J, Radomski MW, Medina C, Gilmer JF",,935414,DTCT0024061,11750457,DTCC01335251,446880,53282
CHEMBL2316256,P22894,,RXBMEHOLQJITJI-LEOXJPRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP8 catalytic domain (21 to 261) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935210,DTCT0024061,11751197,DTCC01339596,71045,53441
CHEMBL2316257,P22894,,LIUMDGLYGBIKBM-SFYKDHMMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23343195,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human MMP8 catalytic domain (21 to 261) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate by spectrophotometry,Not Active,Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies.,J. Med. Chem.,2013,56,3,"Czarny B, Stura EA, Devel L, Vera L, Cassar-Lajeunesse E, Beau F, Calderone V, Fragai M, Luchinat C, Dive V",,935210,DTCT0024061,11751196,DTCC01339597,589403,53441
CHEMBL2338554,P22894,SYMPLOSTATIN 5,KPKJQINJXGFAPS-NBGICTFWSA-M,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23350733,ACTIVITY,=,100,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using (5-FAM/QXLTM) FRET peptide substrate assessed as residual activity at 10 uM incubated for 15 mins prior to substrate addition measured for 2 hrs,,Potent elastase inhibitors from cyanobacteria: structural basis and mechanisms mediating cytoprotective and anti-inflammatory effects in bronchial epithelial cells.,J. Med. Chem.,2013,56,3,"Salvador LA, Taori K, Biggs JS, Jakoncic J, Ostrov DA, Paul VJ, Luesch H",,944686,DTCT0024061,11803597,DTCC01351885,686495,53882
CHEMBL234034,P22894,,NMHJSIJTDAPUMQ-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17276676,IC50,>,3000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,A new 4-(2-methylquinolin-4-ylmethyl)phenyl P1' group for the beta-amino hydroxamic acid derived TACE inhibitors.,Bioorg. Med. Chem. Lett.,2007,17,7,"Chen XT, Ghavimi B, Corbett RL, Xue CB, Liu RQ, Covington MB, Qian M, Vaddi KG, Christ DD, Hartman KD, Ribadeneira MD, Trzaskos JM, Newton RC, Decicco CP, Duan JJ",,447086,DTCT0024061,2169400,DTCC00464775,876465,23623
CHEMBL234350,P22894,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14759282,DTCC00461900,2111482,69259
CHEMBL234350,P22894,,PUHDBKGWNNZTBP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14759931,DTCC00461900,2111482,69259
CHEMBL234529,P22894,,QSOYTCHABFMDFV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800853,DTCC00463157,1071223,31524
CHEMBL234530,P22894,,HFLSBITWFGZVGL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,0.74,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800871,DTCC00111741,1071224,31524
CHEMBL234735,P22894,,LQNSDZTXHZUYKJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800862,DTCC00111742,1685708,31524
CHEMBL235095,P22894,,BUEVFADAMKTXGD-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,0.9,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204573,DTCC00471862,195973,24059
CHEMBL235318,P22894,,JOIDQCSRISGBOH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,22000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204572,DTCC00471863,67005,24059
CHEMBL235916,P22894,,WGTWQHQAJDQPEW-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,105,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204631,DTCC00471841,228357,24059
CHEMBL236130,P22894,,VUFJIPWRAIIGQA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,14000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204587,DTCC00471848,1491086,24059
CHEMBL236446,P22894,,QROXNPLBULDOSL-QGRTWZNFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17512742,IC50,=,101,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Simultaneous presence of unsaturation and long alkyl chain at P'1 of Ilomastat confers selectivity for gelatinase A (MMP-2) over gelatinase B (MMP-9) inhibition as shown by molecular modelling studies.,Bioorg. Med. Chem.,2007,15,14,"Moroy G, Denhez C, El Mourabit H, Toribio A, Dassonville A, Decarme M, Renault JH, Mirand C, Bellon G, Sapi J, Alix AJ, Hornebeck W, Bourguet E",,447909,DTCT0024061,2176053,DTCC00468601,163984,23716
CHEMBL236565,P22894,,REIYGWGAFRRHED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8,Not Determined,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204579,DTCC00471856,326506,24059
CHEMBL236770,P22894,,YVCXCHMORKNFGU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,18,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204577,DTCC00471858,1716115,24059
CHEMBL236974,P22894,,YJBLORWBSQLNFW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204583,DTCC00471852,1841312,24059
CHEMBL237177,P22894,,GYLCNFGXAVLQBI-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,2460,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204581,DTCC00471854,1905591,24059
CHEMBL2372437,P22894,,FGSNBBSHVNLDMX-YUMQZZPRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,121000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1539322,DTCC01369007,562663,15030
CHEMBL237384,P22894,,PMSJHLLBCDOJAE-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,228,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204586,DTCC00471849,521031,24059
CHEMBL2385479,P22894,,QTUCHEGSWFEUBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452648,DTCC01376381,771114,54626
CHEMBL2385480,P22894,,CWDYQHCEZVYJNX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,75,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452646,DTCC01376382,1223051,54626
CHEMBL2385481,P22894,,FTQOZDRDOVWSBK-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452645,DTCC01376383,1515521,54626
CHEMBL2385482,P22894,,LMKSZZKXCRCXFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452643,DTCC01376384,1450589,54626
CHEMBL2385483,P22894,,BLXHYKZAZZIQOC-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452642,DTCC01376385,2092444,54626
CHEMBL2385484,P22894,,JXZUMXBHWMKALL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,32,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452641,DTCC01376386,1962854,54626
CHEMBL2385485,P22894,,PLJKONSYASWBHO-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,98,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452640,DTCC01376387,1190853,54626
CHEMBL2385486,P22894,,AMHJUVNJSCPYSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452638,DTCC01376388,416675,54626
CHEMBL2385487,P22894,,UIMOJSHBVUUXAE-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452637,DTCC01376389,1353845,54626
CHEMBL2385488,P22894,,AQWIHDVVCANJLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452636,DTCC01376390,188159,54626
CHEMBL2385489,P22894,,XYXRFODFDUOQKS-NSHDSACASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452635,DTCC01376391,1223052,54626
CHEMBL2385490,P22894,,DOZFSSIRRROWRF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452634,DTCC01376392,1768575,54626
CHEMBL2385491,P22894,,OEXQBZKLEMTXMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,364,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452633,DTCC01376393,220369,54626
CHEMBL2385492,P22894,,YJKZJSXUMXIJNB-VIFPVBQESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452632,DTCC01376394,1418784,54626
CHEMBL2385493,P22894,,UYVXUYVAIIWBSW-LURJTMIESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,275,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452631,DTCC01376395,416676,54626
CHEMBL240963,P22894,LAWSONE,CSFWPUWCSPOLJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,86,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103704,DTCC00473933,1057327,43205
CHEMBL242073,P22894,,HOAKXOLFZXBTCB-UEUJIKQLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17267227,IC50,=,110000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441980,DTCT0024061,2144981,DTCC00460316,2079532,23207
CHEMBL242074,P22894,,PAWMGXIJYPYCIU-WQMPYENHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17267227,IC50,=,11000,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Synthesis and in vitro evaluation of targeted tetracycline derivatives: effects on inhibition of matrix metalloproteinases.,Bioorg. Med. Chem.,2007,15,6,"Vidal A, Sabatini M, Rolland-Valognes G, Renard P, Madelmont JC, Mounetou E",,441980,DTCT0024061,2144980,DTCC00460317,661441,23207
CHEMBL2425930,P22894,,PECBDMOWKLTTSB-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577936,DTCC01394954,1780885,55760
CHEMBL2425931,P22894,,ZTOBNNQGIRZHDO-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577935,DTCC01394955,396398,55760
CHEMBL2425932,P22894,,XMVQXBAGOTVZDD-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.9,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577934,DTCC01394956,977332,55760
CHEMBL2425933,P22894,,UCWSKTMFEWSSSI-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577933,DTCC01394957,589788,55760
CHEMBL2425934,P22894,,BDPAGEAOFNRCNJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577932,DTCC01394958,1720338,55760
CHEMBL2425935,P22894,,WCHOGKFWHQMHQW-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577931,DTCC01394959,945221,55760
CHEMBL2425936,P22894,,WTEZGXPTIFMTCH-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.4,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577930,DTCC01394960,200173,55760
CHEMBL2425937,P22894,,MIKGRMSWGTVOSA-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,35,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577929,DTCC01394961,1720339,55760
CHEMBL2425938,P22894,,XJNFMEAYBQFDAS-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.05,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577927,DTCC01394962,686766,55760
CHEMBL2425939,P22894,,CMKYCYOBCXIZPF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.7,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577926,DTCC01394963,493235,55760
CHEMBL2425940,P22894,,NXCSXUBVRRHHLE-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577925,DTCC01394964,622205,55760
CHEMBL2425941,P22894,,NTDGKPHATDVYNT-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.3,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577924,DTCC01394965,913758,55760
CHEMBL2425942,P22894,,VPDOXKSDXTZFIX-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577923,DTCC01394966,428918,55760
CHEMBL2425943,P22894,,ADDYZQRMSCIHFH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.2,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577922,DTCC01394967,1748898,55760
CHEMBL2425944,P22894,,WUGYYDAXBPEKAI-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.3,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577921,DTCC01394968,686767,55760
CHEMBL2425946,P22894,,OPJBQWSZZMIIHX-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577941,DTCC01394970,21657,55760
CHEMBL2425947,P22894,,MFOJAATVHNHXKB-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.4,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577940,DTCC01394971,331061,55760
CHEMBL2425948,P22894,,LTTRJMCJTUBEGF-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577939,DTCC01394972,1430830,55760
CHEMBL2425949,P22894,,ZXGBSFAKYZEOPJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.5,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577938,DTCC01394973,525520,55760
CHEMBL2425950,P22894,,SMKRBNFEFJZHAI-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,0.2,NM,,,,,,,,,,,,,,"Inhibition of MMP-8 (unknown origin) using 7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl)Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by fluorescence assay",,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983463,DTCT0024061,12577937,DTCC01394974,1909986,55760
CHEMBL243236,P22894,,NVJUVGMOOGFJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,90,NM,,,,,,,,,,,,,,Inhibition of MMP9,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442206,DTCT0024061,2162219,DTCC00463665,110626,23225
CHEMBL243236,P22894,,NVJUVGMOOGFJLZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442205,DTCT0024061,2162217,DTCC00463665,110626,23225
CHEMBL2437163,P22894,,JRAYHZWPXHIVJI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24044937,IC50,=,47000,NM,,,,,,,,,,,,,,Inhibition of human MMP-8 using Mca-Pro-Cha-Gly-Nva-His-Ala-Dpa-NH2 as substrate after 120 mins,,Aggrecanase-2 inhibitors based on the acylthiosemicarbazide zinc-binding group.,Eur. J. Med. Chem.,2013,69,,"Maingot L, Elbakali J, Dumont J, Bosc D, Cousaert N, Urban A, Deglane G, Villoutreix B, Nagase H, Sperandio O, Leroux F, Deprez B, Deprez-Poulain R",,986692,DTCT0024061,12607874,DTCC01400189,751355,56087
CHEMBL243874,P22894,,IEFFRLNSCQIVBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP9,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442206,DTCT0024061,2162337,DTCC00463738,2047468,23225
CHEMBL243874,P22894,,IEFFRLNSCQIVBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,1300,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442205,DTCT0024061,2162335,DTCC00463738,2047468,23225
CHEMBL24398,P22894,,UACUZULRKJKTHE-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,171,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1422369,DTCC00158787,1693988,16438
CHEMBL24398,P22894,,UACUZULRKJKTHE-CZYKHXBRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,171,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457507,DTCC00158787,1696785,32556
CHEMBL2440429,P22894,,MDQNHUVXMAEAFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,61000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629020,DTCC01400793,1158679,56259
CHEMBL2440430,P22894,,GPHBFHLZRQMFLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,44000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629024,DTCC01400794,1708742,56259
CHEMBL2440431,P22894,,VRCNSKZUURJQAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,39900,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629023,DTCC01400795,252959,56259
CHEMBL2440432,P22894,,ZSBBJNVNCGRSOS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,43000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629022,DTCC01400796,1158680,56259
CHEMBL2440433,P22894,"3,4-DICHLOROPHENYLAMINOMETHYLENEBISPHOSPHONIC ACID",ADHSWFUIIRWNHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,25500,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629028,DTCC01400797,220619,56259
CHEMBL2440434,P22894,,GSMGLRFAXIPFLS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629027,DTCC01400798,1062292,56259
CHEMBL2440435,P22894,,SENUMOHBDKDZCG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629032,DTCC01400799,1127369,56259
CHEMBL2440436,P22894,,SCLGFWTXZFUITP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629031,DTCC01400800,1321323,56259
CHEMBL2440437,P22894,,ZEZSYIYQVUYORL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629035,DTCC01400801,1256310,56259
CHEMBL2440438,P22894,,XQVNOYYFZWUDCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629034,DTCC01400802,1095361,56259
CHEMBL2440439,P22894,(P-TOLYLAMINO)METHYLENEDIPHOSPHONIC ACID,FVJHDPVFVSTFKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,36000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629037,DTCC01400803,642669,56259
CHEMBL2440440,P22894,,RBHODZPTKHWXDX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629036,DTCC01400804,1062293,56259
CHEMBL2440441,P22894,,AXIAQHKDCQVIKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,2400,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629040,DTCC01400805,318637,56259
CHEMBL2440578,P22894,,HTWBLJFKBSZUAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,15000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629038,DTCC01400943,1938015,56259
CHEMBL2440579,P22894,(4-CHLOROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,PPOZCMYPJMEBPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629041,DTCC01400944,416940,56259
CHEMBL2440580,P22894,(PHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,XVNZXEWQQDCZSM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629043,DTCC01400945,1515790,56259
CHEMBL2440581,P22894,,CXOBNZQSLVRTMZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629042,DTCC01400946,383983,56259
CHEMBL2442878,P22894,,KXYWMKRIKCLADT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639832,DTCC01403249,188424,56235
CHEMBL2442879,P22894,,VFVIUYYQHAEKJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639831,DTCC01403250,91625,56235
CHEMBL2442880,P22894,,SJWVELZZBPYZRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639830,DTCC01403251,220656,56235
CHEMBL2442881,P22894,,NPWUBXHYMWVDKN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639829,DTCC01403252,351448,56235
CHEMBL2442882,P22894,,XCRZYFVDWZHDQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639828,DTCC01403253,1547821,56235
CHEMBL2442883,P22894,,IUYSNQXMHWEVJW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639827,DTCC01403254,252989,56235
CHEMBL2442884,P22894,,PXYTTWPKWBWEHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639826,DTCC01403255,2092731,56235
CHEMBL2442885,P22894,,NKVKCTYTQNQNIH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,=,13000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639825,DTCC01403256,1256330,56235
CHEMBL2442886,P22894,,LJRIZWAWUQHHTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,=,15000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639824,DTCC01403257,1354112,56235
CHEMBL2442887,P22894,,KDYJIWZXMZGJQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639823,DTCC01403258,2060629,56235
CHEMBL2442888,P22894,,FNTWGXGOCVTLKR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639822,DTCC01403259,1030030,56235
CHEMBL2442889,P22894,,MWMLZWBDIRKPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639837,DTCC01403260,1450847,56235
CHEMBL2442890,P22894,,JOSPLESHDLLQSD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639836,DTCC01403261,1062314,56235
CHEMBL2442891,P22894,,NDWDLJQCZNKAHG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639835,DTCC01403262,481047,56235
CHEMBL2442892,P22894,,FWECVAAARPJXSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639834,DTCC01403263,57219,56235
CHEMBL2442893,P22894,,LYYLWOIDTXRRLW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24028490,KI,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP-8 catalytic domain using McaKPLGL9(Dpa)AR-NH2 as substrate by fluorescence spectrophotometric analysis,Not Determined,O-phenyl carbamate and phenyl urea thiiranes as selective matrix metalloproteinase-2 inhibitors that cross the blood-brain barrier.,J. Med. Chem.,2013,56,20,"Gooyit M, Song W, Mahasenan KV, Lichtenwalter K, Suckow MA, Schroeder VA, Wolter WR, Mobashery S, Chang M",,990996,DTCT0024061,12639833,DTCC01403264,1547822,56235
CHEMBL24447,P22894,PHENETHYLCARBAMOYLPHOSPHONIC ACID,GHFCXEYUGIXTHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1320461,DTCC00158289,2077403,17838
CHEMBL24510,P22894,FUSARIC ACID,DGMPVYSXXIOGJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,47,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103023,DTCC00104041,2055567,43205
CHEMBL253261,P22894,,APXZBXMVEOBZDS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.24,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258660,DTCC00487206,972940,24803
CHEMBL253275,P22894,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18242982,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462367,DTCT0024061,2282465,DTCC00003908,392011,25163
CHEMBL253275,P22894,BMS-566394,PGVYYPZKXKGBLD-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,>,10000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457235,DTCC00003908,404569,32556
CHEMBL253470,P22894,,WUJKUDYOBOSPIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,190546.07,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258687,DTCC00487208,553254,24803
CHEMBL253680,P22894,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1312042,DTCC00487204,1035283,16328
CHEMBL253680,P22894,,LFOGEPKUSWRLCL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258670,DTCC00487204,1037850,24803
CHEMBL256157,P22894,,PRJCFROAJDAXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,0.6,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14744861,DTCC00490063,2108850,69259
CHEMBL262264,P22894,,FEGDHECAHSRZEF-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,528840,DTCC00204608,128555,15186
CHEMBL262676,P22894,,HNXQLWUITFQYPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1606266,DTCC00299222,2045764,15919
CHEMBL262758,P22894,,CMNKCJOQYZYEJJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,735771,DTCC00235043,949631,5658
CHEMBL262758,P22894,,CMNKCJOQYZYEJJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457535,DTCC00235043,952986,32556
CHEMBL262921,P22894,,JUFXBRBJBRYADB-KEKNWZKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,12000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1542954,DTCC00291066,2013368,15030
CHEMBL266292,P22894,,SUFSQYXUPYDFHG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,102,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1315162,DTCC00133589,1631533,4760
CHEMBL267939,P22894,,XDYZXHJJAIXYOR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,3.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1312865,DTCC00133464,1275453,4760
CHEMBL268114,P22894,,CNDCCBOSTVCBMM-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,6.6,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1315169,DTCC00133623,2015284,4760
CHEMBL268377,P22894,,SRBWJOFRJIEWKS-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,6.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1322469,DTCC00133440,2015283,4760
CHEMBL269019,P22894,,RCXJWFMVFQBLSC-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1298436,DTCC00133541,1599275,4760
CHEMBL270050,P22894,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18251495,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain,Not Active,"Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2008,51,4,"Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK",,465549,DTCT0024061,2311298,DTCC00503704,1636500,25409
CHEMBL270050,P22894,,YOFJHCFIKFPSLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP8,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457323,DTCC00503704,1632393,32556
CHEMBL270083,P22894,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18257543,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465797,DTCT0024061,2311839,DTCC00004596,2020286,25428
CHEMBL270083,P22894,CIS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-NTSWFWBYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457400,DTCC00004596,2016157,32556
CHEMBL270296,P22894,TRANS-2-AMINOCYCLOHEXYLCARBAMOYLPHOSPHONIC ACID,XHCXISPZIHYKQD-PHDIDXHHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18257543,IC50,=,50000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,"Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis.",J. Med. Chem.,2008,51,5,"Hoffman A, Qadri B, Frant J, Katz Y, Bhusare SR, Breuer E, Hadar R, Reich R",,465797,DTCT0024061,2311847,DTCC00004597,1151799,25428
CHEMBL270515,P22894,DELANZOMIB,SJFBTAPEPRWNKH-CCKFTAQKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18247547,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human MMP8 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464578,DTCT0024061,2308332,DTCC00504722,1442592,25324
CHEMBL271235,P22894,,SIICAQVADMFEDB-LADGPHEKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18061445,KI,=,2000,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,"Alpha,beta-cyclic-beta-benzamido hydroxamic acids: novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-alpha converting enzyme (TACE).",Bioorg. Med. Chem. Lett.,2008,18,2,"Ott GR, Asakawa N, Lu Z, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Traskos JM, Decicco CP, Duan JJ",,463240,DTCT0024061,2296559,DTCC00502102,1776559,25233
CHEMBL27577,P22894,SALICYLAMIDE,SKZKKFZAGNVIMN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,24,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102659,DTCC00161342,183413,43205
CHEMBL277792,P22894,,KKRBZYCHOUTMBU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1083350,DTCC00249127,615165,15258
CHEMBL279785,P22894,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1478661,DTCC00151612,917406,3373
CHEMBL279785,P22894,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579851,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (matrix metalloprotease-8),,New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.,J. Med. Chem.,1999,42,23,"Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R",,105067,DTCT0024061,1584428,DTCC00151612,907625,15496
CHEMBL279785,P22894,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11754593,IC50,=,0.47,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,105209,DTCT0024061,1580593,DTCC00151612,906350,16699
CHEMBL279785,P22894,MARIMASTAT,OCSMOTCMPXTDND-OUAUKWLOSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26653735,IC50,=,10000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) catalytic domain using MCA-Arg-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-Glu-Arg-NH2 as substrate preincubated for 60 mins followed by substrate addition by fluorescence assay,,"Discovery of N-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis.",J. Med. Chem.,2016,59,1,"Ruminski PG, Massa M, Strohbach J, Hanau CE, Schmidt M, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Shieh HS, Caspers N, Collins B, Grapperhaus M, Palmquist KE, Collins J, Baldus JE, Hitchcock J, Kleine HP, Rogers MD, McDonald J, Munie GE, Messing DM, Portolan S, Whiteley LO, Sunyer T, Schnute ME.",,1552514,DTCT0024061,73305,DTCC00151612,915925,65989
CHEMBL280017,P22894,,RSMQCSLXBNSQJJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1683006,DTCC00201392,937808,16216
CHEMBL280998,P22894,CATECHOL,YCIMNLLNPGFGHC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103295,DTCC00161195,517323,43205
CHEMBL281795,P22894,,GCBPAPVOMPJQHK-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,0.4,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1449483,DTCC00157778,1049545,1206
CHEMBL282146,P22894,,AKWKBACKRMYPRV-NQIIRXRSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,14,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1470038,DTCC00168996,726366,1206
CHEMBL284104,P22894,DIPICOLINIC ACID,WJJMNDUMQPNECX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,17,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103302,DTCC00159433,280901,43205
CHEMBL285112,P22894,,YKHOQKKUOWOUDP-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8 (not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105203,DTCT0024061,1476123,DTCC00168915,888195,1206
CHEMBL285418,P22894,,OONXADPQRATYFL-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,0.5,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1476115,DTCC00104294,35210,1206
CHEMBL286204,P22894,QUINOLINIC ACID,GJAWHXHKYYXBSV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103262,DTCC00158604,151276,43205
CHEMBL286904,P22894,,BQOKFWQTKSZIMZ-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,163,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1473751,DTCC00169030,856017,1206
CHEMBL287556,P22894,KOJIC ACID,BEJNERDRQOWKJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,51,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103897,DTCC00159276,1381648,43205
CHEMBL287899,P22894,"PYRIDINE-2,3-DIOL",GGOZGYRTNQBSSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,7,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103009,DTCC01739869,1316336,43205
CHEMBL288099,P22894,,SMWGTYPHHCYQHB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,80,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1033065,DTCC00173333,647042,4214
CHEMBL290377,P22894,,UTSFQPTVPZNJJH-YPJJGMIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824028,IC50,=,0.77,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,105210,DTCT0024061,1488311,DTCC00181446,853101,5648
CHEMBL291307,P22894,,DNFKKMGBEKWECE-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,531611,DTCC00204309,2065194,15186
CHEMBL291691,P22894,,KGEKBYNTOIYJHE-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,533530,DTCC00204415,550097,15186
CHEMBL291697,P22894,,YNCNUFDRUOIACX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,540087,DTCC00204418,2000483,15186
CHEMBL291757,P22894,,OREVCDGKIGJEIW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,7,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, Matrix Metalloprotease-8",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105811,DTCT0024061,518839,DTCC00204754,711580,15186
CHEMBL291757,P22894,,OREVCDGKIGJEIW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020027,DTCC00204754,712956,15462
CHEMBL291758,P22894,,FKBDRAKAEJZJEQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,534390,DTCC00204755,1649539,15186
CHEMBL291758,P22894,,FKBDRAKAEJZJEQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1047271,DTCC00204755,1650909,15462
CHEMBL291898,P22894,,PPELJLBDXLMTEW-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,527829,DTCC00204356,550095,15186
CHEMBL291898,P22894,,PPELJLBDXLMTEW-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1054929,DTCC00204356,551562,15462
CHEMBL291965,P22894,,AGYRDWGTLLSXLW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542037,DTCC00204417,1391493,15186
CHEMBL292128,P22894,,SRXJKOWUSBFUNU-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,600,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518846,DTCC00204307,1293454,15186
CHEMBL292226,P22894,,JXSWSZIEDSTKDW-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,516789,DTCC00204373,1617390,15186
CHEMBL292431,P22894,,DCSHLVVGHNRVCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1719466,DTCC00200601,1325927,16216
CHEMBL292636,P22894,,FSKXYSMYBLXDDL-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518840,DTCC00204204,1455549,15186
CHEMBL292636,P22894,,FSKXYSMYBLXDDL-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1042532,DTCC00204204,1456926,15462
CHEMBL292657,P22894,,UALGGXUAYUNRBS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,58,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1703174,DTCC00200819,1584625,16216
CHEMBL292659,P22894,,QZGLUUHBLOQISE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,526815,DTCC00204020,452386,15186
CHEMBL292671,P22894,,MKTUSESWUSYVIL-SGTLLEGYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518844,DTCC00203869,1552483,15186
CHEMBL292916,P22894,,HYNBRLICGGQMNU-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,50,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,532549,DTCC00204516,388750,15186
CHEMBL293044,P22894,,RNWNGVUCFRPGIO-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,523024,DTCC00204349,1358790,15186
CHEMBL293305,P22894,,BEKYMPWGANBKBK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,11,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1694308,DTCC00201393,1741622,16216
CHEMBL293357,P22894,,DYSNZNGQZPYHHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1712506,DTCC00200657,808246,16216
CHEMBL293359,P22894,,LTRQYQYXWUQKJZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,514769,DTCC00203969,2033437,15186
CHEMBL293479,P22894,,BHTYFFISFVNOLJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,30000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629025,DTCC00200892,318636,56259
CHEMBL293503,P22894,,GWQRQVFEMGHPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,0.1,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1707061,DTCC00201391,1934658,16216
CHEMBL293503,P22894,,GWQRQVFEMGHPMD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,0.1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1618959,DTCC00201391,1947698,15919
CHEMBL293504,P22894,,HOSIVTBRRYYOOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1705680,DTCC00200534,1805904,16216
CHEMBL293528,P22894,,MHGISLAIZQKUNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1696763,DTCC00200538,969875,16216
CHEMBL293571,P22894,,CVMQTPIUJOGYIP-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,541047,DTCC00204003,647374,15186
CHEMBL293774,P22894,,LOYIGNDQOZNJNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1707066,DTCC00201035,1773398,16216
CHEMBL293774,P22894,,LOYIGNDQOZNJNZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1613758,DTCC00201035,1786101,15919
CHEMBL294167,P22894,,ZOJMJLMSZDGBHC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,534392,DTCC00204330,1649540,15186
CHEMBL294167,P22894,,ZOJMJLMSZDGBHC-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,5,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017364,DTCC00204330,1650910,15462
CHEMBL294374,P22894,,GIKKFOVDJPQBSW-SXSDINLZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,532551,DTCC00204340,647376,15186
CHEMBL294426,P22894,,IGRVUOPMHNISAV-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,513790,DTCC00204677,3135,15186
CHEMBL294654,P22894,,HRMWQQBRFJMAPM-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,543787,DTCC00204353,1520457,15186
CHEMBL294680,P22894,,PSFVLJSHQMPQKQ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,526813,DTCC00204823,1293453,15186
CHEMBL294680,P22894,,PSFVLJSHQMPQKQ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1044756,DTCC00204823,1294864,15462
CHEMBL294896,P22894,,MYZZCJKXPLJTGX-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,527830,DTCC00203968,257660,15186
CHEMBL295066,P22894,,CTONTIQKTODDRQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,585,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1448232,DTCC00193515,1838262,3192
CHEMBL296196,P22894,,PTONAIKVYGVBIS-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061984,DTCC00186419,228138,22402
CHEMBL297488,P22894,,UOHZYJYLFKMPMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1698015,DTCC00200864,1034802,16216
CHEMBL298167,P22894,,PMVTXYIJWIAFKQ-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9599226,KI,=,10,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,105216,DTCT0024061,1357168,DTCC00193648,323312,14640
CHEMBL298606,P22894,,MMCVYPKEJGVLMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1680254,DTCC00200915,743833,16216
CHEMBL298814,P22894,,ULQUQVTVRZFECE-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,1000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,523026,DTCC00204438,1488148,15186
CHEMBL298822,P22894,,JMWYGNIQHYKDCH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1688125,DTCC00201439,1520406,16216
CHEMBL298957,P22894,,BLDIAFCHXVRHEP-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518843,DTCC00204261,2065192,15186
CHEMBL299020,P22894,,CLKXWRSURRSEKP-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,519937,DTCC00204639,1067144,15186
CHEMBL299023,P22894,,CRKJGMQLKRTZPW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1689351,DTCC00201420,1293406,16216
CHEMBL299091,P22894,,QFPRVWUEWDLNPU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,29,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1715033,DTCC00200999,1325931,16216
CHEMBL299600,P22894,,NJSAPXUDAYVTFL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1713860,DTCC00200869,1934657,16216
CHEMBL299664,P22894,,GSLSWNSJTMLFSO-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542893,DTCC00204440,1838384,15186
CHEMBL299720,P22894,,XIMLFZSNGXTRSL-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518845,DTCC00204342,1358791,15186
CHEMBL29976,P22894,,QXLMMZHXXOWCDY-OWCLPIDISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579851,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (matrix metalloprotease-8),,New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.,J. Med. Chem.,1999,42,23,"Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R",,105067,DTCT0024061,1569791,DTCC00163718,907624,15496
CHEMBL299936,P22894,,ROVRDWIOAVCKAV-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,521997,DTCC00204446,2033436,15186
CHEMBL300162,P22894,,FDELEKDMYZLVHP-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,1,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,530686,DTCC00204455,1391494,15186
CHEMBL300362,P22894,,YRUNEWMUGNJMAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1718073,DTCC00200830,1805905,16216
CHEMBL300697,P22894,,XUDODBAIOYVRJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,50,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1465328,DTCC00194150,549968,3192
CHEMBL300807,P22894,,DMOIDCGAIGWXGJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1699214,DTCC00201437,711540,16216
CHEMBL300829,P22894,,CSLRMNGVKPXZNV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,527831,DTCC00204673,647375,15186
CHEMBL300975,P22894,,IMRWXXAPWNPDGA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,800,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,519936,DTCC00203937,161212,15186
CHEMBL301014,P22894,,ZKKQCCSHBYRQHR-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,525945,DTCC00204420,1902661,15186
CHEMBL301048,P22894,,DTFUJQWTCDBNIX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,514771,DTCC00204711,323432,15186
CHEMBL301085,P22894,,NOYXCNRQZBBVGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,2,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1693210,DTCC00200557,1520405,16216
CHEMBL301177,P22894,,YDCLZJDJJGSFJZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,34,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1720812,DTCC00200792,96315,16216
CHEMBL301469,P22894,,IODSZLVGIASSTE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,70000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1612440,DTCC00201002,1435961,15919
CHEMBL301565,P22894,,CTVWOVYWOFCAMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10230616,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,105215,DTCT0024061,1696311,DTCC00194174,939779,3610
CHEMBL301565,P22894,,CTVWOVYWOFCAMW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1477360,DTCC00194174,937726,3192
CHEMBL301626,P22894,,JNBNCWQZPZWAOV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,529713,DTCC00204725,906036,15186
CHEMBL301626,P22894,,JNBNCWQZPZWAOV-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1046076,DTCC00204725,907522,15462
CHEMBL301675,P22894,,VZEDRBAGPXKVHL-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542036,DTCC00203982,421543,15186
CHEMBL301786,P22894,,MZISFPSOTJFTTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1719461,DTCC00200965,257620,16216
CHEMBL301884,P22894,,WVJHDQDLYDFIKS-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518842,DTCC00204263,841092,15186
CHEMBL301900,P22894,,LKNQKZXVRWZYQR-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,516791,DTCC00204374,1391492,15186
CHEMBL301977,P22894,,ATNNMKHWMHMLHP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1720801,DTCC00201068,1358752,16216
CHEMBL302311,P22894,,LUZFASJCLDTWLF-TZIWHRDSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.33,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1385043,DTCC00225565,1207413,14854
CHEMBL302368,P22894,,BWPZARSJOUWFCK-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1.2,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1385039,DTCC00225594,108075,14854
CHEMBL302954,P22894,,FWNRCECLAVXIOV-GKBBYZSKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,14,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1383740,DTCC00224712,29663,14854
CHEMBL303155,P22894,,URVVMIUWONGKFU-IAGOWNOFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.54,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1376171,DTCC00225316,1629208,14854
CHEMBL303918,P22894,,YZDALJROFHNCEI-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,17,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1393650,DTCC00226034,237156,14854
CHEMBL304045,P22894,,NITYDPDXAAFEIT-CXAGYDPISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,390,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1399878,DTCC00225519,658972,14854
CHEMBL304281,P22894,,UTERPWJSMDDIGY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,5.1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1636610,DTCC00227332,562772,15919
CHEMBL304617,P22894,,UKNOMEZXDWRZAF-GMQRUSHYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,6.2,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1379721,DTCC00225488,237157,14854
CHEMBL305069,P22894,2-ACETYLCYCLOPENTANONE,OSWDNIFICGLKEE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103737,DTCC00223385,1283746,43205
CHEMBL305222,P22894,,MOPRTFSMCQNUCT-HUUCEWRRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.82,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368291,DTCC00225617,1079123,14854
CHEMBL305780,P22894,,VZUMDYFAZYINJW-NHCUHLMSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,2.4,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1373606,DTCC00226109,1596639,14854
CHEMBL306189,P22894,,SLZZXDGACSPBLI-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1.6,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1395896,DTCC00225534,368141,14854
CHEMBL306224,P22894,,VKWHTWCAMYPFQG-KUHUBIRLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.34,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1373610,DTCC00225609,1240175,14854
CHEMBL306470,P22894,,AOPYXKATLYBNDC-IERDGZPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1.6,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1373614,DTCC00225336,1629209,14854
CHEMBL306524,P22894,,SMZZZWJJIWYSNC-DVECYGJZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.1,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1386176,DTCC00225147,1785317,14854
CHEMBL306726,P22894,,YXXIQAWIZFAIOP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1629134,DTCC00227196,1818654,15919
CHEMBL306871,P22894,,HYGHKRXESWZJHZ-JPYJTQIMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.49,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1366974,DTCC00225125,1403136,14854
CHEMBL306912,P22894,,CBYPWAIEESKRSM-CZUORRHYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.45,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1366978,DTCC00224800,1207412,14854
CHEMBL307057,P22894,,GDYDGGBDRIVFOF-MUUNZHRXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,35000,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,767570,DTCC00235042,885408,5658
CHEMBL307090,P22894,,YUPQCEGDWHZIJW-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.59,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1373618,DTCC00225129,1435145,14854
CHEMBL30782,P22894,,KSSHTSOSCFKFRS-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8 (not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105203,DTCT0024061,1467653,DTCC00168888,436167,1206
CHEMBL308012,P22894,,MYGNBBVBBNZVCZ-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,3.7,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1369568,DTCC00224756,204695,14854
CHEMBL308032,P22894,,BAYJYFFPKRGRAF-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,460,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1397427,DTCC00225465,1849940,14854
CHEMBL30804,P22894,,UDNLRUDZHBXCON-OFSOJUDTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1455540,DTCC00168891,597107,1206
CHEMBL308228,P22894,,DRZSKJBSLSLPQN-IOMROCGXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.7,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1403418,DTCC00225486,658973,14854
CHEMBL308277,P22894,,VGXYGECPCDQSNI-DINWUYGQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824028,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,105210,DTCT0024061,1510777,DTCC00232492,1532289,5648
CHEMBL308397,P22894,,BAIUIZQDBMFOMK-AOYPEHQESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,4.5,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1399731,DTCC00224637,497653,14854
CHEMBL308429,P22894,,GBFCSIJILLHVFK-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,7.7,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1388713,DTCC00225516,1499818,14854
CHEMBL308598,P22894,,NGIYDDHHYYPZFT-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,27,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368296,DTCC00225496,755586,14854
CHEMBL30980,P22894,,IZYWROOEWSDARX-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8 (not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105203,DTCT0024061,1450647,DTCC00168927,338478,1206
CHEMBL310249,P22894,,HJPHCDCNWWBUEA-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.29,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1378543,DTCC00224949,1596641,14854
CHEMBL310555,P22894,OXYQUINOLINE,MCJGNVYPOGVAJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,92,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103942,DTCC00239255,1090149,43205
CHEMBL311004,P22894,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1291620,DTCC00242427,582684,16328
CHEMBL311004,P22894,,FNURWSLLBXZLRC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,1.82,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258665,DTCC00242427,585411,24803
CHEMBL311097,P22894,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,6.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1305051,DTCC00242342,193495,16328
CHEMBL311097,P22894,,SBYCYYMPCYJMTP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,6.76,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258674,DTCC00242342,196125,24803
CHEMBL311266,P22894,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,0.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1307404,DTCC00242099,744290,16328
CHEMBL311266,P22894,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,3.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1319107,DTCC00242099,744289,16328
CHEMBL311266,P22894,,YUWSFQQPCKKPJG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.39,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258666,DTCC00242099,746931,24803
CHEMBL311336,P22894,,ZGSTVUAZFACDLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1603753,DTCC00243756,820899,15919
CHEMBL311367,P22894,,XBFJQKIHALLFRT-HHHXNRCGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,13000,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,745854,DTCC00234760,562082,5658
CHEMBL31164,P22894,,WATNMHGSJFUVDX-JOMNFKBKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,102,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,13,,,105202,DTCT0024061,1467645,DTCC00168840,1725862,1206
CHEMBL311932,P22894,,JIRXORZYIXSWOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20965620,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP8 by fluorimetric assay,,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,2010,45,12,"Attolino E, Calderone V, Dragoni E, Fragai M, Richichi B, Luchinat C, Nativi C",,694546,DTCT0024061,5018598,DTCC00243867,587481,42241
CHEMBL312100,P22894,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,3.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1301288,DTCC00242298,1773867,16328
CHEMBL312100,P22894,,IOANZCGEYMTXEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.63,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258661,DTCC00242298,1776498,24803
CHEMBL313340,P22894,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,44.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1297512,DTCC00242488,577853,16328
CHEMBL313340,P22894,,IMQVPVWXNJYVAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,44.67,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258664,DTCC00242488,682322,24803
CHEMBL313356,P22894,,FPIZTGFSDBBQIE-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,12,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,499031,DTCC00246995,1391948,13104
CHEMBL313360,P22894,,UFJUEKAJZPTZED-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,5.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1078556,DTCC00249036,1424200,15258
CHEMBL313386,P22894,,XYZHDRSTLPUTBX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,230,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1084518,DTCC00249347,291450,15258
CHEMBL313472,P22894,,RFNUTMXSNZMOSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1059544,DTCC00249282,1002960,15258
CHEMBL313483,P22894,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,<,1,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,475317,DTCC00247651,841549,13104
CHEMBL313483,P22894,,MJERYQQJZATKQA-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,1,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,613719,DTCC00247651,853711,1496
CHEMBL313896,P22894,,NFDNOGJHVSTSMJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1085852,DTCC00249106,422043,15258
CHEMBL314199,P22894,,GKNHTZOPKGQBHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1084525,DTCC00249345,291449,15258
CHEMBL31422,P22894,MALTOL,XPCTZQVDEJYUGT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,19,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102599,DTCC00167287,604861,43205
CHEMBL3142588,P22894,,NMJSZUFFJMVVTC-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,24000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1045737,DTCC01434962,776475,5080
CHEMBL3142589,P22894,,LBXQNROQWCXYOR-JSGCOSHPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,17000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1048215,DTCC01434963,4100,5080
CHEMBL3142590,P22894,,CPXWXSPXARFAMY-UGSOOPFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,9000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1032054,DTCC01434964,1359339,5080
CHEMBL3142591,P22894,,KXEOBTKKJDNBQP-YWZLYKJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,45000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1025916,DTCC01434965,938350,5080
CHEMBL3142592,P22894,,YPHZPHWJIIIDPD-WPRPVWTQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,1000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1054599,DTCC01434966,776476,5080
CHEMBL3142593,P22894,,BUTLOPCSKDMNBW-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,18000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1042211,DTCC01434967,1870833,5080
CHEMBL3142594,P22894,,FBWGSUGKKLTDRD-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,5000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1020954,DTCC01434968,1682213,5080
CHEMBL3142596,P22894,,NUHCNKSHBIFLOX-HOCLYGCPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,6000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1045742,DTCC01434970,1035400,5080
CHEMBL3142598,P22894,,OLEDPIQVUZOZBZ-WMZOPIPTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,25000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1028476,DTCC01434972,486381,5080
CHEMBL3142599,P22894,,GHEPWMPGSKBGIP-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,40000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1019732,DTCC01434973,938351,5080
CHEMBL3142600,P22894,,HBSLPEMCEWWBRI-NHYWBVRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,9000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1040794,DTCC01434974,4099,5080
CHEMBL3142601,P22894,,OMBKWZNZMXWHMG-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,3000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1040941,DTCC01434975,1035401,5080
CHEMBL3142602,P22894,,CLSZSRWILIUAGI-GUYCJALGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1054604,DTCC01434976,841609,5080
CHEMBL3142605,P22894,,KXLQATQMHVLQBR-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,5000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1047028,DTCC01434979,1132658,5080
CHEMBL3142606,P22894,,QULPHXDROMVDLR-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1050771,DTCC01434980,615188,5080
CHEMBL3142607,P22894,,IKFXTEOZLBAELL-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1020959,DTCC01434981,970460,5080
CHEMBL3142608,P22894,,QJVFJOYLFWWFDX-JXFKEZNVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,48000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1040954,DTCC01434982,1968441,5080
CHEMBL3142610,P22894,,CRCHRLLZPJQYMX-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,13000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1032049,DTCC01434984,529938,5080
CHEMBL3142611,P22894,,YBPBIDCTKSJPFD-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,12000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1022251,DTCC01434985,1682214,5080
CHEMBL3142612,P22894,,RRKJXTGNGHGKTN-QYTXMFFNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,34000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1027169,DTCC01434986,906605,5080
CHEMBL3142613,P22894,,PNEADTFJKOWMPK-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,39000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1022256,DTCC01434987,1585216,5080
CHEMBL3142614,P22894,,WXEFGNPPQHTRDV-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,10000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1029601,DTCC01434988,1935200,5080
CHEMBL3142615,P22894,,DNTCJTLVTZKQNR-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,23000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1040936,DTCC01434989,1002989,5080
CHEMBL3142618,P22894,,LOGSBACCMCSGPF-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,25000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1032044,DTCC01434992,1935201,5080
CHEMBL3142625,P22894,,BXPQIAVWFZXLFI-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,18000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1018322,DTCC01434999,1935199,5080
CHEMBL3142626,P22894,,NQPVYHWCSWOQOG-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,20000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1053297,DTCC01435000,129099,5080
CHEMBL3142627,P22894,,XRDWNRBIEZYTNT-LRDDRELGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12217351,KI,=,19000,NM,,,,,,,,,,,,,,Inhibition of human matrix metalloprotease-8,,"Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.",Bioorg. Med. Chem. Lett.,2002,12,19,"Scozzafava A, Supuran CT",,105078,DTCT0024061,1020945,DTCC01435001,1456061,5080
CHEMBL314565,P22894,,YQEMFOGNUTYMTJ-URCIPWINSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,INHIBITION,=,2,%,,,,,,,,,,,,,,Compound was tested for its binding affinity against MMP-8 HNC at 1 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105813,DTCT0024061,1059537,DTCC00248816,2065651,15258
CHEMBL315046,P22894,,JPTZDOYPNCQOTF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1092145,DTCC00249105,291444,15258
CHEMBL315114,P22894,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1297519,DTCC00106157,1838801,16328
CHEMBL315114,P22894,,IIBGHLQTRXDEKI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258659,DTCC00106157,1841441,24803
CHEMBL315843,P22894,,WYBFHVSAXDKMJV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1073917,DTCC00248711,1326511,15258
CHEMBL315900,P22894,,KSMVGBPYLIRIKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,INHIBITION,=,9,%,,,,,,,,,,,,,,Compound was tested for its binding affinity against MMP-8 HNC at 1 uM,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105813,DTCT0024061,1062037,DTCC00249774,1100495,15258
CHEMBL315901,P22894,,LHVGXRIIQBVWQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,45,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1062046,DTCC00249775,1035362,15258
CHEMBL316169,P22894,,JRCGNOYYZQLNTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1616261,DTCC00243846,1723666,15919
CHEMBL316200,P22894,,MERYKHOGOUEPIA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,3.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1063249,DTCC00248814,582756,15258
CHEMBL316332,P22894,,RSWUWSKXIDLCIR-PYNWJHIZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1316170,DTCC00257829,1196483,2323
CHEMBL316892,P22894,8-HYDROXY QUINALDINE,NBYLBWHHTUWMER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,63,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103885,DTCC00262976,508351,43205
CHEMBL316954,P22894,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1466337,DTCC00264378,1723295,3373
CHEMBL316954,P22894,,OHZMUNMVWGUMMY-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258623,DTCC00264378,1716220,24803
CHEMBL316997,P22894,(CYCLOPENTYLAMINO)CARBONYLPHOSPHONIC ACID,CYCCYWRSDZSMIF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1297665,DTCC00261231,303295,17838
CHEMBL317231,P22894,,PVHIFSFEBLXSME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,11000,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1721223,DTCC00271793,1035614,14753
CHEMBL318023,P22894,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1464022,DTCC00264599,1371183,3373
CHEMBL318023,P22894,,ARFFCGXUOISSHZ-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258615,DTCC00264599,1361901,24803
CHEMBL318190,P22894,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1478673,DTCC00264484,949983,3373
CHEMBL318190,P22894,,MVEPSFJZKBVDHV-UXHICEINSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258624,DTCC00264484,940926,24803
CHEMBL318252,P22894,,ODPDWLUYVWCNHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2456479,DTCC00265469,920644,32556
CHEMBL318455,P22894,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1457854,DTCC00263986,1240611,3373
CHEMBL318455,P22894,,VWOQXPBXOWHZCH-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258613,DTCC00263986,1231164,24803
CHEMBL318664,P22894,PENTAN-3-YLCARBAMOYLPHOSPHONIC ACID,NBDIMGROXSSYHE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,10000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1319237,DTCC01741840,723827,17838
CHEMBL318716,P22894,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1477306,DTCC00264594,335905,3373
CHEMBL318716,P22894,,LRVIJTRFTUQDKW-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258609,DTCC00264594,326644,24803
CHEMBL318970,P22894,,UTCZFYMAGMNXSW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1718629,DTCC00271820,1456283,14753
CHEMBL321213,P22894,,UVGAWIJNBYCHSP-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,170,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1681720,DTCC00282582,874479,16424
CHEMBL321556,P22894,,DQDPBMDGDOPPLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,43,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442205,DTCT0024061,2162336,DTCC00259627,564440,23225
CHEMBL321556,P22894,,DQDPBMDGDOPPLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,800,NM,,,,,,,,,,,,,,Inhibition of MMP9,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442206,DTCT0024061,2162338,DTCC00259627,564440,23225
CHEMBL321633,P22894,,REZSPXZZCJTZIK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15177439,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Pyran-containing sulfonamide hydroxamic acids: potent MMP inhibitors that spare MMP-1.,Bioorg. Med. Chem. Lett.,2004,14,13,"Reiter LA, Robinson RP, McClure KF, Jones CS, Reese MR, Mitchell PG, Otterness IG, Bliven ML, Liras J, Cortina SR, Donahue KM, Eskra JD, Griffiths RJ, Lame ME, Lopez-Anaya A, Martinelli GJ, McGahee SM, Yocum SA, Lopresti-Morrow LL, Tobiassen LM, Vaughn-Bowser ML",,105211,DTCT0024061,1495037,DTCC00288306,1915036,6475
CHEMBL321717,P22894,,SNOUFSTWEYTZQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,2300,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1704913,DTCC00271732,1871084,14753
CHEMBL3221863,P22894,,BJIOETDXHXZDRQ-LEAFIULHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,1010,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328285,DTCT0024061,13574312,DTCC01468798,1845949,39059
CHEMBL3221864,P22894,,OKHKINWJYOOKOF-GGXMVOPNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,1002,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328285,DTCT0024061,13574313,DTCC01468799,396851,39059
CHEMBL322246,P22894,,LBWCQKKKDGPEQC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,44000,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1718628,DTCC00271857,1359582,14753
CHEMBL322660,P22894,,XPBUDXXBELHNNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1715484,DTCC00271926,1003207,14753
CHEMBL322795,P22894,,LEDMBBYIVRLZAS-GFCCVEGCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,350,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1707159,DTCC00282335,389662,16424
CHEMBL322833,P22894,,UGSSMGYBOXALAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9685244,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of human neutrophil collagenase (Matrix metalloprotease-8),,Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,16,"Graf von Roedern E, Brandstetter H, Engh RA, Bode W, Grams F, Moroder L",,105077,DTCT0024061,1719873,DTCC00271825,1261791,14753
CHEMBL3235911,P22894,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475901,DTCC01474946,235426,63066
CHEMBL3235911,P22894,,RNBZJLOFSRJJMQ-RUPCYPOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,28,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475962,DTCC01474946,235426,63066
CHEMBL3235912,P22894,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475899,DTCC01474947,1433423,63066
CHEMBL3235912,P22894,,ILECMSXDFSLYHA-XOXLXNDPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475964,DTCC01474947,1433423,63066
CHEMBL323874,P22894,,LGRKPVBTQGGKSY-CRAIPNDOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,15300,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1411253,DTCC00287105,820749,16438
CHEMBL323885,P22894,,NRVATKFKFLOMDK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,14711305,KI,=,200000,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,105074,DTCT0024061,1265944,DTCC00287362,1079825,17924
CHEMBL324369,P22894,,ZUZHAPXKYPLQLC-ABAIWWIYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,100,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,829874,DTCC00293038,1947632,1497
CHEMBL324522,P22894,,QEYWSMACTZFJQM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,55000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1520540,DTCC00290561,1500539,15030
CHEMBL324891,P22894,,YDDMVPLLJTZTQL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,14711305,KI,=,38900,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,105074,DTCT0024061,1257649,DTCC00287325,30861,17924
CHEMBL325015,P22894,,NCIVMBVZAUECOS-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,4.7,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,822166,DTCC00293439,917740,1497
CHEMBL325037,P22894,,MGDXGNWHMISTJT-GEVKEYJPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,4000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1542955,DTCC00290662,1980575,15030
CHEMBL325041,P22894,BORTEZOMIB,GXJABQQUPOEUTA-RDJZCZTQSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18247547,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human MMP8 at 10 uM,,"Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer.",J. Med. Chem.,2008,51,4,"Dorsey BD, Iqbal M, Chatterjee S, Menta E, Bernardini R, Bernareggi A, Cassarà PG, D'Arasmo G, Ferretti E, De Munari S, Oliva A, Pezzoni G, Allievi C, Strepponi I, Ruggeri B, Ator MA, Williams M, Mallamo JP",,464578,DTCT0024061,2308370,DTCC00287769,1539678,25324
CHEMBL325048,P22894,,ZYIMYAJZHPOFQU-XPKDYRNWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,37,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1422364,DTCC00287138,1597338,16438
CHEMBL325163,P22894,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585440,KI,=,126,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105199,DTCT0024061,1311924,DTCC00287408,1500490,16439
CHEMBL325163,P22894,,RWKJBOMUESGCBO-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457314,DTCC00287408,1503285,32556
CHEMBL325488,P22894,,ASHODFDXFLFEKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,2300,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1520541,DTCC00290688,853697,15030
CHEMBL325488,P22894,,ASHODFDXFLFEKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,2290.87,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258676,DTCC00290688,844220,24803
CHEMBL325924,P22894,,LYVDOPZAZLWTSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,26000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1553931,DTCC00291040,1273637,15030
CHEMBL32596,P22894,,JYPUUSQERHUIDJ-USQNYJEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10360755,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,105214,DTCT0024061,1587461,DTCC00171178,28573,3139
CHEMBL32631,P22894,,PYHVMKLBOIYJOG-VJBWXMMDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10360755,KI,=,13,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,105214,DTCT0024061,1585151,DTCC00171113,1466837,3139
CHEMBL326760,P22894,,JXOYCIWPPBHZCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,88000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1534688,DTCC00290821,1144812,15030
CHEMBL326760,P22894,,JXOYCIWPPBHZCO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,136000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1531167,DTCC00290821,1144811,15030
CHEMBL327108,P22894,,ONKQNWHNBOMBCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,14711305,KI,=,18400,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.,J. Med. Chem.,2004,47,2,"Matziari M, Beau F, Cuniasse P, Dive V, Yiotakis A",,105074,DTCT0024061,1256342,DTCC00287264,917661,17924
CHEMBL327262,P22894,,JXGACOLDOLFHQF-LGTSYYJHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1309283,DTCC00257763,1968516,2323
CHEMBL327617,P22894,,COMOZYQMQPSLMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,8,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1056163,DTCC00249769,1806421,15258
CHEMBL327641,P22894,,DVBWYFQJLIUTJA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,4.3,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1059530,DTCC00249776,776445,15258
CHEMBL328162,P22894,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1453243,DTCC00264512,1014649,3373
CHEMBL328162,P22894,,IRBWGGQXMBAYQL-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258619,DTCC00264512,1005460,24803
CHEMBL328381,P22894,,NFRICHJLQIOONF-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,600,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1478668,DTCC00264486,1693757,3373
CHEMBL328886,P22894,,YQEMFOGNUTYMTJ-BUAFSUBRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1085845,DTCC00249311,1326512,15258
CHEMBL328910,P22894,"2,4-DIHYDROXYBENZOIC ACID",UIAFKZKHHVMJGS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103075,DTCC00254453,1828599,43205
CHEMBL329002,P22894,,MQOPTJYOSJSPJX-UBFHEZILSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1322234,DTCC00257795,1488748,2323
CHEMBL329145,P22894,,RMAHZBKEPFXNHG-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,50,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1310506,DTCC00257135,129155,2323
CHEMBL329287,P22894,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,90,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1476066,DTCC00264543,465152,3373
CHEMBL329287,P22894,,PTYZKNZXNKWTEF-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,89.13,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258616,DTCC00264543,455575,24803
CHEMBL329298,P22894,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1444453,DTCC00264987,205150,3373
CHEMBL329298,P22894,,GWEITLSXCOXESW-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258607,DTCC00264987,196121,24803
CHEMBL329313,P22894,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1457859,DTCC00265034,853467,3373
CHEMBL329313,P22894,,OKYUILRERWOFCH-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.98,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258611,DTCC00265034,844215,24803
CHEMBL329651,P22894,,BRKOQUQULDVEDN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,19,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1084511,DTCC00249770,1903191,15258
CHEMBL329784,P22894,(CYCLOHEXYLAMINO)CARBONYLPHOSPHONIC ACID,QQRCALUVCOFAOX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1291832,DTCC00261567,401327,17838
CHEMBL330731,P22894,,ZRMAXAMITMCTTB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,240,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1083343,DTCC00249768,1713982,15258
CHEMBL330857,P22894,,VLTOUUSTKONGKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,4.2,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1625323,DTCC00299273,31105,15919
CHEMBL330950,P22894,,GJCGJVYGHHRTHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1605179,DTCC00298620,627501,15919
CHEMBL331114,P22894,,UTOKQYCFEAMQLH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,16000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1631629,DTCC00299140,950357,15919
CHEMBL331308,P22894,,RFJAQRMGTCPTHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,>,100000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1601070,DTCC00298795,303681,15919
CHEMBL331311,P22894,,CDVYEYANHXGLCX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,3.3,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1631605,DTCC00298873,433997,15919
CHEMBL331342,P22894,,VKUYLANQOAKALN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1620360,DTCC00299210,1818652,15919
CHEMBL331669,P22894,,AUIKJLRMPLDORG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,116,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1617675,DTCC00299154,1468302,15919
CHEMBL331784,P22894,,CQGGQNFRJIAPHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,560,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1523077,DTCC00290683,853696,15030
CHEMBL331784,P22894,,CQGGQNFRJIAPHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,562.34,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258678,DTCC00290683,844219,24803
CHEMBL332120,P22894,,HLJHTDAQDAFOFS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627938,DTCC00299400,108901,15919
CHEMBL332145,P22894,,BLBYFZDCNCBJTH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,75000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1602495,DTCC00298760,1597482,15919
CHEMBL332362,P22894,,ZQFMPAUDTOJXIB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1500,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1629142,DTCC00298575,141317,15919
CHEMBL332406,P22894,,VSJBIWYXNLUPIE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,104,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1636603,DTCC00299016,1818653,15919
CHEMBL332429,P22894,,CSAFQHHGNGUQOL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,118,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1607480,DTCC00299120,498462,15919
CHEMBL332439,P22894,,KTJYZIRNJPDNBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,25000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1602487,DTCC00298787,1338994,15919
CHEMBL332709,P22894,,NEDBMCYJGQZOFM-AMVUTOCUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,1700,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1521827,DTCC00290663,498360,15030
CHEMBL332755,P22894,,XFNJKSWXHKYCFN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1631597,DTCC00299302,917813,15919
CHEMBL332858,P22894,,HJAQLIVSMXUHPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,130,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1599868,DTCC00299089,530553,15919
CHEMBL332891,P22894,,SNQRPCRWYVZYNW-YGRLFVJLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,4200,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,854576,DTCC00293462,1338923,1497
CHEMBL333122,P22894,,AUBKGBIPPZSEKF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,76000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1616277,DTCC00298761,950354,15919
CHEMBL333248,P22894,,JCUTWTFOYUXMPS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,111,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1618951,DTCC00299397,1629815,15919
CHEMBL333532,P22894,2-HYDROXYSULFAMOYL-BENZOIC ACID,USQRZPGPLTUIHD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,120,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1603761,DTCC01742806,950356,15919
CHEMBL3337869,P22894,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25192810,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442065,DTCT0024061,13992249,DTCC01523362,1322384,59837
CHEMBL3337869,P22894,,AARSEFXVCWMMKV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25264600,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431423,DTCT0024061,13989095,DTCC01523362,1302071,60036
CHEMBL3337894,P22894,,CDQRIIUMNLMHRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25192810,IC50,=,780,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442065,DTCT0024061,13992250,DTCC01523387,966370,59837
CHEMBL333896,P22894,,VOESHNWTIDIZCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,125,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1617683,DTCC00299583,238021,15919
CHEMBL333973,P22894,2-METHOXYBENZENETHIOL,DSCJETUEDFKYGN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,26,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102629,DTCC01742611,734155,43205
CHEMBL334065,P22894,,VLPFEOZNNBAFGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,50000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1520539,DTCC00290585,594872,15030
CHEMBL334709,P22894,,CAXAOIUOYPZXNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1043540,DTCC00324372,162532,15462
CHEMBL335118,P22894,,XTRJAENNSAJIAU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1052397,DTCC00324760,1650911,15462
CHEMBL3359091,P22894,,YNHGVYGMFAREOF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25264600,IC50,=,720,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431423,DTCT0024061,13989094,DTCC01536542,1108444,60036
CHEMBL336243,P22894,,JXSWSZIEDSTKDW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1038492,DTCC00324591,809612,15462
CHEMBL337585,P22894,,CSLRMNGVKPXZNV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020045,DTCC00324623,907521,15462
CHEMBL337761,P22894,,XIMLFZSNGXTRSL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1051062,DTCC00324498,971248,15462
CHEMBL337793,P22894,,UNRFEBNSHUZKHJ-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1016235,DTCC00323912,1290020,15462
CHEMBL33915,P22894,,SCDTVKKBOXTTSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1023412,DTCC00173329,743590,4214
CHEMBL3394285,P22894,,ABKAFUZUCJSIKV-ZZXKWVIFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26753813,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 expressed in Escherichia coli using (5-FAM/QXLTM) FRET peptide as substrate,,Design and synthesis of an activity-based protein profiling probe derived from cinnamic hydroxamic acid.,Bioorg. Med. Chem.,2016,24,4,"Ai T, Qiu L, Xie J, Geraghty RJ, Chen L.",,1547674,DTCT0024061,50485,DTCC01541321,1869229,65891
CHEMBL33977,P22894,,FDJBYAHLPYLRKD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,3000,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1035540,DTCC00173295,1805633,4214
CHEMBL340461,P22894,,RAPHEYPJGISJNU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1607488,DTCC00298841,1371597,15919
CHEMBL34085,P22894,,UEXHODHUQXSZDN-AABGKKOBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10360755,KI,=,4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8),,"P1, P2'-linked macrocyclic amine derivatives as matrix metalloproteinase inhibitors.",Bioorg. Med. Chem. Lett.,1999,9,10,"Duan JJ, Chen L, Xue CB, Wasserman ZR, Hardman KD, Covington MB, Copeland RR, Arner EC, Decicco CP",,105214,DTCT0024061,1574365,DTCC00172830,1660617,3139
CHEMBL341604,P22894,,VZEDRBAGPXKVHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1054932,DTCC00324354,1489528,15462
CHEMBL3417742,P22894,,GHWPTWVNZOSEBR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472747,DTCT0024061,14105236,DTCC01554158,1140955,61965
CHEMBL3417745,P22894,,PJTIDEQBVYCKIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472747,DTCT0024061,14105239,DTCC01554161,1561095,61965
CHEMBL3417751,P22894,,ZUZGJCNWNOCKEB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472747,DTCT0024061,14105240,DTCC01554167,946456,61965
CHEMBL3417763,P22894,,MKCKIGOKGYMJOH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472747,DTCT0024061,14105241,DTCC01554179,1976632,61965
CHEMBL3417764,P22894,,ZQKGUWOTJVDTGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25686153,INHIBITION,>,90,%,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Design, synthesis, and biological evaluation of novel matrix metalloproteinase inhibitors as potent antihemorrhagic agents: from hit identification to an optimized lead.",J. Med. Chem.,2015,58,5,"Orbe J, Sánchez-Arias JA, Rabal O, Rodríguez JA, Salicio A, Ugarte A, Belzunce M, Xu M, Wu W, Tan H, Ma H, Páramo JA, Oyarzabal J",,1472747,DTCT0024061,14105242,DTCC01554180,1943630,61965
CHEMBL34206,P22894,,SYAAEFMNVNGONW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,15,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1018307,DTCC00173335,290571,4214
CHEMBL342100,P22894,,GPENKXZRTRUYOG-BPQIPLTHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579851,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (matrix metalloprotease-8),,New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.,J. Med. Chem.,1999,42,23,"Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R",,105067,DTCT0024061,1561002,DTCC00332001,1197360,15496
CHEMBL342210,P22894,,CQRAUIRVDKNRIO-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,2.4,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1367833,DTCC00325532,238281,15412
CHEMBL342248,P22894,,RRETZYBLLSHELY-LBPRGKRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,,,,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8) (not determined),Not Determined,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105066,DTCT0024061,1384557,DTCC00326418,854146,15412
CHEMBL342374,P22894,,HPJZLIJTRCEDRH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1035831,DTCC00324181,1586061,15462
CHEMBL342710,P22894,,FJVADCMHIAHBER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1049758,DTCC00324396,1360201,15462
CHEMBL342889,P22894,,IKSAVMPIZWWMKE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,800,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1031127,DTCC00324252,97713,15462
CHEMBL343326,P22894,,IMRWXXAPWNPDGA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,800,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020033,DTCC00323913,65377,15462
CHEMBL343392,P22894,,CWDNVRNHSFACNA-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1049767,DTCC00324624,1294865,15462
CHEMBL34353,P22894,,LQNNJMYUCBDMHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1015891,DTCC00173334,1520107,4214
CHEMBL343547,P22894,,BAAHKTZFKMCWLC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1039864,DTCC00324337,1618734,15462
CHEMBL343775,P22894,,NYWZLYBVEDVMSN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,600,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1052400,DTCC00325260,1036212,15462
CHEMBL343818,P22894,,RNMKXQYTQJNJRJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1054926,DTCC00324445,357522,15462
CHEMBL344029,P22894,,IGJDRNDPWLIBBQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1043545,DTCC00323987,1807303,15462
CHEMBL344410,P22894,,OTJGAHJWYSLTDB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1026187,DTCC00324852,453846,15462
CHEMBL344587,P22894,,JROHDXNIWULULC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1023701,DTCC00323938,712960,15462
CHEMBL344827,P22894,,HXTKAAOSFRMCEF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1049764,DTCC00324547,971250,15462
CHEMBL345768,P22894,THIOURACIL,ZEMGGZBWXRYJHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,37,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103084,DTCC00337992,1283745,43205
CHEMBL35476,P22894,,CTGVDIGFCHCCJU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,300,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1042179,DTCC00173371,1002127,4214
CHEMBL355727,P22894,,FYJZCIXAWTVIOU-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,9,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1096959,DTCC00371202,2067064,5419
CHEMBL355727,P22894,,FYJZCIXAWTVIOU-IUCAKERBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,6000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1096958,DTCC00371202,2067064,5419
CHEMBL355752,P22894,,GPPXSZZXGYMBHW-QKFKETGDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9888835,IC50,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8 (Not determined),Not Determined,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,105810,DTCT0024061,1144687,DTCC00372315,854716,15162
CHEMBL355756,P22894,,JAWBGTRXBCUBLS-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,48,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1111699,DTCC00371502,1904588,5419
CHEMBL355756,P22894,,JAWBGTRXBCUBLS-JTQLQIEISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,38000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1111698,DTCC00371502,1904588,5419
CHEMBL3593549,P22894,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475903,DTCC01651896,333622,63066
CHEMBL3593549,P22894,,DFINJLCZWBDBQX-KDNYSNCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475959,DTCC01651896,333622,63066
CHEMBL3593550,P22894,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475902,DTCC01651897,2010871,63066
CHEMBL3593550,P22894,,SWCOKZUOBSVFCL-NROLRVEYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475961,DTCC01651897,2010871,63066
CHEMBL3593551,P22894,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475900,DTCC01651898,818354,63066
CHEMBL3593551,P22894,,ZEPWGRQYGKUKNA-KFIZHRIMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475963,DTCC01651898,818354,63066
CHEMBL3593552,P22894,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505520,DTCT0024061,14475898,DTCC01651899,980185,63066
CHEMBL3593552,P22894,,QABDTPJMJYQBCF-KQQMQGIYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26192023,INHIBITION,=,0,%,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) using Mca-KLPGL-Dnp-AR as substrate at 100 uM preincubated for 30 mins followed by substrate addition measured after 1 hr by fluorescence assay relative to control,,SAR Studies of Exosite-Binding Substrate-Selective Inhibitors of A Disintegrin And Metalloprotease 17 (ADAM17) and Application as Selective in Vitro Probes.,J. Med. Chem.,2015,58,15,"Knapinska AM, Dreymuller D, Ludwig A, Smith L, Golubkov V, Sohail A, Fridman R, Giulianotti M, LaVoi TM, Houghten RA, Fields GB, Minond D",,1505524,DTCT0024061,14475965,DTCC01651899,980185,63066
CHEMBL3639695,P22894,,PZMQNEDVJSDLAW-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,649,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247576,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168205,DTCC01703280,1130506,64498
CHEMBL3639744,P22894,,SAIHVCSOGMUZPK-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,233,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247610,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,174759,DTCC01708180,1615862,64498
CHEMBL365947,P22894,,WXPUJRINFGPEGC-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,1860384,DTCC00407674,1695368,19837
CHEMBL366997,P22894,,UOBVGDSSMCMKCH-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,4,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1103414,DTCC00371651,681217,5419
CHEMBL366997,P22894,,UOBVGDSSMCMKCH-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,1500,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1103413,DTCC00371651,681217,5419
CHEMBL3670691,P22894,,FBDOWURNGYMLPJ-IBGZPJMESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,119,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247570,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,170283,DTCC01703274,839513,64498
CHEMBL3670692,P22894,,KOVQMCGGWATESY-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,552,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247571,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,173487,DTCC01703275,127019,64498
CHEMBL3670693,P22894,,KOVQMCGGWATESY-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247572,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,183852,DTCC01703276,1098405,64498
CHEMBL3670694,P22894,,KOVQMCGGWATESY-FGZHOGPDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247573,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,160826,DTCC01703277,289306,64498
CHEMBL3670695,P22894,,QCVLVTVGVJUODZ-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,556,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247574,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,162347,DTCC01703278,2031908,64498
CHEMBL3670696,P22894,,MFTZEUCXFCXINH-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,899,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247575,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,162598,DTCC01703279,1518861,64498
CHEMBL3670697,P22894,,CNPRJTXDIHRZPF-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247577,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,182092,DTCC01703281,1357220,64498
CHEMBL3670698,P22894,,LFUNCOOVDREPBK-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,452,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247578,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,177157,DTCC01703282,1711859,64498
CHEMBL3670699,P22894,,QDHXNZRPVLUOML-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,638,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247579,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168306,DTCC01703283,774361,64498
CHEMBL3670700,P22894,,HCTHWCGSCVVHLJ-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,114,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247581,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,169967,DTCC01703284,1583049,64498
CHEMBL3670701,P22894,,FFHINXVCVWQCSG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,383,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247582,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,167348,DTCC01703285,904397,64498
CHEMBL3670702,P22894,,HXOLPPZDNXMRHR-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247583,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,179635,DTCC01703286,1357221,64498
CHEMBL3670703,P22894,,BMJUABISSDGKOA-UNMCSNQZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,832,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247584,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176708,DTCC01703287,580739,64498
CHEMBL3670704,P22894,,NZUPMMOEPOVBQE-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247585,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,184136,DTCC01703288,1680152,64498
CHEMBL3670705,P22894,,JUEZHKLAFJJQNE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247586,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,169143,DTCC01703289,1389860,64498
CHEMBL3670706,P22894,,OFRXWZGHEVNQHU-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,261,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247587,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,177450,DTCC01703290,1836770,64498
CHEMBL3670707,P22894,,VFEIVMVXXWQZER-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247588,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,164711,DTCC01703291,1259462,64498
CHEMBL3670708,P22894,,IIUXBHAJTPNCIR-KKSFZXQISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,351,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247589,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,173969,DTCC01703292,1291821,64498
CHEMBL3670709,P22894,,KNJBHXZWYFARSA-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247590,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176480,DTCC01703293,1647965,64498
CHEMBL3670710,P22894,,FRXRVVOCWBNHOQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,332,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247591,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,172292,DTCC01703294,1065482,64498
CHEMBL3670711,P22894,,MNXXFUIRJNLTHG-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247592,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176069,DTCC01703295,1771871,64498
CHEMBL3670712,P22894,,XNQPIVCSZRQAQO-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247593,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,181080,DTCC01703296,420053,64498
CHEMBL3670713,P22894,,ACXIBBRPTTWRDM-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247594,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,167138,DTCC01703297,839514,64498
CHEMBL3670714,P22894,,RAOGWYCOADLHPD-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247595,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157886,DTCC01703298,548550,64498
CHEMBL3670715,P22894,,AVFCHUYQSZAIFE-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,818,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247596,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157168,DTCC01703299,1998926,64498
CHEMBL3670716,P22894,,GSEYFLJSDKPLAI-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,839,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247597,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157433,DTCC01703300,1550906,64498
CHEMBL3670717,P22894,,VIPIKALUTUDDKU-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247598,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,161026,DTCC01703301,1771872,64498
CHEMBL3670718,P22894,,YUQQWAKBRAEWQZ-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247599,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,159095,DTCC01703302,710012,64498
CHEMBL3670719,P22894,,PLIPLRCYJWMTFY-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247600,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,180710,DTCC01703303,968343,64498
CHEMBL3670720,P22894,,BFJIOGLKGISOKV-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,231,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247601,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,175464,DTCC01703304,1226403,64498
CHEMBL3670721,P22894,,UOTSSZSXOLHXGG-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,373,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247602,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,171220,DTCC01703305,1291822,64498
CHEMBL367331,P22894,,AWCFKZLKKUVLGN-KFJBMODSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,67,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1095535,DTCC00371299,1036733,5419
CHEMBL367331,P22894,,AWCFKZLKKUVLGN-KFJBMODSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,75000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1095534,DTCC00371299,1036733,5419
CHEMBL3675541,P22894,,RESDGLIYQGGYGR-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247603,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,181123,DTCC01708173,1615861,64498
CHEMBL3675542,P22894,,AEOWLQGPNGMHBP-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,52,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247604,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,165749,DTCC01708174,613076,64498
CHEMBL3675543,P22894,,XLKQIIIKETWLMI-HKUYNNGSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,146,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247605,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157989,DTCC01708175,742365,64498
CHEMBL3675544,P22894,,YWXFICBFTYVHJU-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,226,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247606,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,163358,DTCC01708176,1324414,64498
CHEMBL3675545,P22894,,JYGPMNNMAQCQMG-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,285,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247607,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,184732,DTCC01708177,645830,64498
CHEMBL3675546,P22894,,VXYUSBYRYYLNHT-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,657,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247608,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168590,DTCC01708178,2031940,64498
CHEMBL3675547,P22894,,DKTMPYACSYBQIF-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,414,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247609,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,180607,DTCC01708179,1194373,64498
CHEMBL3675548,P22894,,IIRLMDJELCRLPB-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,270,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247611,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176082,DTCC01708181,548584,64498
CHEMBL3675549,P22894,,MXXLMDWJDJQNCZ-KXBFYZLASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,311,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247612,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,171237,DTCC01708182,968371,64498
CHEMBL3675550,P22894,,OTOPPWBRBAVQCM-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,339,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247613,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,156930,DTCC01708183,450759,64498
CHEMBL3675551,P22894,,LHURUBKIFBZDNZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,204,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247614,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,167473,DTCC01708184,2031941,64498
CHEMBL3675552,P22894,,MTMSSQNYFAAJSR-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,364,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247615,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157132,DTCC01708185,321876,64498
CHEMBL3675553,P22894,,XTHLTIMASWPNRH-AKRCKQFNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,929,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247616,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,163654,DTCC01708186,904423,64498
CHEMBL3675554,P22894,,SJWYFGLDVUQIEF-DEOSSOPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,63,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247617,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,172512,DTCC01708187,1259488,64498
CHEMBL3675555,P22894,,HXQNDQXHRNVKIA-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247618,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,171791,DTCC01708188,127053,64498
CHEMBL3675556,P22894,,UIEDXQBYCVBGGE-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247619,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,171103,DTCC01708189,1966318,64498
CHEMBL3675557,P22894,,BBERXYYXGJGELS-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247620,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,162411,DTCC01708190,127054,64498
CHEMBL3675558,P22894,,YUUVADHCMFJYGO-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247621,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157535,DTCC01708191,872152,64498
CHEMBL3675559,P22894,,MVSSFLIDOBOIBL-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247622,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157715,DTCC01708192,1098436,64498
CHEMBL3675560,P22894,,YWAKWFLUKNCYMP-PMACEKPBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247623,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,169046,DTCC01708193,1194374,64498
CHEMBL3675561,P22894,,FHLZDDVMTVCEOC-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247624,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176325,DTCC01708194,1804477,64498
CHEMBL3675562,P22894,,ZQBDVTJLOHIYJN-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,809,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247625,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,169454,DTCC01708195,1550939,64498
CHEMBL3675563,P22894,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,132,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247626,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168624,DTCC01708196,645831,64498
CHEMBL3675563,P22894,,MXFJZXDWWXHXMV-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247637,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,167355,DTCC01708196,645831,64498
CHEMBL3675564,P22894,,RIICMTINBCLPOY-UIOOFZCWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,452,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247627,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,160970,DTCC01708197,806748,64498
CHEMBL3675565,P22894,,BVKYTKVUMKYONQ-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,621,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247628,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,160275,DTCC01708198,1389896,64498
CHEMBL3675566,P22894,,XHPUXKQBUUHEIP-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,287,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247629,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168071,DTCC01708199,1130545,64498
CHEMBL3675567,P22894,,NHZSRXRDEWWJJS-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,793,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247630,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,178845,DTCC01708200,1065520,64498
CHEMBL3675568,P22894,,MDMQULYGCYNXQN-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,532,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247631,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,181642,DTCC01708201,321877,64498
CHEMBL3675569,P22894,,SAJAWNZBKHGJOW-MBMZGMDYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,526,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247632,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,164536,DTCC01708202,1550940,64498
CHEMBL3675570,P22894,,ZQUJAHCTHDEZMJ-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,227,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247633,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,160437,DTCC01708203,211,64498
CHEMBL3675571,P22894,,CKYKLNXMCJIGPN-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,567,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247634,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,158189,DTCC01708204,839552,64498
CHEMBL3675572,P22894,,WLZQVNRDQZYTID-PEFOLFAWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,105,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247635,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,169930,DTCC01708205,2063689,64498
CHEMBL3675573,P22894,,OUZMHHWAGJCAFA-PMERELPUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,99,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247636,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,166279,DTCC01708206,1000927,64498
CHEMBL3675574,P22894,,TYSBKRRVVCMKQG-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247638,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,183104,DTCC01708207,1518882,64498
CHEMBL3675575,P22894,,BICNEVCTASLTLM-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,865,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247639,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,159124,DTCC01708208,1161801,64498
CHEMBL3675576,P22894,,CWSSLFKLYYDKBD-CONSDPRKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247640,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,170339,DTCC01708209,516548,64498
CHEMBL3675577,P22894,,NLIWJNDBQYUCSF-DFBJGRDBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247641,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,174166,DTCC01708210,321878,64498
CHEMBL3675578,P22894,,KHHNQNYSKXXUCV-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247642,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,180016,DTCC01708211,2063690,64498
CHEMBL3675579,P22894,,KAUWQENTXQTKQG-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247643,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,165647,DTCC01708212,1771918,64498
CHEMBL3675580,P22894,,IADFBNIHFKDTRS-NSOVKSMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247644,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,161152,DTCC01708213,1194375,64498
CHEMBL3675581,P22894,,CXPHOOFGGKZGTC-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,40,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247645,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,162378,DTCC01708214,212,64498
CHEMBL3675582,P22894,,GIEQMQWMJSYCKB-IRXDYDNUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,48,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247646,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,162249,DTCC01708215,1033284,64498
CHEMBL3675583,P22894,,CPYISUHNJGFCRY-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247647,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,182915,DTCC01708216,1486575,64498
CHEMBL3675584,P22894,,VCJGVCZITQVJET-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,49,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247648,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,175577,DTCC01708217,1901139,64498
CHEMBL3675585,P22894,,QQGKYSPTORHWNZ-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,41,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247649,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,170289,DTCC01708218,1804478,64498
CHEMBL3675586,P22894,,UWVBDELWTIGPFO-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,62,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247650,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,179031,DTCC01708219,62372,64498
CHEMBL3675587,P22894,,ZMGHGYMGQVMACZ-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,63,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247651,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,167919,DTCC01708220,1486576,64498
CHEMBL3675588,P22894,,GWHSSPUFNDIEEQ-HOTGVXAUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,47,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247652,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,179362,DTCC01708221,677985,64498
CHEMBL3675589,P22894,,CTCTZAXBKWKMKL-OALUTQOASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,73,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247653,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168999,DTCC01708222,904424,64498
CHEMBL3675590,P22894,,PXQPONLRTWLOTH-IJHRGXPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,94,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247654,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,178775,DTCC01708223,1000928,64498
CHEMBL3675591,P22894,,DUPWUQYVKWCUOG-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,18,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247655,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,172603,DTCC01708224,839553,64498
CHEMBL3675592,P22894,,KEHDBOGRIVHUBV-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,10.3,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247656,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,157942,DTCC01708225,968372,64498
CHEMBL3675593,P22894,,QFGALMYSDQBVRH-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,381,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247657,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,158255,DTCC01708226,936273,64498
CHEMBL3675594,P22894,,ZWXRGJMHGHMUMB-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,307,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247658,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,159140,DTCC01708227,1740101,64498
CHEMBL3675595,P22894,,VLFDPMJDVIHWPI-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,233,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247659,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,173842,DTCC01708228,645832,64498
CHEMBL3675596,P22894,,KGPPRBTYRFIDAL-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,10000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247663,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,183901,DTCC01708229,904425,64498
CHEMBL3675597,P22894,,MUGAWCXYWNGHML-GOTSBHOMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247664,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,174222,DTCC01708230,420085,64498
CHEMBL3675598,P22894,,JMWVTDZGNUFBMO-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,559,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247665,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,181562,DTCC01708231,1740102,64498
CHEMBL3675599,P22894,,UUDTVMMARAFNKG-VXKWHMMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,379,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247666,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,166512,DTCC01708232,904426,64498
CHEMBL3675600,P22894,,GOLLITFKIKKRMV-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,5000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247667,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,170933,DTCC01708233,1259489,64498
CHEMBL3675601,P22894,,BLDFRIYOIZRRJI-ZEQRLZLVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,656,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247668,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,159642,DTCC01708234,645833,64498
CHEMBL3675602,P22894,,FXBVEEBXIZYGRY-DQEYMECFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,>,1000,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247669,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,164057,DTCC01708235,580782,64498
CHEMBL3675603,P22894,,FKTHQTYGTOEBAW-MHZLTWQESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,675,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247671,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,168580,DTCC01708236,159656,64498
CHEMBL3675604,P22894,,KSDQQJBQFBNDIC-ROUUACIJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,766,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247672,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,163046,DTCC01708237,159657,64498
CHEMBL3675605,P22894,,NIAIEBGBRXKPAO-NHTMILBNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,520,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,248221,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,158220,DTCC01708238,256074,64498
CHEMBL3675606,P22894,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20817735,KI,=,410,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14739085,DTCC01708239,2106911,69686
CHEMBL3675606,P22894,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,410,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14739084,DTCC01708239,2106910,68703
CHEMBL3675606,P22894,,MMIHYNVQXYWTFM-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,694,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247662,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,182638,DTCC01708239,1901140,64498
CHEMBL3675607,P22894,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,203,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14759267,DTCC01708240,2111479,68703
CHEMBL3675607,P22894,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,203,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14759916,DTCC01708240,2111479,68703
CHEMBL3675607,P22894,,KDDWLGBIYXTPJG-FQEVSTJZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,203,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,247670,Pseudodipeptides as MMP inhibitors,,2014,,,,,1535926,DTCT0024061,176508,DTCC01708240,289344,64498
CHEMBL367722,P22894,,AEBYYXPQFGRZDC-FCHUYYIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,34,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1118072,DTCC00371709,681216,5419
CHEMBL367959,P22894,,IHNYAHCZDRILEC-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,3,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1094289,DTCC00373679,1554396,5419
CHEMBL367959,P22894,,IHNYAHCZDRILEC-AAEUAGOBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,1700,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1094288,DTCC00373679,1554396,5419
CHEMBL368180,P22894,,ONDDWGCONIGAEF-RARQCXRASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,8,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1104962,DTCC00371855,520001,5419
CHEMBL368180,P22894,,ONDDWGCONIGAEF-RARQCXRASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,3000,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1104961,DTCC00371855,520001,5419
CHEMBL368966,P22894,,DBMDIXBZZAINQH-MBSDFSHPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,32,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1131290,DTCC00371356,1683653,5419
CHEMBL369184,P22894,,LWQVGCDPZDYMHI-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,1,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1121065,DTCC00371503,1743528,5419
CHEMBL369184,P22894,,LWQVGCDPZDYMHI-BBRMVZONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,430,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1121064,DTCC00371503,1743528,5419
CHEMBL369419,P22894,,BNFQSPBDDPIXCF-SECBINFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,43,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1107701,DTCC00370757,1069142,5419
CHEMBL369495,P22894,,FWBWWWORJVQVID-YOEHRIQHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,1,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1104956,DTCC00370781,487803,5419
CHEMBL370333,P22894,,HOXYEQZQHOZJQN-NDEPHWFRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,1860432,DTCC00407680,370185,19837
CHEMBL370631,P22894,,RPOIZUWTBLHTNU-YTTGMZPUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,,,,,,,,,,,,,,,,,Inhibitory concentration against MMP-8; - = not available,Not Determined,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321293,DTCT0024061,338870,DTCC00407679,1566231,19837
CHEMBL370662,P22894,(3-BROMOPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,SYHPXVAOJHTCRU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629029,DTCC00001220,2060610,56259
CHEMBL373261,P22894,,DZOZBHZWCFMSKH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16392792,IC50,=,10,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329826,DTCT0024061,1880242,DTCC00411745,1230448,20214
CHEMBL374377,P22894,,VWKXFDZWHLCIIU-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,1.1,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061796,DTCC00447804,1684492,22402
CHEMBL3752419,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,=,42.2,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50629,DTCC00072285,1804884,65936
CHEMBL3752564,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,=,2.97,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50624,DTCC00072278,95261,65936
CHEMBL3752747,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50625,DTCC00072280,1324856,65936
CHEMBL3752826,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50626,DTCC00072281,1933521,65936
CHEMBL37537,P22894,PROTOCATECHUIC ACID,YQUVCSBJEUQKSH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103820,DTCC00174549,313612,43205
CHEMBL3754302,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,=,83.1,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50627,DTCC00072282,840009,65936
CHEMBL3754314,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,26810711,IC50,>,100000,NM,,,,,,,,,,,,,,"Inhibition of MMP8 (unknown origin) using (7-methoxycoumarin-4-yl) acetyl pro-Leu-Gly-Leu-[3-(2,4-dinitrophenyl)-L-2,3-diamino-propionyl]-Ala-Arg-NH2 as substrate preincubated for 30 mins followed by substrate addition by microplate reader analysis",,Fluorinated matrix metalloproteinases inhibitors--Phosphonate based potential probes for positron emission tomography.,Bioorg. Med. Chem.,2016,24,4,"Beutel B, Daniliuc CG, Riemann B, Schafers M, Haufe G.",,1549576,DTCT0024061,50628,DTCC00072283,62801,65936
CHEMBL376557,P22894,,BUKCBCDGRPOFJP-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,0.81,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061795,DTCC00447810,1005132,22402
CHEMBL381189,P22894,,NSZHVJWSFHBPMB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16392792,KI,=,17,NM,,,,,,,,,,,,,,Binding affinity to MMP8,,Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.,J. Med. Chem.,2006,49,1,"Pirard B, Matter H",,329826,DTCT0024061,1880241,DTCC00411959,391231,20214
CHEMBL382201,P22894,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,KI,=,700,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887711,DTCC00413190,563987,20245
CHEMBL382201,P22894,,BZVYQWLRCHLAGK-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,810,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061736,DTCC00413190,552885,22402
CHEMBL3827073,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,21.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317137,DTCC00102284,1869506,67557
CHEMBL3827162,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,59,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317133,DTCC00102280,1422905,67557
CHEMBL3827243,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,39,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317142,DTCC00102294,192238,67557
CHEMBL3827250,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,59.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317131,DTCC00102277,1162527,67557
CHEMBL3827306,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,45.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317130,DTCC00102275,646584,67557
CHEMBL3827453,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,81.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317134,DTCC00102281,646585,67557
CHEMBL3827615,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,64.8,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317135,DTCC00102282,1099203,67557
CHEMBL3827640,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,226,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317132,DTCC00102278,160391,67557
CHEMBL3827680,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,228,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317140,DTCC00102292,1454773,67557
CHEMBL3827735,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,56.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317136,DTCC00102283,1227213,67557
CHEMBL3828051,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,104.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317138,DTCC00102285,840318,67557
CHEMBL3828226,P22894,,,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,27452283,IC50,=,47,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by colorimetric analysis,,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,2016,24,18,"Adhikari N, Halder AK, Mallick S, Saha A, Saha KD, Jha T.",,1589857,DTCT0024061,317143,DTCC00102295,1805194,67557
CHEMBL388453,P22894,,XALJTPOAALNLJP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,4360,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800846,DTCC00463155,425575,31524
CHEMBL388671,P22894,,YTJNSUHDNZWJPI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,8200,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800840,DTCC00463156,683291,31524
CHEMBL389594,P22894,,BLIQFUCBRCDFAI-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP9,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442206,DTCT0024061,2162213,DTCC00463661,564439,23225
CHEMBL389594,P22894,,BLIQFUCBRCDFAI-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17289381,KI,=,1900,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Novel thiol-based TACE inhibitors: rational design, synthesis, and SAR of thiol-containing aryl sulfonamides.",Bioorg. Med. Chem. Lett.,2007,17,8,"Govinda Rao B, Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Tian SK, Saunders JO",,442205,DTCT0024061,2162212,DTCC00463661,564439,23225
CHEMBL389898,P22894,,HTKNWYDCBWYORK-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061991,DTCC00447846,1555210,22402
CHEMBL392088,P22894,,BXSPGECKGKAUCR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204584,DTCC00471851,714474,24059
CHEMBL392308,P22894,,KJOVWWTWOVUHSB-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204580,DTCC00471855,1873303,24059
CHEMBL392571,P22894,,PUBARVPHTAEUJQ-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204578,DTCC00471857,1905592,24059
CHEMBL392572,P22894,,DFWYBNIMFAUWSX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,75,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204575,DTCC00471860,99252,24059
CHEMBL392974,P22894,,UEVLLYXFWPWEDN-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,7480,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204574,DTCC00471861,293894,24059
CHEMBL393793,P22894,,NKCMINBLFYGDJZ-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,71000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204585,DTCC00471850,1329038,24059
CHEMBL393828,P22894,,FGEXLQKMIJWUIY-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204589,DTCC00471838,1361759,24059
CHEMBL393829,P22894,,NVEOTSPQRXNTEA-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,754,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204588,DTCC00471839,1491085,24059
CHEMBL398405,P22894,,SFWRCXWXHAIKBP-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204571,DTCC00471864,2036268,24059
CHEMBL398602,P22894,,SAQZCMSCRMAPLW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,6760,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204570,DTCC00471865,1684738,24059
CHEMBL402393,P22894,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18282708,KI,>,3058,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,6,"Lu Z, Ott GR, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos J, Duan JJ",,463864,DTCT0024061,2317286,DTCC00499750,957099,25272
CHEMBL402393,P22894,,SXDMGWZDRWQMPS-DLBZAZTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,>,3058,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457218,DTCC00499750,952985,32556
CHEMBL402436,P22894,,SDNMPMDMJTYOAW-AZUAARDMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18242982,KI,=,1957,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462367,DTCT0024061,2282333,DTCC00488433,1873486,25163
CHEMBL402745,P22894,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1316693,DTCC00487205,808682,16328
CHEMBL402745,P22894,,LFOGEPKUSWRLCL-QFIPXVFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258669,DTCC00487205,811349,24803
CHEMBL402747,P22894,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18054488,KI,=,2700,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Novel thiol-based TACE inhibitors. Part 2: Rational design, synthesis, and SAR of thiol-containing aryl sulfones.",Bioorg. Med. Chem. Lett.,2008,18,1,"Bandarage UK, Wang T, Come JH, Perola E, Wei Y, Rao BG",,461729,DTCT0024061,2277150,DTCC00487839,196172,25093
CHEMBL402747,P22894,,CARKQNSZFCLNKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,2700,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2456472,DTCC00487839,208204,32556
CHEMBL403186,P22894,,WMWPLQAXVKBJIC-PZJWPPBQSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18242982,KI,=,1865,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462367,DTCT0024061,2282342,DTCC00488436,260773,25163
CHEMBL405600,P22894,,CTEBTZSRXSZTCW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1709812,DTCC00105079,63907,16216
CHEMBL405651,P22894,,WUXSSALNWBMRKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,7.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1072672,DTCC00106276,291445,15258
CHEMBL406023,P22894,,LXWSQOLUGYUJKO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,190000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1536953,DTCC00290791,1014906,15030
CHEMBL407540,P22894,,AMUGNOPZMAZKFD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1056155,DTCC00249365,356662,15258
CHEMBL409536,P22894,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17623656,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507875,DTCT0024061,2388610,DTCC00503784,1950627,29282
CHEMBL409536,P22894,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP8 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497430,DTCT0024061,2457338,DTCC00503784,1950505,32556
CHEMBL409536,P22894,,PLBINCOCFGQAJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1432370,DTCT0024061,13993806,DTCC00503784,1943413,60040
CHEMBL410259,P22894,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,<,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,499034,DTCC00247104,1838852,13104
CHEMBL410259,P22894,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102111,DTCT0024061,582300,DTCC00247104,1850705,1496
CHEMBL410259,P22894,,ABOVSYRJLZIGMD-CTNGQTDRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,833843,DTCC00247104,1850728,1497
CHEMBL415482,P22894,,GETQXLAMYOMSJS-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1311761,DTCC00133489,1725495,4760
CHEMBL415879,P22894,PHENANTHROLINE,DGEZNRSVGBDHLK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104002,DTCC00177236,247838,43205
CHEMBL416304,P22894,,SILYLRSFWCVUFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,28,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1707075,DTCC00200716,1034801,16216
CHEMBL417200,P22894,,HSJPSXSXQYYJSY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1700490,DTCC00200548,421498,16216
CHEMBL417749,P22894,,IHPUTEIJIZVYPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,43,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1699209,DTCC00201248,679478,16216
CHEMBL417757,P22894,,MXZLDTSVPDTTAN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1690796,DTCC00201006,1358751,16216
CHEMBL417926,P22894,,BXZZUNDHINECCH-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542892,DTCC00203938,485874,15186
CHEMBL417945,P22894,,PZNZBFBEAZCEQK-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,9,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,528839,DTCC00204075,452387,15186
CHEMBL418099,P22894,,IGJDRNDPWLIBBQ-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,514768,DTCC00204242,679525,15186
CHEMBL418442,P22894,,INVXSBCIDABVMG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17088065,IC50,,,,,,,,,,,,,,,,,Inhibition of MMP8,Not Determined,alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs.,Bioorg. Med. Chem.,2007,15,2,"Biasone A, Tortorella P, Campestre C, Agamennone M, Preziuso S, Chiappini M, Nuti E, Carelli P, Rossello A, Mazza F, Gallina C",,432506,DTCT0024061,2061973,DTCC00186442,1037472,22402
CHEMBL418619,P22894,,OMXNRRSBGWIVMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,53000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1521828,DTCC00181790,724110,15030
CHEMBL418619,P22894,,OMXNRRSBGWIVMU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,KI,=,52480.75,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258685,DTCC00181790,714626,24803
CHEMBL419044,P22894,,MNSIUKHRGJOOFL-WCSIJFPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,9600,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1552613,DTCC00291059,594873,15030
CHEMBL41928,P22894,,YBEJDLYIFZAISG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16242329,IC50,>,120000,NM,,,,,,,,,,,,,,Inhibitory activity against MMP8,,N-Hydroxyurea as zinc binding group in matrix metalloproteinase inhibition: mode of binding in a complex with MMP-8.,Bioorg. Med. Chem. Lett.,2006,16,1,"Campestre C, Agamennone M, Tortorella P, Preziuso S, Biasone A, Gavuzzo E, Pochetti G, Mazza F, Hiller O, Tschesche H, Consalvi V, Gallina C",,327981,DTCT0024061,1875157,DTCC00179962,1263318,20151
CHEMBL419301,P22894,,AILNNKVMFUWMQL-NFBKMPQASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,,,,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8 (not determined),Not Determined,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105201,DTCT0024061,837375,DTCC00247295,1306247,1497
CHEMBL419750,P22894,,VTRJTXRAOIMSTL-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,180,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1719486,DTCC00282282,258562,16424
CHEMBL419751,P22894,,CHAFUQVXOKHDCA-APWZRJJASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,0.45,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1429715,DTCC00287233,205368,16438
CHEMBL420487,P22894,,QDCHOZJXLIIHRT-BJZITVGISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,70,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1418545,DTCC00286603,885959,16438
CHEMBL420932,P22894,,JBXOGQUSYPCSQK-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.35,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1394807,DTCC00225652,75833,14854
CHEMBL422105,P22894,,KVMNMFKBWZIOKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1020030,DTCC00323965,1489533,15462
CHEMBL422250,P22894,,IIABJCHWKFZJBK-ZDUSSCGKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,220,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1708542,DTCC00281784,389664,16424
CHEMBL422251,P22894,,JOKZNFFZUNYVMR-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11563922,KI,=,4370,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,"Structure-based design and synthesis of potent matrix metalloproteinase inhibitors derived from a 6H-1,3,4-thiadiazine scaffold.",J. Med. Chem.,2001,44,20,"Schröder J, Henke A, Wenzel H, Brandstetter H, Stammler HG, Stammler A, Pfeiffer WD, Tschesche H",,105197,DTCT0024061,1719502,DTCC00282610,906992,16424
CHEMBL422948,P22894,,YIEJUKBUYFONED-XXBNENTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.39,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1377318,DTCC00224757,853033,14854
CHEMBL423001,P22894,,UOAOZROEXYBQHF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1026183,DTCC00324329,1327431,15462
CHEMBL423366,P22894,,QZGLUUHBLOQISE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1039866,DTCC00324648,1229457,15462
CHEMBL424,P22894,SALICYLIC ACID,YGSDEFSMJLZEOE-UHFFFAOYSA-N,3,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,14,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103818,DTCC00133347,47753,43205
CHEMBL424106,P22894,,GEFPLKDZRKGIKM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,7000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1017361,DTCC00323914,1003830,15462
CHEMBL42420,P22894,PD-169469,GJOCABIDMCKCEG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,INHIBITION,,,,,,,,,,,,,,,,,Inhibitory activity against MMP8,Not Determined,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887716,DTCC01739891,1274997,20245
CHEMBL424472,P22894,,BLDIAFCHXVRHEP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1028714,DTCC00324357,939176,15462
CHEMBL424473,P22894,,HRMWQQBRFJMAPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1026190,DTCC00325023,712957,15462
CHEMBL425020,P22894,,PYNQNWZHEDOQHX-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,52,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860373,DTCC00407673,1177224,19837
CHEMBL426581,P22894,,UHYUCCHEBUTXHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,39,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1118075,DTCC00370748,325445,5419
CHEMBL427366,P22894,,USIMDPVZFWUXPH-VWLOTQADSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16153831,IC50,=,94,NM,,,,,,,,,,,,,,Inhibitory concentration against MMP-8,,Synthesis and SAR of highly selective MMP-13 inhibitors.,Bioorg. Med. Chem. Lett.,2005,15,22,"Li J, Rush TS, Li W, DeVincentis D, Du X, Hu Y, Thomason JR, Xiang JS, Skotnicki JS, Tam S, Cunningham KM, Chockalingam PS, Morris EA, Levin JI",,321188,DTCT0024061,1860417,DTCC00407677,1113845,19837
CHEMBL427616,P22894,,KKVTZTBYJGHGCO-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1284943,DTCC00133624,2079565,4760
CHEMBL428554,P22894,,SZTBUYMVXLGMJO-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,78000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204576,DTCC00471859,488834,24059
CHEMBL429800,P22894,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204582,DTCC00471853,876522,24059
CHEMBL429800,P22894,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563924,DTCC00471853,899521,48958
CHEMBL429800,P22894,,NSDMBIOAMTZMED-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983457,DTCT0024061,12575114,DTCC00471853,881014,55760
CHEMBL430612,P22894,,IVFPKTAJBISJDW-YKSBVNFPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,16,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1395985,DTCC00226002,853032,14854
CHEMBL430838,P22894,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,454134,DTCC00246969,1617841,13104
CHEMBL430838,P22894,,ALDQBTGTDJBFBQ-RTWAWAEBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,604515,DTCC00246969,1629724,1496
CHEMBL430943,P22894,,FJVADCMHIAHBER-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542035,DTCC00204401,1132131,15186
CHEMBL431268,P22894,,PBUKUIIGUHJHQN-OJSMNCEXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1316167,DTCC00258271,1294064,2323
CHEMBL43152,P22894,PD-166793,GJOCABIDMCKCEG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,INHIBITION,,,,,,,,,,,,,,,,,Inhibitory activity against MMP8,Not Determined,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887724,DTCC01739899,2014806,20245
CHEMBL431680,P22894,,DQLDJYJWPVFOFC-REUBFRLUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585440,KI,=,672,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release.",J. Med. Chem.,2001,44,21,"Xue CB, He X, Corbett RL, Roderick J, Wasserman ZR, Liu RQ, Jaffee BD, Covington MB, Qian M, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105199,DTCT0024061,1294914,DTCC00286954,336147,16439
CHEMBL432079,P22894,BB-1101,GKHRDWHFKKUYAX-KSZLIROESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579851,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (matrix metalloprotease-8),,New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.,J. Med. Chem.,1999,42,23,"Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R",,105067,DTCT0024061,1564933,DTCC01739584,487325,15496
CHEMBL432223,P22894,,VDDKIBQLKXMKIW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1617691,DTCC00298906,595003,15919
CHEMBL432532,P22894,,DVXDZENYHAGFRW-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,739734,DTCC00234968,1014335,5658
CHEMBL432770,P22894,,QUIDRRLYQSJQMX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1056170,DTCC00249346,161690,15258
CHEMBL432882,P22894,,NQPIHEUUYRAYII-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,INHIBITION,,,,,,,,,,,,,,,,,Inhibitory activity against MMP8,Not Determined,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887721,DTCC00186511,2047007,20245
CHEMBL433262,P22894,,VHCRBJFCQRNNFG-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,INHIBITION,,,,,,,,,,,,,,,,,Inhibitory activity against MMP8,Not Determined,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887723,DTCC00185901,1663324,20245
CHEMBL433455,P22894,,JNBNCWQZPZWAOV-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,4000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,523027,DTCC00204641,1552484,15186
CHEMBL433455,P22894,,JNBNCWQZPZWAOV-NRFANRHFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,4000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1042544,DTCC00204641,1553845,15462
CHEMBL434446,P22894,,GEPDPACRTHVSTD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1041219,DTCC00324369,809610,15462
CHEMBL434655,P22894,,PVTAZXXDKDMCRE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1018572,DTCC00324356,1319548,15462
CHEMBL435713,P22894,,YEIKCNCZZRBAHT-UGSOOPFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,INHIBITION,=,2,%,,,,,,,,,,,,,,Percent remaining enzyme activity (RA) in neutrophil collagenase (matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105073,DTCT0024061,1132637,DTCC00373308,1328008,5419
CHEMBL435713,P22894,,YEIKCNCZZRBAHT-UGSOOPFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11958997,KI,=,400,NM,,,,,,,,,,,,,,Tested for its inhibitory activity against neutrophil collagenase (Matrix metalloprotease-8),,Oxal hydroxamic acid derivatives with inhibitory activity against matrix metalloproteinases.,Bioorg. Med. Chem. Lett.,2002,12,6,"Krumme D, Tschesche H",,105204,DTCT0024061,1132636,DTCC00373308,1328008,5419
CHEMBL435820,P22894,,ICZVHRMXNBNXEY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1028717,DTCC00108082,1360203,15462
CHEMBL43644,P22894,,VHCRBJFCQRNNFG-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16451058,INHIBITION,,,,,,,,,,,,,,,,,Inhibitory activity against MMP8,Not Determined,Structural insight into the stereoselective inhibition of MMP-8 by enantiomeric sulfonamide phosphonates.,J. Med. Chem.,2006,49,3,"Pochetti G, Gavuzzo E, Campestre C, Agamennone M, Tortorella P, Consalvi V, Gallina C, Hiller O, Tschesche H, Tucker PA, Mazza F",,330547,DTCT0024061,1887722,DTCC00186536,174787,20245
CHEMBL439931,P22894,,UGBFTDFVLBACAS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1712500,DTCC00201013,1132089,16216
CHEMBL439983,P22894,,DJQJEICJRBFEOV-HLAWJBBLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579851,IC50,=,0.2,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (matrix metalloprotease-8),,New alpha-substituted succinate-based hydroxamic acids as TNFalpha convertase inhibitors.,J. Med. Chem.,1999,42,23,"Barlaam B, Bird TG, Lambert-Van Der Brempt C, Campbell D, Foster SJ, Maciewicz R",,105067,DTCT0024061,1568494,DTCC00332304,745354,15496
CHEMBL440498,P22894,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,1.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14741468,DTCC01741261,2107724,69259
CHEMBL440498,P22894,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25192810,IC50,=,0.097,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using fluorescence peptide Cy3-PLGLK(Cy5Q)AR-NH2 substrate by fluorescence assay,,"Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1¿ binding site.",Bioorg. Med. Chem.,2014,22,19,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1442065,DTCT0024061,13992251,DTCC01741261,611029,59837
CHEMBL440498,P22894,RS-130830,ROSNVSQTEGHUKU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25264600,IC50,=,0.097,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 using Cy3-PLGLK(Cy5Q)AR-NH2 as substrate after 40 mins by spectrofluorimetry,,"Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach.",J. Med. Chem.,2014,57,21,"Nara H, Sato K, Naito T, Mototani H, Oki H, Yamamoto Y, Kuno H, Santou T, Kanzaki N, Terauchi J, Uchikawa O, Kori M",,1431423,DTCT0024061,13989093,DTCC01741261,590804,60036
CHEMBL440713,P22894,,WVXYEZUPRPJJNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9464365,KI,=,168000,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",,Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,1998,41,3,"Graf von Roedern E, Grams F, Brandstetter H, Moroder L",,105076,DTCT0024061,1547582,DTCC00290816,1306218,15030
CHEMBL440714,P22894,,QTXKDSNGGLBSKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1616269,DTCC00298905,465562,15919
CHEMBL441084,P22894,,GBQQHIUTXSUOPE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,5.3,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627922,DTCC00299221,1144920,15919
CHEMBL441662,P22894,,AKNDZTHCJLFZCF-HNNXBMFYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1367841,DTCC00326356,1565298,15412
CHEMBL443478,P22894,,YDDLGJKZEJWWDF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,527828,DTCC00204203,96357,15186
CHEMBL443478,P22894,,YDDLGJKZEJWWDF-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1035828,DTCC00204203,97714,15462
CHEMBL44383,P22894,,MDWFJTBWOFNAQX-KRWDZBQOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,10.6,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1297400,DTCC00186509,582683,16328
CHEMBL445994,P22894,,MYTAFXBNPKBRNX-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,Not Determined,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438478,DTCC00512741,1809282,30977
CHEMBL447457,P22894,,YDDMVPLLJTZTQL-LAABSITASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,38.9,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457432,DTCC00115970,79316,32556
CHEMBL447787,P22894,,HWRTYSUSQVJAGF-RBBKRZOGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18242982,KI,>,3058,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"Potent, exceptionally selective, orally bioavailable inhibitors of TNF-alpha Converting Enzyme (TACE): novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1' substituents.",Bioorg. Med. Chem. Lett.,2008,18,5,"Ott GR, Asakawa N, Lu Z, Anand R, Liu RQ, Covington MB, Vaddi K, Qian M, Newton RC, Christ DD, Trzaskos JM, Duan JJ",,462367,DTCT0024061,2282351,DTCC00488438,1684915,25163
CHEMBL448246,P22894,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,10,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708861,DTCC00516462,2047968,32215
CHEMBL448246,P22894,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518906,DTCT0024061,2708996,DTCC00516462,2047969,32218
CHEMBL448246,P22894,,RRXQHLQCQYPPMF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,IC50,=,670,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518917,DTCT0024061,2709029,DTCC00516462,2047969,32218
CHEMBL448399,P22894,HYDROXYTOLUIC ACID,WHSXTWFYRGOBGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,18,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103749,DTCC00565293,1703863,43205
CHEMBL449092,P22894,,AIGCCIDMQBSCJA-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,7000,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,734391,DTCC00235044,1499918,5658
CHEMBL450327,P22894,,XVUIGVGFVWRFJO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1635498,DTCC00227650,1338995,15919
CHEMBL450431,P22894,,NRHSKONRJVZHAX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,53,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103896,DTCC00571871,896234,43205
CHEMBL450721,P22894,,SBTMZMWGVVORIF-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,29.2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800817,DTCC00562380,973846,31524
CHEMBL450938,P22894,(3-NITROPHENYLAMINO)METHYLENEDIPHOSPHONIC ACID,VPXZTOOBAWPNGR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629033,DTCC00406538,156505,56259
CHEMBL452082,P22894,,RMPMGGGCHRCWIU-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,=,150000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438446,DTCC00512738,9768,30977
CHEMBL452083,P22894,,MOPRTFSMCQNUCT-GJZGRUSLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438459,DTCC00512739,1841747,30977
CHEMBL452584,P22894,,MXMAVZMWYSUCJZ-SFTDATJTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438465,DTCC00512740,261085,30977
CHEMBL454808,P22894,"2,6-DIHYDROXYBENZOIC ACID",AKEUNCKRJATALU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102651,DTCC00005081,86519,43205
CHEMBL45483,P22894,SC-44463,QYZPDCGWIJYZMN-ZBFHGGJFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1416201,DTCC01740008,401646,16438
CHEMBL456774,P22894,,LKJAZJMUPQPJNA-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,4.3,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800822,DTCC00562381,1809896,31524
CHEMBL460725,P22894,,QHDIXGPUTSAIJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19173605,IC50,=,57,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494620,DTCT0024061,2596037,DTCC00517113,715017,32135
CHEMBL460899,P22894,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19173605,IC50,=,7.4,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).,J. Med. Chem.,2009,52,4,"Pochetti G, Montanari R, Gege C, Chevrier C, Taveras AG, Mazza F",,494620,DTCT0024061,2596046,DTCC00114032,1166828,32135
CHEMBL460899,P22894,,ITADELAVAWJACR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,IC50,=,7.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14718583,DTCC00114032,2101638,68703
CHEMBL46183,P22894,,ZKUXVTKGURJPOW-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9599226,KI,=,531,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,105216,DTCT0024061,1347401,DTCC00193499,969802,14640
CHEMBL462627,P22894,,MNYLANCSXOSQBA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,34,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708856,DTCC00516390,758694,32215
CHEMBL462628,P22894,,ITQDPSGUKJGOJF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,8,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708857,DTCC00516392,565008,32215
CHEMBL462629,P22894,,XEXZOINHSIFHFY-XFXZXTDPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,80,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708858,DTCC00516393,175688,32215
CHEMBL468900,P22894,,NHPBWKYFMTXWAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP8 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497430,DTCT0024061,2457348,DTCC00530186,2016158,32556
CHEMBL471537,P22894,,GSWRTFGMHRKLKT-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,0.29,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800880,DTCC00514690,489269,31524
CHEMBL472899,P22894,,ZRAUMSIZBNBIFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800898,DTCC00514692,1296946,31524
CHEMBL473107,P22894,,YNKDEHKXKOAEBW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,32,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708863,DTCC00515624,984986,32215
CHEMBL473314,P22894,,DIPCWZOATLQURP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,36,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708864,DTCC00515689,305973,32215
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518906,DTCT0024061,2708994,DTCC00516458,694221,32218
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518917,DTCT0024061,2709027,DTCC00516458,694221,32218
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,ACTIVITY,=,81.7,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells assessed as residual activity using Knight SSP as substrate at 100 uM after 1.5 to 4 hrs by spectrofluorometric analysis relative to control,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799332,DTCT0024061,7596133,DTCC00516458,704135,47025
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,IC50,>,40000,NM,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799328,DTCT0024061,7596121,DTCC00516458,704135,47025
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22018790,INHIBITION,=,17,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of MMP8 expressed in CHO-K1 cells using triple-helical fTHP-15 as substrate at 40 uM after 4 hrs by FRET assay,,"Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds.",Bioorg. Med. Chem. Lett.,2011,21,23,"Roth J, Minond D, Darout E, Liu Q, Lauer J, Hodder P, Fields GB, Roush WR",,799264,DTCT0024061,7596108,DTCC00516458,704135,47025
CHEMBL473326,P22894,,HKDAECHYHSQLRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,>,39840,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late stage results from the probe development efforts to identify inhibitors of Matrix Metalloprotease-13 (MMP-13). (Class of assay: screening) [Related pubchem assays (depositor defined):AID1931, AID570, AID734, AID735, AID769] Panel member name: MMP-8 [IC50 Assay]",Active,PUBCHEM BIOASSAY DATA SET,,,,,,,737460,DTCT0024061,5384325,DTCC00516458,702649,33038
CHEMBL473327,P22894,,ZHNBFYMZDUSWSL-OWBHPGMISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,100,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708859,DTCC00516459,597255,32215
CHEMBL475540,P22894,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,2,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708853,DTCC00515616,1178193,32215
CHEMBL475540,P22894,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518906,DTCT0024061,2708997,DTCC00515616,1178199,32218
CHEMBL475540,P22894,,IQGHPUPMOUUHPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,IC50,=,1024,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518917,DTCT0024061,2709030,DTCC00515616,1178199,32218
CHEMBL475742,P22894,,RLJYCZREXIWYAI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,50,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708854,DTCC00515618,2015780,32215
CHEMBL48256,P22894,,DOXXSEYJDIFFAY-KMDXXIMOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9599226,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,105216,DTCT0024061,1359475,DTCC00193645,1099889,14640
CHEMBL48310,P22894,HINOKITIOL,FUWUEFKEXZQKKA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,100,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104001,DTCC00192828,1763870,43205
CHEMBL484261,P22894,,VMOSDDURWLNMNG-GXFFZTMASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,=,35,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2456508,DTCC00115945,888681,32556
CHEMBL48474,P22894,,XOVSRAFNJNQNRK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,8,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1473747,DTCC00194147,808187,3192
CHEMBL48786,P22894,,WMVFFTPYCGKWCT-PCCBWWKXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9599226,KI,=,293,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,105216,DTCT0024061,1355639,DTCC00193466,1934553,14640
CHEMBL489100,P22894,BMS-561392,QVNZBDLTUKCPGJ-SHQCIBLASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,299,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin) by fluorescence-based FRET assay,,,MedChemComm,2011,2,10,,,1328285,DTCT0024061,13574314,DTCC00005548,590183,39059
CHEMBL48969,P22894,,UGLOKYALFGIDPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10230616,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Discovery of a novel series of selective MMP inhibitors: identification of the gamma-sulfone-thiols.,Bioorg. Med. Chem. Lett.,1999,9,7,"Freskos JN, Mischke BV, DeCrescenzo GA, Heintz R, Getman DP, Howard SC, Kishore NN, McDonald JJ, Munie GE, Rangwala S, Swearingen CA, Voliva C, Welsch DJ",,105215,DTCT0024061,1714736,DTCC00193516,1425572,3610
CHEMBL48969,P22894,,UGLOKYALFGIDPP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,36,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1476112,DTCC00193516,1423570,3192
CHEMBL495502,P22894,,OBBSDCUMPDPHQF-BEEZEEGUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,2050,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457265,DTCC00547246,1983210,32556
CHEMBL496942,P22894,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17623656,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain,,Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.,J. Biol. Chem.,2007,282,38,"Johnson AR, Pavlovsky AG, Ortwine DF, Prior F, Man CF, Bornemeier DA, Banotai CA, Mueller WT, McConnell P, Yan C, Baragi V, Lesch C, Roark WH, Wilson M, Datta K, Guzman R, Han HK, Dyer RD",,507875,DTCT0024061,2388628,DTCC00547183,1983321,29282
CHEMBL496942,P22894,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of MMP8 up to 100 uM,Not Active,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497430,DTCT0024061,2457330,DTCC00547183,1983207,32556
CHEMBL496942,P22894,,FLTYDFYSVZBKOB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,25265401,IC50,>,30000,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin),,"Targeting matrix metalloproteinases: exploring the dynamics of the s1' pocket in the design of selective, small molecule inhibitors.",J. Med. Chem.,2014,57,24,"Fabre B, Ramos A, de Pascual-Teresa B",,1432370,DTCT0024061,13993807,DTCC00547183,1976454,60040
CHEMBL497772,P22894,,KQIFSUSWYMDFOC-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,=,42,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457439,DTCC00547182,823604,32556
CHEMBL500351,P22894,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,80,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708860,DTCC00516461,984995,32215
CHEMBL500351,P22894,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 200 uM by HxBPyne probe-based competitive activity based protein profiling assay in presence of 5 uM HxBpane competitor,Not Active,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518906,DTCT0024061,2708995,DTCC00516461,984998,32218
CHEMBL500351,P22894,,XMFWHLZTTUUQHL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18364257,IC50,>,100000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 by fluorogenic substrate assay,,Ranking the selectivity of PubChem screening hits by activity-based protein profiling: MMP13 as a case study.,Bioorg. Med. Chem.,2009,17,3,"Nakai R, Salisbury CM, Rosen H, Cravatt BF",,518917,DTCT0024061,2709028,DTCC00516461,984998,32218
CHEMBL501715,P22894,,RMPMGGGCHRCWIU-KBPBESRZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,=,70000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438440,DTCC00560261,100290,30977
CHEMBL50228,P22894,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9599226,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Macrocyclic amino carboxylates as selective MMP-8 inhibitors.,J. Med. Chem.,1998,41,11,"Cherney RJ, Wang L, Meyer DT, Xue CB, Wasserman ZR, Hardman KD, Welch PK, Covington MB, Copeland RA, Arner EC, DeGrado WF, Decicco CP",,105216,DTCT0024061,1349980,DTCC00193676,969803,14640
CHEMBL50228,P22894,,NSZHVJWSFHBPMB-OKZBNKHCSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,17,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457444,DTCC00193676,985350,32556
CHEMBL503470,P22894,,HLLDDDNIWYZZJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,94,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708862,DTCC00516463,1082310,32215
CHEMBL506570,P22894,,WSVIQCQIJLDTEK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,59,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103723,DTCC00571870,1381649,43205
CHEMBL507420,P22894,,PTUCPHGSAFOJAU-MGONOCMRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,KI,=,271,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457424,DTCC00115971,1788790,32556
CHEMBL508461,P22894,,VMTJQZUZINLEKC-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457355,DTCC00115944,1950497,32556
CHEMBL509027,P22894,,WRHZVMBBRYBTKZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-24,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102606,DTCC00541055,669654,43205
CHEMBL510082,P22894,,MYTAFXBNPKBRNX-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17719700,IC50,>,300000,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP8,,Peptidyl 3-substituted 1-hydroxyureas as isosteric analogues of succinylhydroxamate MMP inhibitors.,Eur. J. Med. Chem.,2008,43,5,"Campestre C, Tortorella P, Agamennone M, Preziuso S, Biasone A, Nuti E, Rossello A, Gallina C",,510907,DTCT0024061,2438474,DTCC00512742,1971363,30977
CHEMBL51013,P22894,,JDPMCWHMTGTQGU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,,,,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8) (Not tested),Not Determined,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102107,DTCT0024061,1482437,DTCC00194083,1099907,3192
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9888835,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.,J. Med. Chem.,1999,42,1,"Pikul S, McDow Dunham KL, Almstead NG, De B, Natchus MG, Anastasio MV, McPhail SJ, Snider CE, Taiwo YO, Chen L, Dunaway CM, Gu F, Mieling GE",,105809,DTCT0024061,1170613,DTCC00514693,1241881,15162
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1395525,DTCC00514693,1241292,15412
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1321330,DTCC00514693,1242834,4760
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17956082,IC50,=,2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Novel fluorinated derivatives of the broad-spectrum MMP inhibitors N-hydroxy-2(R)-[[(4-methoxyphenyl)sulfonyl](benzyl)- and (3-picolyl)-amino]-3-methyl-butanamide as potential tools for the molecular imaging of activated MMPs with PET.,J. Med. Chem.,2007,50,23,"Wagner S, Breyholz HJ, Law MP, Faust A, Höltke C, Schröer S, Haufe G, Levkau B, Schober O, Schäfers M, Kopka K",,451366,DTCT0024061,2204546,DTCC00514693,1231041,24059
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800905,DTCC00514693,1231512,31524
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21514700,IC50,=,7.7,NM,,,,,,,,,,,,,,Inhibition of human MMP8 by fluorometric assay,,Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.,Eur. J. Med. Chem.,2011,46,7,"Nuti E, Casalini F, Santamaria S, Gabelloni P, Bendinelli S, Da Pozzo E, Costa B, Marinelli L, La Pietra V, Novellino E, Margarida Bernardo M, Fridman R, Da Settimo F, Martini C, Rossello A",,753769,DTCT0024061,6000260,DTCC00514693,1252235,44948
CHEMBL514138,P22894,CGS-27023A,ZVYIZSNCEAHMCF-UNTBIKODSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563922,DTCC00514693,1254588,48958
CHEMBL514495,P22894,,PTRVCICYKILIEH-SQFISAMPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18358729,ACTIVITY,=,100,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition recombinant MMP8 expressed in CHO-K1 cells at 100 uM,,High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate.,Bioorg. Med. Chem.,2009,17,3,"Lauer-Fields JL, Minond D, Chase PS, Baillargeon PE, Saldanha SA, Stawikowska R, Hodder P, Fields GB",,518661,DTCT0024061,2708855,DTCC00515685,78922,32215
CHEMBL515083,P22894,,QVAVQQVTOJMLHH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,1010,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800891,DTCC00514691,521492,31524
CHEMBL515980,P22894,,KBZNOZAJAJRTII-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19053764,IC50,=,0.4,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Dual inhibitors of matrix metalloproteinases and carbonic anhydrases: iminodiacetyl-based hydroxamate-benzenesulfonamide conjugates.,J. Med. Chem.,2008,51,24,"Marques SM, Nuti E, Rossello A, Supuran CT, Tuccinardi T, Martinelli A, Santos MA",,561987,DTCT0024061,2800827,DTCC00562382,2004561,31524
CHEMBL51638,P22894,,JIFLEYNNNKKNOQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10406637,IC50,=,1100,NM,,,,,,,,,,,,,,Inhibition of human recombinant matrix metalloprotease-8 (hMMP-8),,Synthesis and identification of conformationally constrained selective MMP inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,13,"Freskos JN, McDonald JJ, Mischke BV, Mullins PB, Shieh HS, Stegeman RA, Stevens AM",,102106,DTCT0024061,1479986,DTCC00194120,1713372,3192
CHEMBL51862,P22894,,DBYYJEGRUPLGLD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,15,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1681668,DTCC00201061,1261010,16216
CHEMBL52209,P22894,,QUKDWRYJPHUXQR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,13,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103308,DTCC00193427,1024887,43205
CHEMBL52531,P22894,,WEACEEZKOJLZFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,6,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1716533,DTCC00200795,161166,16216
CHEMBL52532,P22894,,ONOMIQQPBDQZDA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,22,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1686728,DTCC00200796,1423651,16216
CHEMBL52994,P22894,,NJSIDFBPVWKNNH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1689346,DTCC00201450,808248,16216
CHEMBL53009,P22894,,RTBPRRSADWSXAD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,27,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1720807,DTCC00200715,1773397,16216
CHEMBL53044,P22894,,WPXAJFJACNOICK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1715028,DTCC00200878,1681643,16216
CHEMBL53051,P22894,,KOFNJKLYWDTWHZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1681678,DTCC00200549,614602,16216
CHEMBL53091,P22894,,YTZCQIFAVXLXHV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,26,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1718063,DTCC00200970,1293404,16216
CHEMBL53094,P22894,,WYVILPRSBDCCKY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,20,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1712491,DTCC00201456,1423652,16216
CHEMBL53116,P22894,,JGJZJJQMNAKKDG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,23,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711289,DTCC00201046,485829,16216
CHEMBL53457,P22894,,AQKDLUIAUGFUEC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,18,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711274,DTCC00201027,647325,16216
CHEMBL53847,P22894,,SKADGQGCAOBKKC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,2.1,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1696773,DTCC00200740,582202,16216
CHEMBL53949,P22894,,FTUOECQUSPMQQZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,24,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1707056,DTCC00200918,1325929,16216
CHEMBL54049,P22894,,XGAYQDWZIPRBPF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,3,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103123,DTCC00200085,1445792,43205
CHEMBL54054,P22894,,FEWWJFPIJXNCFE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,0.7,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1718068,DTCC00201389,96316,16216
CHEMBL540952,P22894,(CYCLOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,XNEFJXZBPPJDHR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,200,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1298911,DTCC00261593,1305900,17838
CHEMBL541293,P22894,,BBMGCFPHSKQSMM-BTQNPOSSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,517800,DTCC00579927,841091,15186
CHEMBL542088,P22894,,YHLIANIUQRLCCV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11378378,IC50,=,3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Arylsulphonyl hydroxamic acids: potent and selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,2001,11,11,"Baxter AD, Bhogal R, Bird J, Keily JF, Manallack DT, Montana JG, Owen DA, Pitt WR, Watson RJ, Wills RE",,105212,DTCT0024061,1042184,DTCC00573690,1099676,4214
CHEMBL54406,P22894,,UTVAYVOWTJFEEU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,30,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711294,DTCC00200736,1488101,16216
CHEMBL54436,P22894,,RCGPSTRFXVIUQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1712495,DTCC00201253,1391445,16216
CHEMBL54483,P22894,,CNZGQRARNYMASL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1704475,DTCC00200539,518045,16216
CHEMBL54501,P22894,,HHSADBHNZPOTTJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,39,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1698025,DTCC00200582,1132088,16216
CHEMBL54535,P22894,,VURZBHKGMIEEFK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1691941,DTCC00201047,969874,16216
CHEMBL54566,P22894,,IYEVXJPUTMBOTO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,31,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1696758,DTCC00200735,808247,16216
CHEMBL54617,P22894,,DFPDFXUEOXPMIV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,10,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1689357,DTCC00200815,1067099,16216
CHEMBL54621,P22894,,ACSSJLXQNWFMSO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,4,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711284,DTCC00201400,1902622,16216
CHEMBL54697,P22894,,SESYXDSEOCRODR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1680259,DTCC00201436,193005,16216
CHEMBL54904,P22894,,GHHVNOZFZMDYFQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1688120,DTCC00200547,1163303,16216
CHEMBL54915,P22894,,PCQHVURJJBFBQG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1691936,DTCC00200608,711539,16216
CHEMBL54965,P22894,,HVHBPSLGXXXKOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,8,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1708468,DTCC00200812,969876,16216
CHEMBL54981,P22894,,YMYDSTVSNKTLJM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,17,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1681673,DTCC00200987,1293405,16216
CHEMBL550038,P22894,,FWPVXLYOKAOERT-SFHVURJKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19725580,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of human MMP8,,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,2009,52,17,"Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ, Abraham W, Williams C, Sypek J, Mansour TS",,579119,DTCT0024061,2894758,DTCC00589403,941987,34869
CHEMBL550081,P22894,,RPWGPXSVYLHGRZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,37,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859464,DTCC00590514,489960,34421
CHEMBL550148,P22894,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,7,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859463,DTCC00592085,1588878,34421
CHEMBL550148,P22894,,NKGRTRASISLCCZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,9,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452639,DTCC00592085,1612364,54626
CHEMBL550350,P22894,,DKTYDWAJILHINP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,1700,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859467,DTCC00592090,1653714,34421
CHEMBL550548,P22894,,UTCUOTDVVXFCLJ-AREMUKBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,63,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859474,DTCC00592094,327760,34421
CHEMBL550628,P22894,,FRFSAUPOCJTACG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,7600,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859470,DTCC00589012,1038878,34421
CHEMBL55107,P22894,,OPYOHFRGHGDNSJ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,35,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1716528,DTCC00201049,614603,16216
CHEMBL55110,P22894,,UGMRVUAZVAXFHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1693205,DTCC00201048,323389,16216
CHEMBL55110,P22894,,UGMRVUAZVAXFHK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,2.4,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1627930,DTCC00201048,336295,15919
CHEMBL55154,P22894,,HIWQTXDWQYKMGH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,9,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1686723,DTCC00200813,1805903,16216
CHEMBL55236,P22894,,UJKQHAYQMMMAEL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,45,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1699204,DTCC00201249,1227975,16216
CHEMBL55310,P22894,N-HYDROXY-BENZENESULFONAMIDE,BRMDATNYMUMZLN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,74000,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1626742,DTCC01740306,31107,15919
CHEMBL55321,P22894,,UOAOZROEXYBQHF-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,513789,DTCC00105203,1870285,15186
CHEMBL55371,P22894,,IXFMBXNLOHKCPT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,52000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629021,DTCC00200900,383980,56259
CHEMBL554269,P22894,,OBHHLEXVYGNCHI-INFYBVPRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19093877,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to MMP8 assessed as enzyme mediated cleavage of compound by measuring increase in fluorescence after 16 hrs by HPLC-MS,Not Active,Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.,J. Med. Chem.,2009,52,2,"Lo PC, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G",,495038,DTCT0024061,2594659,DTCC00582506,1049706,32091
CHEMBL55453,P22894,,XTRJAENNSAJIAU-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,529714,DTCC00204308,518083,15186
CHEMBL55521,P22894,,MOHDKNTXJIGORP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1698030,DTCC00200537,290900,16216
CHEMBL55522,P22894,,HGCCQMHYESJBML-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1715038,DTCC00200741,1741621,16216
CHEMBL55561,P22894,,RGDPJPMKLABBRX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,32,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1699219,DTCC00200776,1325928,16216
CHEMBL55744,P22894,,BITXXJKMASUYME-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,13,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1690791,DTCC00200914,1805906,16216
CHEMBL55752,P22894,,WVDBZKCLVKPIHE-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,535321,DTCC00204336,388749,15186
CHEMBL55907,P22894,,JVBPIOHSXSYBRG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,19,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711269,DTCC00201010,225329,16216
CHEMBL55984,P22894,,XCCIACQOXSWRJQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1.4,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1712511,DTCC00200742,937807,16216
CHEMBL56025,P22894,,ULPVLGUDYQAPPV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,3.3,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1707071,DTCC00201417,1488102,16216
CHEMBL56065,P22894,,NEUXHEKNAOUEQU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,12,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1698020,DTCC00200847,1681642,16216
CHEMBL560837,P22894,,LBKCSOUMADYGHM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,65,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859465,DTCC00122971,1717205,34421
CHEMBL56093,P22894,,YJKSIUVAMOZWEF-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,519935,DTCC00204315,1713494,15186
CHEMBL561036,P22894,,HZTQDRLCDGHQSA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,560,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859466,DTCC00122972,748051,34421
CHEMBL561038,P22894,,WVAIZSKMOMDPIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,66,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859469,DTCC00122975,910381,34421
CHEMBL561039,P22894,,KJDPTHLLJDQIMT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,140,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859472,DTCC00122976,715703,34421
CHEMBL56137,P22894,,PNICWAPKRSLYIU-BTYIYWSLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,536371,DTCC00204202,1228014,15186
CHEMBL56158,P22894,,LERSXUYNVGTZOT-XMMPIXPASA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,524924,DTCC00204686,1520456,15186
CHEMBL561625,P22894,,PZJJOMPTIHBGHO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,48,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859462,DTCC00587403,1492221,34421
CHEMBL561630,P22894,,JSQUVSOHRBZSNW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,110,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859473,DTCC00587413,489961,34421
CHEMBL56250,P22894,,CCOMNSWISYQLEX-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,8,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,524922,DTCC00204245,906035,15186
CHEMBL563026,P22894,,MRYXWLVKWYVRPC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,440,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859471,DTCC00584342,327759,34421
CHEMBL56320,P22894,,CAXAOIUOYPZXNV-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542034,DTCC00203867,2065193,15186
CHEMBL56321,P22894,,ALUHGPANWKZMAA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,538320,DTCC00203868,193054,15186
CHEMBL563679,P22894,,ZQBRASLBYJYZLM-CMDGGOBGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19606871,IC50,=,3600,NM,,,,,,,,,,,,,,Inhibition of MMP8,,"N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.",J. Med. Chem.,2009,52,15,"Nuti E, Casalini F, Avramova SI, Santamaria S, Cercignani G, Marinelli L, La Pietra V, Novellino E, Orlandini E, Nencetti S, Tuccinardi T, Martinelli A, Lim NH, Visse R, Nagase H, Rossello A",,571084,DTCT0024061,2859468,DTCC00587409,425709,34421
CHEMBL56443,P22894,,DOLJQSYCTYZCTL-BREAQWACSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,60,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,515715,DTCC00204352,937845,15186
CHEMBL56498,P22894,,CSPDSJARPZQPMQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,1,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1696768,DTCC00200743,1584624,16216
CHEMBL56527,P22894,,NYWZLYBVEDVMSN-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,600,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,533533,DTCC00204709,841093,15186
CHEMBL56621,P22894,,KVMNMFKBWZIOKY-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,516790,DTCC00204348,1552481,15186
CHEMBL567893,P22894,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19715320,ACTIVITY,=,70,%,,,,,,,,,,,,,,Inhibition of MMP8 assessed as residual activity at 10 uM after 10 to 15 mins by fluorescence assay relative to control,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600017,DTCT0024061,3096285,DTCC00604795,1039098,36236
CHEMBL567893,P22894,GRASSYSTATIN A,JZYWSTGTBRHGTL-BIXXXADNSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19715320,IC50,=,5000,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain after 10 to 15 mins by fluorescence assay,,"Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.",J. Med. Chem.,2009,52,18,"Kwan JC, Eksioglu EA, Liu C, Paul VJ, Luesch H",,600074,DTCT0024061,3096342,DTCC00604795,1039098,36236
CHEMBL56816,P22894,,LKFQHLGPHTXZAW-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,90,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,539155,DTCC00204771,647377,15186
CHEMBL56845,P22894,,UJACCCBUXXMATQ-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,533532,DTCC00204002,1838382,15186
CHEMBL56855,P22894,,RDHFQPOQGDBVBN-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,70,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,535319,DTCC00204468,1584665,15186
CHEMBL56867,P22894,,WYWULSIANADMTA-OAHLLOKOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,521998,DTCC00203985,550098,15186
CHEMBL56871,P22894,,PVTAZXXDKDMCRE-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,525944,DTCC00204004,582237,15186
CHEMBL56893,P22894,,BYJSIHNQXBCYBX-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,540088,DTCC00204638,161213,15186
CHEMBL56909,P22894,,OGWVESDVKZYNCK-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,513787,DTCC00204323,1034848,15186
CHEMBL56947,P22894,,GEFPLKDZRKGIKM-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,7000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,539154,DTCC00204447,96356,15186
CHEMBL56951,P22894,,PFPVZWIKTNGHGO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10794702,KI,=,21,NM,,,,,,,,,,,,,,Inhibitory activity against the Matrix Metalloprotease-8,,Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.,J. Med. Chem.,2000,43,9,"Scozzafava A, Supuran CT",,105807,DTCT0024061,1711279,DTCC00201024,1325930,16216
CHEMBL56965,P22894,,CWDNVRNHSFACNA-GMUIIQOCSA-M,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,541048,DTCC00204702,1423696,15186
CHEMBL56967,P22894,,BMKJAROLBFYRMM-SGTLLEGYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,532550,DTCC00204016,582238,15186
CHEMBL57044,P22894,,JROHDXNIWULULC-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,541046,DTCC00204215,323431,15186
CHEMBL572780,P22894,,ZCRWOWSOWBMWGI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,54,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044405,DTCC00597333,618949,35647
CHEMBL57316,P22894,,QESMDPOTHYLJHG-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,80,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,535320,DTCC00204448,290935,15186
CHEMBL573714,P22894,,ITWGWXCEGHFMHT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,280,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044430,DTCC00597369,1427807,35647
CHEMBL573715,P22894,,YOMXWXIANUYIMH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,5.1,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044392,DTCC00597370,1297783,35647
CHEMBL573934,P22894,,OREDIHYKGISTDR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,87,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044413,DTCC00597353,327896,35647
CHEMBL573935,P22894,,HGICQEUHJFERNR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,290,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044432,DTCC00597354,393223,35647
CHEMBL573936,P22894,,FIPYOKGRSDJCAR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,99,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044416,DTCC00597355,1427806,35647
CHEMBL574,P22894,P-TOLUENESULFONAMIDE,LMYRWZFENFIFIT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,9,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103201,DTCC00146038,508352,43205
CHEMBL57414,P22894,,OTJGAHJWYSLTDB-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,10,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,537320,DTCC00204402,1195902,15186
CHEMBL574370,P22894,,YYBFXMXFWMJGLB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,370,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044438,DTCC00597263,12430,35647
CHEMBL574589,P22894,,WQRJSSRVHCJAKB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044459,DTCC00597341,1071501,35647
CHEMBL574605,P22894,,CPUBMGYGVNFLPZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,390,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044440,DTCC00597298,327895,35647
CHEMBL57461,P22894,,GEPDPACRTHVSTD-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,537319,DTCC00204433,1552482,15186
CHEMBL57479,P22894,,HXTKAAOSFRMCEF-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,40,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,540086,DTCC00204515,1358792,15186
CHEMBL57518,P22894,,ICZVHRMXNBNXEY-RUZDIDTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,541045,DTCC00204216,1261049,15186
CHEMBL575881,P22894,,ABXUEPSHNXWTBZ-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,2000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044910,DTCC00597225,1653861,35647
CHEMBL575895,P22894,,QPFIKHZWPMXTRS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,72000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044527,DTCC00597330,1427805,35647
CHEMBL575896,P22894,,MYZHQACPXTZCJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,620,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044446,DTCC00597331,554423,35647
CHEMBL576762,P22894,,RPBGCJQDVJCGSK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,9200,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044503,DTCC00597340,1265255,35647
CHEMBL57725,P22894,,HRTBORRCNRXWRR-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,518841,DTCC00204860,1488147,15186
CHEMBL57725,P22894,,HRTBORRCNRXWRR-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1047274,DTCC00204860,1489535,15462
CHEMBL57746,P22894,,NKTGQIQCKMXEOS-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,7,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,534393,DTCC00204014,1520455,15186
CHEMBL57830,P22894,,RNMKXQYTQJNJRJ-HXUWFJFHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,524923,DTCC00204381,550096,15186
CHEMBL579067,P22894,,YMAXKJGQKQACFZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,1200,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044464,DTCC00597343,812562,35647
CHEMBL579068,P22894,,HSMGGAWDRKACFW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044476,DTCC00597380,1842555,35647
CHEMBL57982,P22894,,VOORVZQGMACJHE-OAQYLSRUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,200,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,515714,DTCC00204437,518084,15186
CHEMBL58371,P22894,,ZQJORJBIVFLYIE-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,523947,DTCC00204262,421542,15186
CHEMBL584122,P22894,,OAJUMLCSJOEUON-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,1900,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044475,DTCC00597332,715843,35647
CHEMBL584147,P22894,,XORCBTCEBZUVES-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,290,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044433,DTCC00597381,2037631,35647
CHEMBL584365,P22894,,DJZNIZCARKSSDE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,120,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044418,DTCC00597271,165336,35647
CHEMBL585376,P22894,,BZWDHUMJSSLVCR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,19775099,IC50,=,74000,NM,,,,,,,,,,,,,,Inhibition of para-aminophenylmercuric acetate-activated human pro-MMP8 after 4 hrs by fluorimetry,,"Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.",J. Med. Chem.,2009,52,20,"Nuti E, Panelli L, Casalini F, Avramova SI, Orlandini E, Santamaria S, Nencetti S, Tuccinardi T, Martinelli A, Cercignani G, D'Amelio N, Maiocchi A, Uggeri F, Rossello A",,591600,DTCT0024061,3044529,DTCC00597342,100632,35647
CHEMBL58708,P22894,,HPJZLIJTRCEDRH-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,300,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,533529,DTCC00204264,225373,15186
CHEMBL58829,P22894,,DHXMAFQQCCOWGL-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,517802,DTCC00203977,775953,15186
CHEMBL58932,P22894,,FNUQESAUEFWUCJ-HSZRJFAPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,542038,DTCC00204712,1584667,15186
CHEMBL58933,P22894,,YOFBHXUFTFPQDW-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,500,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,534391,DTCC00203870,1100024,15186
CHEMBL59023,P22894,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,<,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,512531,DTCC00208380,452901,13104
CHEMBL59023,P22894,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102111,DTCT0024061,597368,DTCC00208380,465465,1496
CHEMBL59023,P22894,,RRLGEVWMENCJGJ-IRLDBZIGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,850838,DTCC00208380,465491,1497
CHEMBL59365,P22894,,YXXPZIJDDIJKDH-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,90,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,514770,DTCC00204317,356162,15186
CHEMBL59527,P22894,,IKSAVMPIZWWMKE-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,800,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,521999,DTCC00204199,1488149,15186
CHEMBL59534,P22894,,BAAHKTZFKMCWLC-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,517801,DTCC00204400,775952,15186
CHEMBL59539,P22894,,MSWCSYXARJOPRA-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,100,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,526814,DTCC00203983,421544,15186
CHEMBL603656,P22894,,KOTGODCEORJYIF-QAQDUYKDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20005097,KI,>,25000,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.,Bioorg. Med. Chem. Lett.,2010,20,2,"Schnute ME, O'Brien PM, Nahra J, Morris M, Howard Roark W, Hanau CE, Ruminski PG, Scholten JA, Fletcher TR, Hamper BC, Carroll JN, Patt WC, Shieh HS, Collins B, Pavlovsky AG, Palmquist KE, Aston KW, Hitchcock J, Rogers MD, McDonald J, Johnson AR, Munie GE, Wittwer AJ, Man CF, Settle SL, Nemirovskiy O, Vickery LE, Agawal A, Dyer RD, Sunyer T",,605232,DTCT0024061,3176043,DTCC00610540,534004,36915
CHEMBL60579,P22894,,PBJWRLBRUGJQMR-LJQANCHMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,533531,DTCC00204445,518082,15186
CHEMBL60624,P22894,,PPELJLBDXLMTEW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,521996,DTCC00204355,1934708,15186
CHEMBL60624,P22894,,PPELJLBDXLMTEW-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579815,IC50,=,4,NM,,,,,,,,,,,,,,"Inhibitory concentration against human matrix metalloprotease-8 (human neutrophil collagenase, MMP-8)",,Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins.,J. Med. Chem.,1999,42,22,"Matter H, Schwab W",,105071,DTCT0024061,1044761,DTCC00204355,1936007,15462
CHEMBL60688,P22894,,SDOLDYMSRUFDDY-MRXNPFEDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10354399,IC50,=,2000,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase [Matrix Metalloprotease-8, MMP-8]",,Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.,J. Med. Chem.,1999,42,11,"Matter H, Schwab W, Barbier D, Billen G, Haase B, Neises B, Schudok M, Thorwart W, Schreuder H, Brachvogel V, Lönze P, Weithmann KU",,105812,DTCT0024061,513788,DTCC00204514,1423697,15186
CHEMBL6572,P22894,,QPEZTCMCOIDQRV-SMDDNHRTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,,,,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (not determined),Not Determined,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105072,DTCT0024061,1316353,DTCC00133465,34547,4760
CHEMBL68049,P22894,,ZRSUANFPMBWMDZ-YKSBVNFPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,77,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1399735,DTCC00224780,1661211,14854
CHEMBL68149,P22894,,IWLYSDNBOSWMRQ-JWQCQUIFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,4.5,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1398506,DTCC00224685,1817827,14854
CHEMBL68890,P22894,,NDJSPXLINRRDIS-DYVFJYSZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.3,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1387371,DTCC00224920,2012678,14854
CHEMBL69024,P22894,,BCORPMHFJPQWGD-WOJBJXKFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.96,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1385047,DTCC00224864,302885,14854
CHEMBL69072,P22894,,MXPPQWXYSRGIMR-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,17,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1383736,DTCC00224774,2012677,14854
CHEMBL69506,P22894,,UIHJPRDGPQZWAH-WOJBJXKFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.63,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1402226,DTCC00225596,1661212,14854
CHEMBL6973,P22894,,DRWHINQPSIPRHF-LLVKDONJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,47.3,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1301010,DTCC00133507,110647,4760
CHEMBL70049,P22894,,VWIDRIAWTQJPLN-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,8.5,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1393594,DTCC00225610,1435144,14854
CHEMBL70110,P22894,,LCWFIBYPSAWVLI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,29,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102669,DTCC00224425,1349087,43205
CHEMBL70315,P22894,,KXYFKTLZKSANJT-SJLPKXTDSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1381110,DTCC00226033,29662,14854
CHEMBL70354,P22894,,CVRRBTAXFZBMPH-KAYWLYCHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,6.8,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1380993,DTCC00225598,1914295,14854
CHEMBL70398,P22894,,OKGPERFMUXABQD-UTUOFQBUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.53,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1386227,DTCC00225984,1403135,14854
CHEMBL70406,P22894,,OUMHWPMKRPJGKY-XDAJTCOGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,13,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1382342,DTCC00224975,1693318,14854
CHEMBL70417,P22894,,BOHIPQBVCFMFFK-GCJKJVERSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.11,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1382338,DTCC00225271,433223,14854
CHEMBL70426,P22894,,SBOCVCYAEHVMEA-UZLBHIALSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,6.9,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368300,DTCC00225464,1564220,14854
CHEMBL70430,P22894,,UMZQUWRHZNAVMN-ILBGXUMGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.3,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1365749,DTCC00225049,1596640,14854
CHEMBL70492,P22894,,FYGGOGPIPBSHEF-IEBWSBKVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.64,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1393598,DTCC00224896,335444,14854
CHEMBL70570,P22894,,CJQLPOBRKZCBHK-VXGBXAGGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.65,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368417,DTCC00225946,335443,14854
CHEMBL70571,P22894,,JHRIMEDFWCLALJ-PVAVHDDUSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.41,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1395989,DTCC00225947,204694,14854
CHEMBL70639,P22894,,UHJDYMMCTFTTSW-JKSUJKDBSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,12,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1388629,DTCC00225490,1111858,14854
CHEMBL70953,P22894,,UKNOMEZXDWRZAF-GSMMQLOJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,73,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1372217,DTCC00225487,1079125,14854
CHEMBL70965,P22894,,FNRRTPCWYWKARV-VGSWGCGISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.43,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1372221,DTCC00225239,140536,14854
CHEMBL71014,P22894,,XQEHCUFTCDJVSN-ZWKOTPCHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,7.8,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1383744,DTCC00225460,820108,14854
CHEMBL71071,P22894,,QUSCQVGYLGWIJY-NRYAXDJKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.75,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1379725,DTCC00225563,1079124,14854
CHEMBL7108,P22894,,VAQNHYAKIUNIKM-CYBMUJFWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1286295,DTCC00133441,1209922,4760
CHEMBL71468,P22894,,GPKYERMOQBHGRC-KDOFPFPSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,21,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368312,DTCC00224782,1046648,14854
CHEMBL71482,P22894,,YSZLQAVPFNEECF-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.24,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1402229,DTCC00225535,1014237,14854
CHEMBL71618,P22894,,USFNQSYWKLKGHX-RTBURBONSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1.3,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1380998,DTCC00224917,787755,14854
CHEMBL71630,P22894,,DEDGVHPWRWYTIC-IXCJQBJRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,13,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368308,DTCC00224922,981927,14854
CHEMBL71713,P22894,,OFIZOTOQCJTVRO-UTKZUKDTSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,6.5,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1391193,DTCC00225339,1753206,14854
CHEMBL71800,P22894,,LWHRQCDZIRQSAN-KAYWLYCHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,3.6,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1386180,DTCC00225114,75834,14854
CHEMBL71801,P22894,,NITYDPDXAAFEIT-GUYCJALGSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,54,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1392422,DTCC00225088,949541,14854
CHEMBL71995,P22894,,VXXBOZLJRUCYLE-BEFAXECRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.56,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1390046,DTCC00225710,1946874,14854
CHEMBL72337,P22894,,PJVJLPSYNZOOCE-JWQCQUIFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,7.7,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1368304,DTCC00225298,302884,14854
CHEMBL72457,P22894,,XIYFEESCIBNMIC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,31,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103353,DTCC00224003,1185922,43205
CHEMBL72628,P22894,2-PICOLINIC ACID,SIOXPEMLGUPBBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,30,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102608,DTCC00227813,1251244,43205
CHEMBL72678,P22894,,UTMWGWRRRXPAQY-PBHICJAKSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.66,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1403422,DTCC00224830,1661210,14854
CHEMBL72743,P22894,,QZRDSGNFNCBFPU-HXOBKFHXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,5.2,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1395892,DTCC00225158,1564219,14854
CHEMBL72788,P22894,,GNHMOHGVWISYSN-IERDGZPVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.49,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1390042,DTCC00225656,755585,14854
CHEMBL73173,P22894,2-CARBOXYPYRIDINE 1-OXIDE,FHYMLBVGNFVFBT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,21,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5102619,DTCC01740992,1510695,43205
CHEMBL734,P22894,ACETOHYDROXAMIC ACID,RRUDCFGSUDOHDG-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,5,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5104054,DTCC00163357,637574,43205
CHEMBL7390,P22894,,SUSMVCKSLVPRCL-QGZVFWFLSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1310679,DTCC00133540,693701,4760
CHEMBL74175,P22894,,LICFKTFLYQYXDH-ZIAGYGMSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,1.7,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1385035,DTCC00225651,1499819,14854
CHEMBL74182,P22894,,FFEXFXFAIZBMGO-BWKNWUBXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,9457244,KI,=,0.94,NM,,,,,,,,,,,,,,The compound was tested for its binding affinity towards neutrophil collagenase (Matrix metalloprotease-8),,Matrix metalloproteinase inhibitors: a structure-activity study.,J. Med. Chem.,1998,41,2,"Levy DE, Lapierre F, Liang W, Ye W, Lange CW, Li X, Grobelny D, Casabonne M, Tyrrell D, Holme K, Nadzan A, Galardy RE",,105205,DTCT0024061,1390038,DTCC00225310,1240177,14854
CHEMBL75094,P22894,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10579818,IC50,<,0.4,NM,,,,,,,,,,,,,,Inhibition of neutrophil collagenase (Matrix metalloprotease-8),,"Design, synthesis, and biological evaluation of potent thiazine- and thiazepine-based matrix metalloproteinase inhibitors.",J. Med. Chem.,1999,42,22,"Almstead NG, Bradley RS, Pikul S, De B, Natchus MG, Taiwo YO, Gu F, Williams LE, Hynd BA, Janusz MJ, Dunaway CM, Mieling GE",,105065,DTCT0024061,1369140,DTCC00231104,336627,15412
CHEMBL75094,P22894,PRINOMASTAT,YKPYIPVDTNNYCN-INIZCTEOSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11754593,IC50,=,0.54,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8 (MMP-8) in fluorimetric assay,,"Phenoxyphenyl sulfone N-formylhydroxylamines (retrohydroxamates) as potent, selective, orally bioavailable matrix metalloproteinase inhibitors.",J. Med. Chem.,2002,45,1,"Wada CK, Holms JH, Curtin ML, Dai Y, Florjancic AS, Garland RB, Guo Y, Heyman HR, Stacey JR, Steinman DH, Albert DH, Bouska JJ, Elmore IN, Goodfellow CL, Marcotte PA, Tapang P, Morgan DW, Michaelides MR, Davidsen SK",,105209,DTCT0024061,1565055,DTCC00231104,323739,16699
CHEMBL77163,P22894,,VAQVSMUJBPTVIS-ZBAATNBSSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824028,IC50,=,0.56,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,105210,DTCT0024061,1491832,DTCC00232704,1403218,5648
CHEMBL7756,P22894,,HTNLSTWGHBHDPS-CQSZACIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11327577,IC50,=,3.7,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,Heterocycle-based MMP inhibitors with P2' substituents.,Bioorg. Med. Chem. Lett.,2001,11,8,"Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE",,105070,DTCT0024061,1292488,DTCC00133590,207299,4760
CHEMBL77995,P22894,,WFQFQAQNCYHBTC-FUJFQHJFSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824028,IC50,=,2.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,105210,DTCT0024061,1497637,DTCC00232836,820189,5648
CHEMBL78233,P22894,,ROFAQOFULLWONA-FOIFJWKZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824028,IC50,=,12,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.,Bioorg. Med. Chem. Lett.,2003,13,14,"Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD",,105210,DTCT0024061,1501943,DTCC00232527,335546,5648
CHEMBL79267,P22894,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,5.3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1322795,DTCC00242002,1163761,16328
CHEMBL79267,P22894,,UYFGGWJRPCRSHW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,5.25,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258668,DTCC00242002,1166448,24803
CHEMBL79433,P22894,,IMKDKHQDFFLOKK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12773042,IC50,=,1,NM,,,,,,,,,,,,,,Inhibition of Matrix metalloprotease-8,,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,2003,46,12,"Aranapakam V, Davis JM, Grosu GT, Baker J, Ellingboe J, Zask A, Levin JI, Sandanayaka VP, Du M, Skotnicki JS, DiJoseph JF, Sung A, Sharr MA, Killar LM, Walter T, Jin G, Cowling R, Tillett J, Zhao W, McDevitt J, Xu ZB",,105207,DTCT0024061,494321,DTCC00235743,75938,17340
CHEMBL79857,P22894,,VEYIMQVTPXPUHA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,43,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103290,DTCC00238936,701896,43205
CHEMBL79906,P22894,,QPSBVVFMTSFAJY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,30.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1313204,DTCC00242125,1903109,16328
CHEMBL80486,P22894,,XHLWYEWXYHRDQW-JOCHJYFZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,12824039,KI,=,6,NM,,,,,,,,,,,,,,Inhibition of MMP-8,,Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.,Bioorg. Med. Chem. Lett.,2003,13,14,"Robinson LA, Wilson DM, Delaet NG, Bradley EK, Dankwardt SM, Campbell JA, Martin RL, Van Wart HE, Walker KA, Sullivan RW",,105213,DTCT0024061,735767,DTCC00235673,1753301,5658
CHEMBL81398,P22894,,SNUSZUYTMHKCPM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,42,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103801,DTCC00239383,927980,43205
CHEMBL82113,P22894,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,25.8,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1290352,DTCC00242452,1773868,16328
CHEMBL82113,P22894,,PYGZWPVJQNBFNS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,25.7,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258663,DTCC00242452,1776497,24803
CHEMBL82169,P22894,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1298767,DTCC00241974,550551,16328
CHEMBL82169,P22894,,LFOGEPKUSWRLCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,1.2,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258671,DTCC00241974,553253,24803
CHEMBL82597,P22894,,YHUAHVPZGNXPMS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,34,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103085,DTCC00238679,1892887,43205
CHEMBL82868,P22894,,QCLOBJCDRHHNCL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,31,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1613742,DTCC00243186,950353,15919
CHEMBL83282,P22894,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,3,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1292789,DTCC00242039,1585074,16328
CHEMBL83282,P22894,,ICFOTHUAZLHTNP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.02,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258667,DTCC00242039,1587772,24803
CHEMBL83368,P22894,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,1.5,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1287855,DTCC00242344,323868,16328
CHEMBL83368,P22894,,HGCZRPPCNXJXAB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,1.51,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258672,DTCC00242344,326645,24803
CHEMBL83508,P22894,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,=,155,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1612431,DTCC00243572,238020,15919
CHEMBL83508,P22894,,WLZISXXOYYGJNT-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,59,NM,,,,,,,,,,,,,,Inhibition of MMP8 (unknown origin)-mediated Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 by fluorimetric assay,,,ACS Med. Chem. Lett.,2013,4,6,,,960930,DTCT0024061,12452644,DTCC00243572,252699,54626
CHEMBL83616,P22894,,JXAGDPXECXQWBC-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,303,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1310936,DTCC00242500,1773869,16328
CHEMBL83955,P22894,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,2.7,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1316684,DTCC00242203,1067615,16328
CHEMBL83955,P22894,,ILTCMGUVAAYHSE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,2.69,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258673,DTCC00242203,1070280,24803
CHEMBL85026,P22894,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,294,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1286652,DTCC00242319,421955,16328
CHEMBL85026,P22894,,IRVGVLJCCVMVAY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,295.12,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258662,DTCC00242319,424709,24803
CHEMBL85030,P22894,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22540974,KI,=,23,NM,,,,,,,,,,,,,,"Inhibition of MMP8 using (7-methoxycoumarin-4-yl)acetyl-Pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured for 10 mins by fluorometry",,A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.,J. Med. Chem.,2012,55,10,"Hugenberg V, Breyholz HJ, Riemann B, Hermann S, Schober O, Schäfers M, Gangadharmath U, Mocharla V, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,832926,DTCT0024061,10563923,DTCC01741458,543755,48958
CHEMBL85030,P22894,CGS-25966,ZGSTVUAZFACDLH-GOSISDBHSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,23899323,KI,=,23,NM,,,,,,,,,,,,,,Inhibition of MMP-8 (unknown origin),,"Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.",J. Med. Chem.,2013,56,17,"Hugenberg V, Riemann B, Hermann S, Schober O, Schäfers M, Szardenings K, Lebedev A, Gangadharmath U, Kolb H, Walsh J, Zhang W, Kopka K, Wagner S",,983457,DTCT0024061,12575117,DTCC01741458,525519,55760
CHEMBL85374,P22894,,BLYHHTXBRXLLOI-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472202,IC50,=,3.2,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-8,,Potent and selective carboxylic acid-based inhibitors of matrix metalloproteinases.,J. Med. Chem.,2001,44,16,"Pikul S, Ohler NE, Ciszewski G, Laufersweiler MC, Almstead NG, De B, Natchus MG, Hsieh LC, Janusz MJ, Peng SX, Branch TM, King SL, Taiwo YO, Mieling GE",,105068,DTCT0024061,1320329,DTCC00242381,1455978,16328
CHEMBL85744,P22894,,ZGTPJERIIBYCFG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,40,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1093447,DTCC00248613,1002961,15258
CHEMBL85766,P22894,,JNFMXXAZBVSNRC-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,479951,DTCC00247454,1649994,13104
CHEMBL85766,P22894,,JNFMXXAZBVSNRC-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,605659,DTCC00247454,1661897,1496
CHEMBL85806,P22894,,QSONFBZTWRVCKO-PKTZIBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,476408,DTCC00247106,615125,13104
CHEMBL85933,P22894,,NBDGYUOAVSOSOD-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,270,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,499028,DTCC00247467,1067665,13104
CHEMBL85933,P22894,,NBDGYUOAVSOSOD-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,270,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,604512,DTCC00247467,1079879,1496
CHEMBL86390,P22894,,HCCYYUWFQWPMDZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,20,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1072665,DTCC00248612,452924,15258
CHEMBL86468,P22894,,URNQLXVLIBILTE-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,7,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,478835,DTCC00247430,291411,13104
CHEMBL86468,P22894,,URNQLXVLIBILTE-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,7,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,612501,DTCC00247430,303581,1496
CHEMBL86797,P22894,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,32,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,477607,DTCC00247429,422017,13104
CHEMBL86797,P22894,,WSGLDBYEABEDRD-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,32,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,357851,DTCC00247429,433910,1496
CHEMBL87046,P22894,,HCELOWJRPJWTPO-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,4,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,489187,DTCC00247443,874091,13104
CHEMBL87046,P22894,,HCELOWJRPJWTPO-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,4,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102112,DTCT0024061,604509,DTCC00247443,886020,1496
CHEMBL87159,P22894,,SFORRVNMTYAPLQ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,2.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1065675,DTCC00248280,291448,15258
CHEMBL87229,P22894,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,7629797,KI,=,2,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase (HNC), MMP-8",,Inhibition of matrix metalloproteinases by hydroxamates containing heteroatom-based modifications of the P1' group.,J. Med. Chem.,1995,38,14,"Gowravaram MR, Tomczuk BE, Johnson JS, Delecki D, Cook ER, Ghose AK, Mathiowetz AM, Spurlino JC, Rubin B, Smith DL",,49517,DTCT0024061,477610,DTCC00247084,582733,13104
CHEMBL87229,P22894,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,<,2,NM,,,,,,,,,,,,,,Inhibition of human Matrix metalloprotease-8,,,Bioorg. Med. Chem. Lett.,1995,5,4,,,105200,DTCT0024061,819549,DTCC00247084,594918,1497
CHEMBL87229,P22894,,IYJLBIPCLHKYKU-YADHBBJMSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,KI,=,20,NM,,,,,,,,,,,,,,"Inhibition of human neutrophil collagenase, matrix metalloprotease-8",,,Bioorg. Med. Chem. Lett.,1995,5,4,,,102111,DTCT0024061,593830,DTCC00247084,594887,1496
CHEMBL87300,P22894,,BVONHINTCXADCU-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,4.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1056176,DTCC00248279,291447,15258
CHEMBL87786,P22894,,UERCGTJUVRFNRO-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,25,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1084532,DTCC00248815,1456037,15258
CHEMBL88187,P22894,,BVNHOVTUHKATJL-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,34,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1082202,DTCC00249128,323966,15258
CHEMBL88188,P22894,,LWTYDGJEOHWGQD-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,7,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1092152,DTCC00249129,582755,15258
CHEMBL88520,P22894,,HFAGTNGCAZYYLZ-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472217,KI,=,0.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105196,DTCT0024061,1674083,DTCC00251150,291473,16346
CHEMBL88972,P22894,"PYRIDINE-2,5-DICARBOXYLIC ACID",LVPMIMZXDYBCDF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,-1,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103761,DTCC00250420,2087684,43205
CHEMBL89057,P22894,,RIOJMNDNYHZZFM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,=,5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1082210,DTCC00249245,1838879,15258
CHEMBL8943,P22894,,VXDKQRWTOJFQKH-BJZITVGISA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11585439,KI,=,8600,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design and synthesis of a series of (2R)-N(4)-hydroxy-2-(3-hydroxybenzyl)-N(1)- [(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide derivatives as potent, selective, and orally bioavailable aggrecanase inhibitors.",J. Med. Chem.,2001,44,21,"Yao W, Wasserman ZR, Chao M, Reddy G, Shi E, Liu RQ, Covington MB, Arner EC, Pratta MA, Tortorella M, Magolda RL, Newton R, Qian M, Ribadeneira MD, Christ D, Wexler RR, Decicco CP",,105198,DTCT0024061,1409055,DTCC00135827,1468155,16438
CHEMBL90622,P22894,,RZDDQWJXBRPPTM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10411481,KI,<,0.5,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.,J. Med. Chem.,1999,42,14,"Vassiliou S, Mucha A, Cuniasse P, Georgiadis D, Lucet-Levannier K, Beau F, Kannan R, Murphy G, Knäuper V, Rio MC, Basset P, Yiotakis A, Dive V",,105814,DTCT0024061,1091003,DTCC00249364,1742142,15258
CHEMBL91636,P22894,,DONMTDNLNMLOIC-OTWHNJEPSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11472217,KI,=,1.1,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-8,,"Design, synthesis, and structure-activity relationships of macrocyclic hydroxamic acids that inhibit tumor necrosis factor alpha release in vitro and in vivo.",J. Med. Chem.,2001,44,16,"Xue CB, Voss ME, Nelson DJ, Duan JJ, Cherney RJ, Jacobson IC, He X, Roderick J, Chen L, Corbett RL, Wang L, Meyer DT, Kennedy K, DeGradodagger WF, Hardman KD, Teleha CA, Jaffee BD, Liu RQ, Copeland RA, Covington MB, Christ DD, Trzaskos JM, Newton RC, Magolda RL, Wexler RR, Decicco CP",,105196,DTCT0024061,1647510,DTCC00251443,1261581,16346
CHEMBL924,P22894,ZOLEDRONIC ACID,XRASPMIURGNCCH-UHFFFAOYSA-N,4,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,24071448,IC50,=,17600,NM,,,,,,,,,,,,,,Inhibition of MMP8 catalytic domain (unknown origin) using Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2 as substrate incubated for 30 mins prior to substrate addition measured after 2 to 4 hrs by fluorometric assay,,Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,Bioorg. Med. Chem.,2013,21,21,"Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P",,990169,DTCT0024061,12629948,DTCC00200651,1095364,56259
CHEMBL92512,P22894,,RSWUWSKXIDLCIR-ULQDDVLXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,3,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1311590,DTCC00257798,518678,2323
CHEMBL92835,P22894,,SJEBBPDOLJCLQH-OJSMNCEXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1306829,DTCC00258294,1196484,2323
CHEMBL92970,P22894,,RSWUWSKXIDLCIR-YESZJQIVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,30,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1295706,DTCC00257891,356750,2323
CHEMBL93155,P22894,,DCCBWHQCASKYJR-NTZARQNWSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,25,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1300778,DTCC00258060,1163956,2323
CHEMBL93320,P22894,,CXNJLMYOAJTOHP-ADUPEVMXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,14,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1318618,DTCC00257892,1163955,2323
CHEMBL93357,P22894,,FYYNAVTYOZPHTC-JWDFLIAJSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,125,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1287265,DTCC00258033,2065748,2323
CHEMBL94256,P22894,,DKPAZQOKVRHHON-ADUPEVMXSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,19,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1322237,DTCC00257864,1035462,2323
CHEMBL94346,P22894,(PROPYLAMINO)CARBONYLPHOSPHONIC ACID,KMYNAIWKMORGAF-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1288012,DTCC00260739,1850377,17838
CHEMBL94348,P22894,(ETHYLAMINO)CARBONYLPHOSPHONIC ACID,IZWWUWVUAGTWGV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1319229,DTCC00260740,949944,17838
CHEMBL95068,P22894,PIPERIDIN-1-YLCARBONYLPHOSPHONIC ACID,LPCNDTNDDXIPDM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1290506,DTCC01741836,820511,17838
CHEMBL95483,P22894,,DYYRCQAVWNBEBP-MNOVXSKESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,1000,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1457844,DTCC00264377,917407,3373
CHEMBL95614,P22894,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,40,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1451871,DTCC00264573,205149,3373
CHEMBL95614,P22894,,QHRUJPVXLYJUEM-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,39.81,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258614,DTCC00264573,196120,24803
CHEMBL95763,P22894,(CYCLOBUTYLAMINO)CARBONYLPHOSPHONIC ACID,UILNVWQPBYOCJX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,40,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1286795,DTCC00261232,788164,17838
CHEMBL96438,P22894,(DIBUTYLAMINO)CARBONYLPHOSPHONIC ACID,NEQAQLUTBGWNLE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,90000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1307519,DTCC00261385,465117,17838
CHEMBL96473,P22894,,LTRFXCQZLSSSPG-UBFHEZILSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,,IC50,=,15,NM,,,,,,,,,,,,,,"Inhibition of matrix metalloprotease-8, MMP-8",,,Bioorg. Med. Chem. Lett.,1997,7,21,,,102109,DTCT0024061,1298177,DTCC00257913,129156,2323
CHEMBL97034,P22894,(ISOPROPYLAMINO)CARBONYLPHOSPHONIC ACID,ZBIIKTYRXGHZSP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,50000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1307511,DTCC00261507,335874,17838
CHEMBL97057,P22894,(DIETHYLAMINO)CARBONYLPHOSPHONIC ACID,DCJBWQGCBUBISK-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,70000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1296412,DTCC00261591,1240575,17838
CHEMBL97382,P22894,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1448190,DTCC00264485,433638,3373
CHEMBL97382,P22894,,ZNTBEHZFMMNDRG-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258625,DTCC00264485,424706,24803
CHEMBL97388,P22894,(METHYLAMINO)CARBONYLPHOSPHONIC ACID,DKRGQDKOWKPDBY-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,20000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1314464,DTCC00261329,659364,17838
CHEMBL97389,P22894,SODIUM HYDROGEN (BUTYLAMINO)CARBONYLPHOSPHONATE,XZWWCSRZYGUJCH-UHFFFAOYSA-M,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1318100,DTCC00261330,368532,17838
CHEMBL97510,P22894,(SEC-BUTYLAMINO)CARBONYLPHOSPHONIC ACID,FRMUISNHCCQMGM-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1305207,DTCC01741841,1273346,17838
CHEMBL97614,P22894,(CYCLOHEPTYLAMINO)CARBONYLPHOSPHONIC ACID,PZCAQCXIXVTXSS-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,>,100000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1313342,DTCC00261524,1753576,17838
CHEMBL97709,P22894,(CYCLOOCTYLAMINO)CARBONYLPHOSPHONIC ACID,RDECIIJACWTCQB-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,4000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1309956,DTCC00261479,917368,17838
CHEMBL97838,P22894,MORPHOLIN-4-YLCARBONYLPHOSPHONIC ACID,XUDXDIFMUCLQQH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,30000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1313351,DTCC01741839,1564617,17838
CHEMBL97936,P22894,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,4,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1457849,DTCC00264930,401357,3373
CHEMBL97936,P22894,,FCGVXISUYVDDPU-RPWUZVMVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,3.98,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258617,DTCC00264930,391949,24803
CHEMBL97951,P22894,CYCLOHEXYLMETHYLCARBAMOYLPHOSPHONIC ACID,XBMRQHZMWARLEG-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,15139760,IC50,=,80000,NM,,,,,,,,,,,,,,In vitro inhibitory activity against recombinant matrix metalloprotease-8 was determined,,"Carbamoylphosphonates, a new class of in vivo active matrix metalloproteinase inhibitors. 1. Alkyl- and cycloalkylcarbamoylphosphonic acids.",J. Med. Chem.,2004,47,11,"Breuer E, Salomon CJ, Katz Y, Chen W, Lu S, Röschenthaler GV, Hadar R, Reich R",,105208,DTCT0024061,1320469,DTCC00106572,1273345,17838
CHEMBL98017,P22894,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,20,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1451876,DTCC00264988,2013090,3373
CHEMBL98017,P22894,,OEPLGUBYTRYCJX-CABCVRRESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,19.95,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258608,DTCC00264988,2003620,24803
CHEMBL98044,P22894,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1474977,DTCC00264954,76259,3373
CHEMBL98044,P22894,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,199.53,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258621,DTCC00264954,67153,24803
CHEMBL98044,P22894,,MVRHXCGLUWVMKH-CVEARBPZSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,18790648,IC50,=,200,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.,Bioorg. Med. Chem.,2008,16,19,"Georgiadis D, Yiotakis A",,497405,DTCT0024061,2457480,DTCC00264954,79308,32556
CHEMBL98328,P22894,N-HYDROXY-METHANESULFONAMIDE,YKSVNSKYIUPAKW-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,11020282,KI,>,100,NM,,,,,,,,,,,,,,Inhibitory activity against Matrix metalloprotease-8,,"Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.",J. Med. Chem.,2000,43,20,"Scozzafava A, Supuran CT",,105195,DTCT0024061,1622873,DTCC01741913,1014996,15919
CHEMBL98917,P22894,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1472418,DTCC00264408,755981,3373
CHEMBL98917,P22894,,OVICMAJBKGLSNC-KGLIPLIRSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,100,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258606,DTCC00264408,746928,24803
CHEMBL99148,P22894,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1450626,DTCC00264513,788198,3373
CHEMBL99148,P22894,,ZVAKMIZOMSWYGQ-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258620,DTCC00264513,778988,24803
CHEMBL99189,P22894,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1466342,DTCC00265032,1532650,3373
CHEMBL99189,P22894,,YLYMDJMYRSEUOA-SJORKVTESA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,10,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258610,DTCC00265032,1523430,24803
CHEMBL99932,P22894,8-AMINOQUINOLINE,WREVVZMUNPAPOV-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21189019,INHIBITION,=,61,%,,,,,,,,,,,,,,Inhibition of human recombinant MMP8 at 1 mM after 30 mins,,Identifying chelators for metalloprotein inhibitors using a fragment-based approach.,J. Med. Chem.,2011,54,2,"Jacobsen JA, Fullagar JL, Miller MT, Cohen SM",,715233,DTCT0024061,5103888,DTCC00265364,540480,43205
CHEMBL99981,P22894,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,10522712,IC50,=,9,NM,,,,,,,,,,,,,,Inhibition of HNC MMP-8,,The synthesis and biological evaluation of non-peptidic matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,1999,9,19,"Martin FM, Beckett RP, Bellamy CL, Courtney PF, Davies SJ, Drummond AH, Dodd R, Pratt LM, Patel SR, Ricketts ML, Todd RS, Tuffnell AR, Ward JW, Whittaker M",,102108,DTCT0024061,1456613,DTCC00265035,173185,3373
CHEMBL99981,P22894,,ZBTKKYFIZQHNDQ-MSOLQXFVSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,17275314,IC50,=,8.91,NM,,,,,,,,,,,,,,Inhibition of MMP8,,Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs.,Bioorg. Med. Chem.,2007,15,6,"Verma RP, Hansch C",,458937,DTCT0024061,2258612,DTCC00265035,164159,24803
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,2.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14754610,DTCC01744004,2108945,69259
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,3.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14745306,DTCC01744004,2108945,69259
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16899369,IC50,=,513000,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14708326,DTCC01744004,2096656,67898
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,20817735,KI,=,271,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14753301,DTCC01744004,2110394,69686
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21827363,IC50,=,650,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14710282,DTCC01744004,2096753,67989
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21827363,IC50,=,730,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14709361,DTCC01744004,2096753,67989
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21827363,IC50,=,800,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14723986,DTCC01744004,2096753,67989
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21827363,IC50,=,900,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14723760,DTCC01744004,2096753,67989
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,21827363,IC50,=,2300,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14723764,DTCC01744004,2096753,67989
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,IC50,=,37,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14725225,DTCC01744004,2098141,68703
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,5.3,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14745582,DTCC01744004,2098141,68703
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,100,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14753300,DTCC01744004,2098141,68703
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,205,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14751481,DTCC01744004,2098141,68703
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,338,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14749096,DTCC01744004,2098141,68703
,P22894,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,22689580,KI,=,671,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14746895,DTCC01744004,2098141,68703
,P22894,AGN-PC-00AW7I,ZBOSPOSQGJWURE-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,0.7,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14746238,DTCC01746086,2109118,69259
,P22894,AGN-PC-00B1B8,QVHYJMPAZNGFHN-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,9.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14753706,DTCC01745743,2103471,69259
,P22894,AGN-PC-00B1IZ,BEQXRWLSEUIFKP-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14747800,DTCC01746160,2109488,69259
,P22894,AGN-PC-00BMEK,QYCUMAKSYBUWER-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,0.85,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14753766,DTCC01746699,2110472,69259
,P22894,AGN-PC-00COJ9,WDPVPUZANMBBLA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,0.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14732731,DTCC01745926,2104739,69259
,P22894,AGN-PC-00D2VZ,NKHJMAWHLPBSOA-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,11.4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14752276,DTCC01746561,2110229,69259
,P22894,AGN-PC-00ERPQ,YLRBOIVJMWEGGX-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,12.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14745119,DTCC01745987,2108904,69259
,P22894,ALPHA-SULFONE 27B,LFIZWBFUWVSLOR-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,3.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14755210,DTCC01746809,2110669,69259
,P22894,ALPHA-SULFONE 35G,KLWUGXOQJJWEBZ-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14754584,DTCC01746770,2110582,69259
,P22894,ALPHA-SULFONE 35H,XJMDDZUUIUEEJH-UHFFFAOYSA-N,0,MATRIX METALLOPROTEINASE 8,MMP8,Enzyme,,,16220987,KI,=,4,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0024061,14746921,DTCC01746132,2109290,69259
